Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

A NE
novel NE
mitogen NE
-inducible NE
gene NE
product NE
related NE
to NE
p50/p105-NF-kappa NE
B NE
participates NE
in NE
transactivation NE
through NE
a NE
kappa NE
B NE
site NE
. NE

A NE
Rel-related NE
, NE
mitogen NE
-inducible NE
, NE
kappa NE
B NE
-binding NE
protein NE
has NE
been NE
cloned NE
as NE
an NE
immediate-early NE
activation NE
gene NE
of NE
human NE
peripheral NE
blood NE
T NE
cells NE
. NE

The NE
cDNA DNA_family_or_group
has NE
an NE
open DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
900 DNA_domain_or_region_B
amino DNA_domain_or_region_M
acids DNA_domain_or_region_E
capable NE
of NE
encoding NE
a NE
97-kDa Protein_molecule_B
protein Protein_molecule_E
. NE

This NE
protein NE
is NE
most NE
similar NE
to NE
the NE
105-kDa Peptide_B
precursor Peptide_M
polypeptide Peptide_E
of NE
p50-NF-kappa Protein_molecule_B
B Protein_molecule_E
. NE

Like NE
the NE
105-kDa NE
precursor NE
, NE
it NE
contains NE
an NE
amino-terminal Protein_domain_or_region_B
Rel-related Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
about NE
300 NE
amino NE
acids NE
and NE
a NE
carboxy-terminal Protein_domain_or_region_B
domain Protein_domain_or_region_E
containing NE
six NE
full Protein_substructure_B
cell Protein_substructure_M
cycle Protein_substructure_E
or NE
ankyrin Protein_substructure_B
repeats Protein_substructure_E
. NE

In NE
vitro-translated NE
proteins NE
, NE
truncated NE
downstream NE
of NE
the NE
Rel NE
domain NE
and NE
excluding NE
the NE
repeats NE
, NE
bind NE
kappa NE
B NE
sites NE
. NE

We NE
refer NE
to NE
the NE
kappa NE
B NE
-binding NE
, NE
truncated NE
protein NE
as NE
p50B NE
by NE
analogy NE
with NE
p50-NF-kappa NE
B NE
and NE
to NE
the NE
full-length NE
protein NE
as NE
p97 NE
. NE

p50B Protein_molecule
is NE
able NE
to NE
form NE
heteromeric NE
kappa NE
B NE
-binding NE
complexes NE
with NE
RelB NE
, NE
as NE
well NE
as NE
with NE
p65 NE
and NE
p50 NE
, NE
the NE
two NE
subunits NE
of NE
NF-kappa NE
B NE
. NE

Transient-transfection NE
experiments NE
in NE
embryonal Cell_cultured_B
carcinoma Cell_cultured_M
cells Cell_cultured_E
demonstrate NE
a NE
functional NE
cooperation NE
between NE
p50B Protein_molecule
and NE
RelB Protein_molecule
or NE
p65 Protein_molecule
in NE
transactivation NE
of NE
a NE
reporter DNA_molecule_B
plasmid DNA_molecule_E
dependent NE
on NE
a NE
kappa DNA_domain_or_region_B
B DNA_domain_or_region_M
site DNA_domain_or_region_E
. NE

The NE
data NE
imply NE
the NE
existence NE
of NE
a NE
complex NE
family NE
of NE
NF-kappa NE
B NE
-like NE
transcription NE
factors NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

A NE
novel NE
mitogen NE
-inducible NE
gene NE
product NE
related NE
to NE
p50/p105-NF-kappa NE
B NE
participates NE
in NE
transactivation NE
through NE
a NE
kappa NE
B NE
site NE
. NE

A NE
Rel-related NE
, NE
mitogen NE
-inducible NE
, NE
kappa NE
B NE
-binding NE
protein NE
has NE
been NE
cloned NE
as NE
an NE
immediate-early NE
activation NE
gene NE
of NE
human NE
peripheral NE
blood NE
T NE
cells NE
. NE

The NE
cDNA DNA_family_or_group
has NE
an NE
open DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
900 DNA_domain_or_region_B
amino DNA_domain_or_region_M
acids DNA_domain_or_region_E
capable NE
of NE
encoding NE
a NE
97-kDa Protein_molecule_B
protein Protein_molecule_E
. NE

This NE
protein NE
is NE
most NE
similar NE
to NE
the NE
105-kDa Peptide_B
precursor Peptide_M
polypeptide Peptide_E
of NE
p50-NF-kappa Protein_molecule_B
B Protein_molecule_E
. NE

Like NE
the NE
105-kDa NE
precursor NE
, NE
it NE
contains NE
an NE
amino-terminal Protein_domain_or_region_B
Rel-related Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
about NE
300 NE
amino NE
acids NE
and NE
a NE
carboxy-terminal Protein_domain_or_region_B
domain Protein_domain_or_region_E
containing NE
six NE
full Protein_substructure_B
cell Protein_substructure_M
cycle Protein_substructure_E
or NE
ankyrin Protein_substructure_B
repeats Protein_substructure_E
. NE

In NE
vitro-translated NE
proteins NE
, NE
truncated NE
downstream NE
of NE
the NE
Rel NE
domain NE
and NE
excluding NE
the NE
repeats NE
, NE
bind NE
kappa NE
B NE
sites NE
. NE

We NE
refer NE
to NE
the NE
kappa NE
B NE
-binding NE
, NE
truncated NE
protein NE
as NE
p50B NE
by NE
analogy NE
with NE
p50-NF-kappa NE
B NE
and NE
to NE
the NE
full-length NE
protein NE
as NE
p97 NE
. NE

p50B Protein_molecule
is NE
able NE
to NE
form NE
heteromeric NE
kappa NE
B NE
-binding NE
complexes NE
with NE
RelB NE
, NE
as NE
well NE
as NE
with NE
p65 NE
and NE
p50 NE
, NE
the NE
two NE
subunits NE
of NE
NF-kappa NE
B NE
. NE

Transient-transfection NE
experiments NE
in NE
embryonal Cell_cultured_B
carcinoma Cell_cultured_M
cells Cell_cultured_E
demonstrate NE
a NE
functional NE
cooperation NE
between NE
p50B Protein_molecule
and NE
RelB Protein_molecule
or NE
p65 Protein_molecule
in NE
transactivation NE
of NE
a NE
reporter DNA_molecule_B
plasmid DNA_molecule_E
dependent NE
on NE
a NE
kappa DNA_domain_or_region_B
B DNA_domain_or_region_M
site DNA_domain_or_region_E
. NE

The NE
data NE
imply NE
the NE
existence NE
of NE
a NE
complex NE
family NE
of NE
NF-kappa NE
B NE
-like NE
transcription NE
factors NE
. NE

A NE
novel DNA_domain_or_region_B
SP-1 DNA_domain_or_region_M
site DNA_domain_or_region_E
in NE
the NE
human NE
interleukin-1 NE
beta NE
promoter NE
confers NE
preferential NE
transcriptional NE
activity NE
in NE
keratinocytes NE
. NE

To NE
investigate NE
the NE
mechanisms NE
of NE
transcriptional Other_B
activation Other_E
of NE
interleukin-1beta Protein_molecule
( NE
IL-1beta Protein_molecule
) NE
in NE
non-monocytic NE
cells NE
, NE
we NE
constructed NE
a NE
series NE
of NE
reporter NE
plasmids NE
with NE
the NE
bacterial NE
chloramphenicol NE
acetyltransferase NE
gene NE
linked NE
to NE
various NE
parts NE
of NE
the NE
human DNA_domain_or_region_B
IL-1beta DNA_domain_or_region_M
promoter DNA_domain_or_region_E
and NE
performed NE
transient NE
transfection NE
experiments NE
. NE

We NE
identified NE
a NE
promoter NE
segment NE
that NE
activates NE
transcription NE
most NE
efficiently NE
in NE
keratinocytes Cell_natural
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
( NE
EMSA Other
) NE
with NE
a NE
43-mer DNA_domain_or_region_B
oligonucleotide DNA_domain_or_region_E
derived NE
from NE
the NE
functionally NE
identified NE
cis-acting DNA_domain_or_region_B
element DNA_domain_or_region_E
revealed NE
specific NE
complexes NE
. NE

By NE
competition NE
analysis NE
with NE
transcription DNA_family_or_group_B
factor DNA_family_or_group_M
consensus DNA_family_or_group_M
sequence DNA_family_or_group_M
oligonucleotides DNA_family_or_group_E
and NE
by NE
immunosupershift Other
, NE
transcription Protein_molecule_B
factor Protein_molecule_M
SP-1 Protein_molecule_E
or NE
a NE
closely NE
related NE
protein NE
was NE
shown NE
to NE
bind NE
to NE
this NE
regulatory DNA_domain_or_region_B
element DNA_domain_or_region_E
. NE

The NE
closest NE
match NE
to NE
the NE
known NE
SP-1 DNA_domain_or_region_B
consensus DNA_domain_or_region_M
sequence DNA_domain_or_region_E
within NE
the NE
respective NE
region NE
is NE
a NE
TCCCCTCCCCT NE
motif NE
. NE

Mutation NE
of NE
this NE
motif NE
almost NE
completely NE
, NE
and NE
specifically NE
, NE
abolished NE
the NE
binding NE
of NE
two NE
low-mobility NE
complexes NE
and NE
led NE
to NE
a NE
95% NE
decrease NE
of NE
constitutive NE
transcriptional NE
activation NE
of NE
a NE
reporter NE
construct NE
IL-1beta NE
(-170/+108) NE
. NE

Likewise NE
, NE
activation NE
of NE
this NE
reporter NE
construct NE
by NE
tumor Protein_molecule_B
necrosis Protein_molecule_M
factor-alpha Protein_molecule_E
depended NE
on NE
the NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
. NE

These NE
observations NE
suggest NE
that NE
a NE
so-far-unrecognized NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
human NE
IL-1beta NE
promoter NE
may NE
participate NE
in NE
the NE
transcriptional NE
regulation NE
of NE
this NE
gene NE
in NE
keratinocytes NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

A NE
novel NE
mitogen NE
-inducible NE
gene NE
product NE
related NE
to NE
p50/p105-NF-kappa NE
B NE
participates NE
in NE
transactivation NE
through NE
a NE
kappa NE
B NE
site NE
. NE

A NE
Rel-related NE
, NE
mitogen NE
-inducible NE
, NE
kappa NE
B NE
-binding NE
protein NE
has NE
been NE
cloned NE
as NE
an NE
immediate-early NE
activation NE
gene NE
of NE
human NE
peripheral NE
blood NE
T NE
cells NE
. NE

The NE
cDNA DNA_family_or_group
has NE
an NE
open DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
900 DNA_domain_or_region_B
amino DNA_domain_or_region_M
acids DNA_domain_or_region_E
capable NE
of NE
encoding NE
a NE
97-kDa Protein_molecule_B
protein Protein_molecule_E
. NE

This NE
protein NE
is NE
most NE
similar NE
to NE
the NE
105-kDa Peptide_B
precursor Peptide_M
polypeptide Peptide_E
of NE
p50-NF-kappa Protein_molecule_B
B Protein_molecule_E
. NE

Like NE
the NE
105-kDa NE
precursor NE
, NE
it NE
contains NE
an NE
amino-terminal Protein_domain_or_region_B
Rel-related Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
about NE
300 NE
amino NE
acids NE
and NE
a NE
carboxy-terminal Protein_domain_or_region_B
domain Protein_domain_or_region_E
containing NE
six NE
full Protein_substructure_B
cell Protein_substructure_M
cycle Protein_substructure_E
or NE
ankyrin Protein_substructure_B
repeats Protein_substructure_E
. NE

In NE
vitro-translated NE
proteins NE
, NE
truncated NE
downstream NE
of NE
the NE
Rel NE
domain NE
and NE
excluding NE
the NE
repeats NE
, NE
bind NE
kappa NE
B NE
sites NE
. NE

We NE
refer NE
to NE
the NE
kappa NE
B NE
-binding NE
, NE
truncated NE
protein NE
as NE
p50B NE
by NE
analogy NE
with NE
p50-NF-kappa NE
B NE
and NE
to NE
the NE
full-length NE
protein NE
as NE
p97 NE
. NE

p50B Protein_molecule
is NE
able NE
to NE
form NE
heteromeric NE
kappa NE
B NE
-binding NE
complexes NE
with NE
RelB NE
, NE
as NE
well NE
as NE
with NE
p65 NE
and NE
p50 NE
, NE
the NE
two NE
subunits NE
of NE
NF-kappa NE
B NE
. NE

Transient-transfection NE
experiments NE
in NE
embryonal Cell_cultured_B
carcinoma Cell_cultured_M
cells Cell_cultured_E
demonstrate NE
a NE
functional NE
cooperation NE
between NE
p50B Protein_molecule
and NE
RelB Protein_molecule
or NE
p65 Protein_molecule
in NE
transactivation NE
of NE
a NE
reporter DNA_molecule_B
plasmid DNA_molecule_E
dependent NE
on NE
a NE
kappa DNA_domain_or_region_B
B DNA_domain_or_region_M
site DNA_domain_or_region_E
. NE

The NE
data NE
imply NE
the NE
existence NE
of NE
a NE
complex NE
family NE
of NE
NF-kappa NE
B NE
-like NE
transcription NE
factors NE
. NE

A NE
novel DNA_domain_or_region_B
SP-1 DNA_domain_or_region_M
site DNA_domain_or_region_E
in NE
the NE
human NE
interleukin-1 NE
beta NE
promoter NE
confers NE
preferential NE
transcriptional NE
activity NE
in NE
keratinocytes NE
. NE

To NE
investigate NE
the NE
mechanisms NE
of NE
transcriptional Other_B
activation Other_E
of NE
interleukin-1beta Protein_molecule
( NE
IL-1beta Protein_molecule
) NE
in NE
non-monocytic NE
cells NE
, NE
we NE
constructed NE
a NE
series NE
of NE
reporter NE
plasmids NE
with NE
the NE
bacterial NE
chloramphenicol NE
acetyltransferase NE
gene NE
linked NE
to NE
various NE
parts NE
of NE
the NE
human DNA_domain_or_region_B
IL-1beta DNA_domain_or_region_M
promoter DNA_domain_or_region_E
and NE
performed NE
transient NE
transfection NE
experiments NE
. NE

We NE
identified NE
a NE
promoter NE
segment NE
that NE
activates NE
transcription NE
most NE
efficiently NE
in NE
keratinocytes Cell_natural
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
( NE
EMSA Other
) NE
with NE
a NE
43-mer DNA_domain_or_region_B
oligonucleotide DNA_domain_or_region_E
derived NE
from NE
the NE
functionally NE
identified NE
cis-acting DNA_domain_or_region_B
element DNA_domain_or_region_E
revealed NE
specific NE
complexes NE
. NE

By NE
competition NE
analysis NE
with NE
transcription DNA_family_or_group_B
factor DNA_family_or_group_M
consensus DNA_family_or_group_M
sequence DNA_family_or_group_M
oligonucleotides DNA_family_or_group_E
and NE
by NE
immunosupershift Other
, NE
transcription Protein_molecule_B
factor Protein_molecule_M
SP-1 Protein_molecule_E
or NE
a NE
closely NE
related NE
protein NE
was NE
shown NE
to NE
bind NE
to NE
this NE
regulatory DNA_domain_or_region_B
element DNA_domain_or_region_E
. NE

The NE
closest NE
match NE
to NE
the NE
known NE
SP-1 DNA_domain_or_region_B
consensus DNA_domain_or_region_M
sequence DNA_domain_or_region_E
within NE
the NE
respective NE
region NE
is NE
a NE
TCCCCTCCCCT NE
motif NE
. NE

Mutation NE
of NE
this NE
motif NE
almost NE
completely NE
, NE
and NE
specifically NE
, NE
abolished NE
the NE
binding NE
of NE
two NE
low-mobility NE
complexes NE
and NE
led NE
to NE
a NE
95% NE
decrease NE
of NE
constitutive NE
transcriptional NE
activation NE
of NE
a NE
reporter NE
construct NE
IL-1beta NE
(-170/+108) NE
. NE

Likewise NE
, NE
activation NE
of NE
this NE
reporter NE
construct NE
by NE
tumor Protein_molecule_B
necrosis Protein_molecule_M
factor-alpha Protein_molecule_E
depended NE
on NE
the NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
. NE

These NE
observations NE
suggest NE
that NE
a NE
so-far-unrecognized NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
human NE
IL-1beta NE
promoter NE
may NE
participate NE
in NE
the NE
transcriptional NE
regulation NE
of NE
this NE
gene NE
in NE
keratinocytes NE
. NE

Regulation NE
of NE
the NE
beta-globin DNA_domain_or_region_B
locus DNA_domain_or_region_E
. NE

Transcription NE
of NE
the NE
human DNA_domain_or_region_B
beta-globin DNA_domain_or_region_M
gene DNA_domain_or_region_M
cluster DNA_domain_or_region_E
depends NE
upon NE
upstream DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
sequences DNA_domain_or_region_E
, NE
which NE
are NE
collectively NE
termed NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
. NE

Recent NE
studies NE
have NE
provided NE
new NE
insights NE
into NE
how NE
the NE
individual NE
genes NE
of NE
the NE
cluster NE
are NE
regulated NE
through NE
development NE
. NE

The NE
crux NE
of NE
transcriptional Other_B
activation Other_E
is NE
how NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
communicates NE
with NE
the NE
gene-proximal DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
elements DNA_domain_or_region_E
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

A NE
novel NE
mitogen NE
-inducible NE
gene NE
product NE
related NE
to NE
p50/p105-NF-kappa NE
B NE
participates NE
in NE
transactivation NE
through NE
a NE
kappa NE
B NE
site NE
. NE

A NE
Rel-related NE
, NE
mitogen NE
-inducible NE
, NE
kappa NE
B NE
-binding NE
protein NE
has NE
been NE
cloned NE
as NE
an NE
immediate-early NE
activation NE
gene NE
of NE
human NE
peripheral NE
blood NE
T NE
cells NE
. NE

The NE
cDNA DNA_family_or_group
has NE
an NE
open DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
900 DNA_domain_or_region_B
amino DNA_domain_or_region_M
acids DNA_domain_or_region_E
capable NE
of NE
encoding NE
a NE
97-kDa Protein_molecule_B
protein Protein_molecule_E
. NE

This NE
protein NE
is NE
most NE
similar NE
to NE
the NE
105-kDa Peptide_B
precursor Peptide_M
polypeptide Peptide_E
of NE
p50-NF-kappa Protein_molecule_B
B Protein_molecule_E
. NE

Like NE
the NE
105-kDa NE
precursor NE
, NE
it NE
contains NE
an NE
amino-terminal Protein_domain_or_region_B
Rel-related Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
about NE
300 NE
amino NE
acids NE
and NE
a NE
carboxy-terminal Protein_domain_or_region_B
domain Protein_domain_or_region_E
containing NE
six NE
full Protein_substructure_B
cell Protein_substructure_M
cycle Protein_substructure_E
or NE
ankyrin Protein_substructure_B
repeats Protein_substructure_E
. NE

In NE
vitro-translated NE
proteins NE
, NE
truncated NE
downstream NE
of NE
the NE
Rel NE
domain NE
and NE
excluding NE
the NE
repeats NE
, NE
bind NE
kappa NE
B NE
sites NE
. NE

We NE
refer NE
to NE
the NE
kappa NE
B NE
-binding NE
, NE
truncated NE
protein NE
as NE
p50B NE
by NE
analogy NE
with NE
p50-NF-kappa NE
B NE
and NE
to NE
the NE
full-length NE
protein NE
as NE
p97 NE
. NE

p50B Protein_molecule
is NE
able NE
to NE
form NE
heteromeric NE
kappa NE
B NE
-binding NE
complexes NE
with NE
RelB NE
, NE
as NE
well NE
as NE
with NE
p65 NE
and NE
p50 NE
, NE
the NE
two NE
subunits NE
of NE
NF-kappa NE
B NE
. NE

Transient-transfection NE
experiments NE
in NE
embryonal Cell_cultured_B
carcinoma Cell_cultured_M
cells Cell_cultured_E
demonstrate NE
a NE
functional NE
cooperation NE
between NE
p50B Protein_molecule
and NE
RelB Protein_molecule
or NE
p65 Protein_molecule
in NE
transactivation NE
of NE
a NE
reporter DNA_molecule_B
plasmid DNA_molecule_E
dependent NE
on NE
a NE
kappa DNA_domain_or_region_B
B DNA_domain_or_region_M
site DNA_domain_or_region_E
. NE

The NE
data NE
imply NE
the NE
existence NE
of NE
a NE
complex NE
family NE
of NE
NF-kappa NE
B NE
-like NE
transcription NE
factors NE
. NE

A NE
novel DNA_domain_or_region_B
SP-1 DNA_domain_or_region_M
site DNA_domain_or_region_E
in NE
the NE
human NE
interleukin-1 NE
beta NE
promoter NE
confers NE
preferential NE
transcriptional NE
activity NE
in NE
keratinocytes NE
. NE

To NE
investigate NE
the NE
mechanisms NE
of NE
transcriptional Other_B
activation Other_E
of NE
interleukin-1beta Protein_molecule
( NE
IL-1beta Protein_molecule
) NE
in NE
non-monocytic NE
cells NE
, NE
we NE
constructed NE
a NE
series NE
of NE
reporter NE
plasmids NE
with NE
the NE
bacterial NE
chloramphenicol NE
acetyltransferase NE
gene NE
linked NE
to NE
various NE
parts NE
of NE
the NE
human DNA_domain_or_region_B
IL-1beta DNA_domain_or_region_M
promoter DNA_domain_or_region_E
and NE
performed NE
transient NE
transfection NE
experiments NE
. NE

We NE
identified NE
a NE
promoter NE
segment NE
that NE
activates NE
transcription NE
most NE
efficiently NE
in NE
keratinocytes Cell_natural
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
( NE
EMSA Other
) NE
with NE
a NE
43-mer DNA_domain_or_region_B
oligonucleotide DNA_domain_or_region_E
derived NE
from NE
the NE
functionally NE
identified NE
cis-acting DNA_domain_or_region_B
element DNA_domain_or_region_E
revealed NE
specific NE
complexes NE
. NE

By NE
competition NE
analysis NE
with NE
transcription DNA_family_or_group_B
factor DNA_family_or_group_M
consensus DNA_family_or_group_M
sequence DNA_family_or_group_M
oligonucleotides DNA_family_or_group_E
and NE
by NE
immunosupershift Other
, NE
transcription Protein_molecule_B
factor Protein_molecule_M
SP-1 Protein_molecule_E
or NE
a NE
closely NE
related NE
protein NE
was NE
shown NE
to NE
bind NE
to NE
this NE
regulatory DNA_domain_or_region_B
element DNA_domain_or_region_E
. NE

The NE
closest NE
match NE
to NE
the NE
known NE
SP-1 DNA_domain_or_region_B
consensus DNA_domain_or_region_M
sequence DNA_domain_or_region_E
within NE
the NE
respective NE
region NE
is NE
a NE
TCCCCTCCCCT NE
motif NE
. NE

Mutation NE
of NE
this NE
motif NE
almost NE
completely NE
, NE
and NE
specifically NE
, NE
abolished NE
the NE
binding NE
of NE
two NE
low-mobility NE
complexes NE
and NE
led NE
to NE
a NE
95% NE
decrease NE
of NE
constitutive NE
transcriptional NE
activation NE
of NE
a NE
reporter NE
construct NE
IL-1beta NE
(-170/+108) NE
. NE

Likewise NE
, NE
activation NE
of NE
this NE
reporter NE
construct NE
by NE
tumor Protein_molecule_B
necrosis Protein_molecule_M
factor-alpha Protein_molecule_E
depended NE
on NE
the NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
. NE

These NE
observations NE
suggest NE
that NE
a NE
so-far-unrecognized NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
human NE
IL-1beta NE
promoter NE
may NE
participate NE
in NE
the NE
transcriptional NE
regulation NE
of NE
this NE
gene NE
in NE
keratinocytes NE
. NE

Regulation NE
of NE
the NE
beta-globin DNA_domain_or_region_B
locus DNA_domain_or_region_E
. NE

Transcription NE
of NE
the NE
human DNA_domain_or_region_B
beta-globin DNA_domain_or_region_M
gene DNA_domain_or_region_M
cluster DNA_domain_or_region_E
depends NE
upon NE
upstream DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
sequences DNA_domain_or_region_E
, NE
which NE
are NE
collectively NE
termed NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
. NE

Recent NE
studies NE
have NE
provided NE
new NE
insights NE
into NE
how NE
the NE
individual NE
genes NE
of NE
the NE
cluster NE
are NE
regulated NE
through NE
development NE
. NE

The NE
crux NE
of NE
transcriptional Other_B
activation Other_E
is NE
how NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
communicates NE
with NE
the NE
gene-proximal DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
elements DNA_domain_or_region_E
. NE

Inhibition NE
of NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
by NE
dehydroepiandrosterone NE
( NE
DHEA NE
) NE
and NE
an NE
analog NE
of NE
DHEA NE
. NE

The NE
initial NE
infection NE
with NE
human Virus_B
immunodeficiency Virus_M
virus Virus_M
type Virus_M
1 Virus_E
( NE
HIV-1 Virus
) NE
in NE
most NE
individuals NE
usually NE
results NE
in NE
the NE
establishment NE
of NE
a NE
latent NE
or NE
chronic Other_B
infection Other_E
before NE
eventual NE
progression NE
toward NE
acquired Other_B
immunodeficiency Other_M
syndrome Other_E
. NE

HIV-1 Virus
can NE
also NE
establish NE
a NE
latent NE
or NE
persistent NE
infection NE
in NE
some NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
that NE
show NE
minimal NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

However NE
, NE
activation NE
of NE
the NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
leading NE
to NE
enhanced NE
HIV-1 Virus
replication NE
can NE
be NE
induced NE
by NE
antigens Protein_family_or_group
, NE
mitogens Other
, NE
and NE
cytokines Protein_family_or_group
( NE
tumor Protein_family_or_group_B
necrosis Protein_family_or_group_M
factor Protein_family_or_group_M
alpha Protein_family_or_group_E
[ NE
TNF-alpha Protein_molecule
] NE
, NE
interleukin Protein_molecule_B
1 Protein_molecule_E
, NE
and NE
interleukin-2 Protein_molecule
) NE
. NE

Various NE
gene NE
products NE
from NE
other NE
viruses NE
( NE
HTLV-1 Virus
, NE
HSV Virus
, NE
EBV Virus
, NE
CMV Virus
, NE
HBV Virus
, NE
and NE
HHV-6 Virus
) NE
can NE
also NE
enhance NE
HIV-1 NE
long NE
terminal NE
repeat NE
( NE
LTR NE
)-driven NE
reporter NE
gene NE
activity NE
. NE

On NE
the NE
basis NE
of NE
these NE
observations NE
, NE
it NE
has NE
been NE
proposed NE
that NE
reactivation NE
of NE
latent NE
HIV-1 Virus
harbored NE
in NE
chronically Cell_natural_B
infected Cell_natural_M
T Cell_natural_M
lymphocytes Cell_natural_E
, NE
monocytes Cell_natural
, NE
or NE
macrophages Cell_natural
plays NE
an NE
important NE
role NE
in NE
the NE
pathogenesis NE
of NE
AIDS Other
. NE

So NE
far NE
, NE
there NE
are NE
no NE
drugs NE
or NE
therapy NE
available NE
that NE
can NE
provide NE
protection NE
against NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
. NE

ACH-2 Cell_cultured
, NE
derived NE
from NE
a NE
human Cell_cultured_B
T Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
( NE
CEM Cell_cultured
) NE
, NE
is NE
chronically NE
infected NE
with NE
HIV-1 Virus
, NE
with NE
low NE
levels NE
of NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

ACH-2 Cell_cultured
can NE
be NE
converted NE
to NE
productive NE
infection NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
12-O-tetradecanoylphorbol-13-acetate Organic_compound_other
( NE
TPA Organic_compound_other
) NE
, NE
mitogen Organic_compound_other
or NE
cytokines Protein_family_or_group
( NE
TNF-alpha Protein_molecule
) NE
, NE
or NE
infection NE
with NE
HSV Virus
. NE

Therefore NE
the NE
ACH-2 Cell_cultured
cell NE
line NE
is NE
a NE
good NE
candidate NE
for NE
studying NE
the NE
effects NE
of NE
drugs NE
on NE
HIV-1 Virus
activation NE
. NE

Previously NE
, NE
we NE
have NE
reported NE
that NE
DHEA Lipid
and NE
synthetic NE
analogs NE
of NE
DHEA NE
can NE
be NE
modest NE
inhibitors NE
of NE
HIV-1 Other_B
IIIB Other_M
replication Other_E
in NE
phytohemagglutinin NE
-stimulated NE
peripheral NE
blood NE
lymphocyte NE
cultures NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

A NE
novel NE
mitogen NE
-inducible NE
gene NE
product NE
related NE
to NE
p50/p105-NF-kappa NE
B NE
participates NE
in NE
transactivation NE
through NE
a NE
kappa NE
B NE
site NE
. NE

A NE
Rel-related NE
, NE
mitogen NE
-inducible NE
, NE
kappa NE
B NE
-binding NE
protein NE
has NE
been NE
cloned NE
as NE
an NE
immediate-early NE
activation NE
gene NE
of NE
human NE
peripheral NE
blood NE
T NE
cells NE
. NE

The NE
cDNA DNA_family_or_group
has NE
an NE
open DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
900 DNA_domain_or_region_B
amino DNA_domain_or_region_M
acids DNA_domain_or_region_E
capable NE
of NE
encoding NE
a NE
97-kDa Protein_molecule_B
protein Protein_molecule_E
. NE

This NE
protein NE
is NE
most NE
similar NE
to NE
the NE
105-kDa Peptide_B
precursor Peptide_M
polypeptide Peptide_E
of NE
p50-NF-kappa Protein_molecule_B
B Protein_molecule_E
. NE

Like NE
the NE
105-kDa NE
precursor NE
, NE
it NE
contains NE
an NE
amino-terminal Protein_domain_or_region_B
Rel-related Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
about NE
300 NE
amino NE
acids NE
and NE
a NE
carboxy-terminal Protein_domain_or_region_B
domain Protein_domain_or_region_E
containing NE
six NE
full Protein_substructure_B
cell Protein_substructure_M
cycle Protein_substructure_E
or NE
ankyrin Protein_substructure_B
repeats Protein_substructure_E
. NE

In NE
vitro-translated NE
proteins NE
, NE
truncated NE
downstream NE
of NE
the NE
Rel NE
domain NE
and NE
excluding NE
the NE
repeats NE
, NE
bind NE
kappa NE
B NE
sites NE
. NE

We NE
refer NE
to NE
the NE
kappa NE
B NE
-binding NE
, NE
truncated NE
protein NE
as NE
p50B NE
by NE
analogy NE
with NE
p50-NF-kappa NE
B NE
and NE
to NE
the NE
full-length NE
protein NE
as NE
p97 NE
. NE

p50B Protein_molecule
is NE
able NE
to NE
form NE
heteromeric NE
kappa NE
B NE
-binding NE
complexes NE
with NE
RelB NE
, NE
as NE
well NE
as NE
with NE
p65 NE
and NE
p50 NE
, NE
the NE
two NE
subunits NE
of NE
NF-kappa NE
B NE
. NE

Transient-transfection NE
experiments NE
in NE
embryonal Cell_cultured_B
carcinoma Cell_cultured_M
cells Cell_cultured_E
demonstrate NE
a NE
functional NE
cooperation NE
between NE
p50B Protein_molecule
and NE
RelB Protein_molecule
or NE
p65 Protein_molecule
in NE
transactivation NE
of NE
a NE
reporter DNA_molecule_B
plasmid DNA_molecule_E
dependent NE
on NE
a NE
kappa DNA_domain_or_region_B
B DNA_domain_or_region_M
site DNA_domain_or_region_E
. NE

The NE
data NE
imply NE
the NE
existence NE
of NE
a NE
complex NE
family NE
of NE
NF-kappa NE
B NE
-like NE
transcription NE
factors NE
. NE

A NE
novel DNA_domain_or_region_B
SP-1 DNA_domain_or_region_M
site DNA_domain_or_region_E
in NE
the NE
human NE
interleukin-1 NE
beta NE
promoter NE
confers NE
preferential NE
transcriptional NE
activity NE
in NE
keratinocytes NE
. NE

To NE
investigate NE
the NE
mechanisms NE
of NE
transcriptional Other_B
activation Other_E
of NE
interleukin-1beta Protein_molecule
( NE
IL-1beta Protein_molecule
) NE
in NE
non-monocytic NE
cells NE
, NE
we NE
constructed NE
a NE
series NE
of NE
reporter NE
plasmids NE
with NE
the NE
bacterial NE
chloramphenicol NE
acetyltransferase NE
gene NE
linked NE
to NE
various NE
parts NE
of NE
the NE
human DNA_domain_or_region_B
IL-1beta DNA_domain_or_region_M
promoter DNA_domain_or_region_E
and NE
performed NE
transient NE
transfection NE
experiments NE
. NE

We NE
identified NE
a NE
promoter NE
segment NE
that NE
activates NE
transcription NE
most NE
efficiently NE
in NE
keratinocytes Cell_natural
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
( NE
EMSA Other
) NE
with NE
a NE
43-mer DNA_domain_or_region_B
oligonucleotide DNA_domain_or_region_E
derived NE
from NE
the NE
functionally NE
identified NE
cis-acting DNA_domain_or_region_B
element DNA_domain_or_region_E
revealed NE
specific NE
complexes NE
. NE

By NE
competition NE
analysis NE
with NE
transcription DNA_family_or_group_B
factor DNA_family_or_group_M
consensus DNA_family_or_group_M
sequence DNA_family_or_group_M
oligonucleotides DNA_family_or_group_E
and NE
by NE
immunosupershift Other
, NE
transcription Protein_molecule_B
factor Protein_molecule_M
SP-1 Protein_molecule_E
or NE
a NE
closely NE
related NE
protein NE
was NE
shown NE
to NE
bind NE
to NE
this NE
regulatory DNA_domain_or_region_B
element DNA_domain_or_region_E
. NE

The NE
closest NE
match NE
to NE
the NE
known NE
SP-1 DNA_domain_or_region_B
consensus DNA_domain_or_region_M
sequence DNA_domain_or_region_E
within NE
the NE
respective NE
region NE
is NE
a NE
TCCCCTCCCCT NE
motif NE
. NE

Mutation NE
of NE
this NE
motif NE
almost NE
completely NE
, NE
and NE
specifically NE
, NE
abolished NE
the NE
binding NE
of NE
two NE
low-mobility NE
complexes NE
and NE
led NE
to NE
a NE
95% NE
decrease NE
of NE
constitutive NE
transcriptional NE
activation NE
of NE
a NE
reporter NE
construct NE
IL-1beta NE
(-170/+108) NE
. NE

Likewise NE
, NE
activation NE
of NE
this NE
reporter NE
construct NE
by NE
tumor Protein_molecule_B
necrosis Protein_molecule_M
factor-alpha Protein_molecule_E
depended NE
on NE
the NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
. NE

These NE
observations NE
suggest NE
that NE
a NE
so-far-unrecognized NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
human NE
IL-1beta NE
promoter NE
may NE
participate NE
in NE
the NE
transcriptional NE
regulation NE
of NE
this NE
gene NE
in NE
keratinocytes NE
. NE

Regulation NE
of NE
the NE
beta-globin DNA_domain_or_region_B
locus DNA_domain_or_region_E
. NE

Transcription NE
of NE
the NE
human DNA_domain_or_region_B
beta-globin DNA_domain_or_region_M
gene DNA_domain_or_region_M
cluster DNA_domain_or_region_E
depends NE
upon NE
upstream DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
sequences DNA_domain_or_region_E
, NE
which NE
are NE
collectively NE
termed NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
. NE

Recent NE
studies NE
have NE
provided NE
new NE
insights NE
into NE
how NE
the NE
individual NE
genes NE
of NE
the NE
cluster NE
are NE
regulated NE
through NE
development NE
. NE

The NE
crux NE
of NE
transcriptional Other_B
activation Other_E
is NE
how NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
communicates NE
with NE
the NE
gene-proximal DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
elements DNA_domain_or_region_E
. NE

Inhibition NE
of NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
by NE
dehydroepiandrosterone NE
( NE
DHEA NE
) NE
and NE
an NE
analog NE
of NE
DHEA NE
. NE

The NE
initial NE
infection NE
with NE
human Virus_B
immunodeficiency Virus_M
virus Virus_M
type Virus_M
1 Virus_E
( NE
HIV-1 Virus
) NE
in NE
most NE
individuals NE
usually NE
results NE
in NE
the NE
establishment NE
of NE
a NE
latent NE
or NE
chronic Other_B
infection Other_E
before NE
eventual NE
progression NE
toward NE
acquired Other_B
immunodeficiency Other_M
syndrome Other_E
. NE

HIV-1 Virus
can NE
also NE
establish NE
a NE
latent NE
or NE
persistent NE
infection NE
in NE
some NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
that NE
show NE
minimal NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

However NE
, NE
activation NE
of NE
the NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
leading NE
to NE
enhanced NE
HIV-1 Virus
replication NE
can NE
be NE
induced NE
by NE
antigens Protein_family_or_group
, NE
mitogens Other
, NE
and NE
cytokines Protein_family_or_group
( NE
tumor Protein_family_or_group_B
necrosis Protein_family_or_group_M
factor Protein_family_or_group_M
alpha Protein_family_or_group_E
[ NE
TNF-alpha Protein_molecule
] NE
, NE
interleukin Protein_molecule_B
1 Protein_molecule_E
, NE
and NE
interleukin-2 Protein_molecule
) NE
. NE

Various NE
gene NE
products NE
from NE
other NE
viruses NE
( NE
HTLV-1 Virus
, NE
HSV Virus
, NE
EBV Virus
, NE
CMV Virus
, NE
HBV Virus
, NE
and NE
HHV-6 Virus
) NE
can NE
also NE
enhance NE
HIV-1 NE
long NE
terminal NE
repeat NE
( NE
LTR NE
)-driven NE
reporter NE
gene NE
activity NE
. NE

On NE
the NE
basis NE
of NE
these NE
observations NE
, NE
it NE
has NE
been NE
proposed NE
that NE
reactivation NE
of NE
latent NE
HIV-1 Virus
harbored NE
in NE
chronically Cell_natural_B
infected Cell_natural_M
T Cell_natural_M
lymphocytes Cell_natural_E
, NE
monocytes Cell_natural
, NE
or NE
macrophages Cell_natural
plays NE
an NE
important NE
role NE
in NE
the NE
pathogenesis NE
of NE
AIDS Other
. NE

So NE
far NE
, NE
there NE
are NE
no NE
drugs NE
or NE
therapy NE
available NE
that NE
can NE
provide NE
protection NE
against NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
. NE

ACH-2 Cell_cultured
, NE
derived NE
from NE
a NE
human Cell_cultured_B
T Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
( NE
CEM Cell_cultured
) NE
, NE
is NE
chronically NE
infected NE
with NE
HIV-1 Virus
, NE
with NE
low NE
levels NE
of NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

ACH-2 Cell_cultured
can NE
be NE
converted NE
to NE
productive NE
infection NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
12-O-tetradecanoylphorbol-13-acetate Organic_compound_other
( NE
TPA Organic_compound_other
) NE
, NE
mitogen Organic_compound_other
or NE
cytokines Protein_family_or_group
( NE
TNF-alpha Protein_molecule
) NE
, NE
or NE
infection NE
with NE
HSV Virus
. NE

Therefore NE
the NE
ACH-2 Cell_cultured
cell NE
line NE
is NE
a NE
good NE
candidate NE
for NE
studying NE
the NE
effects NE
of NE
drugs NE
on NE
HIV-1 Virus
activation NE
. NE

Previously NE
, NE
we NE
have NE
reported NE
that NE
DHEA Lipid
and NE
synthetic NE
analogs NE
of NE
DHEA NE
can NE
be NE
modest NE
inhibitors NE
of NE
HIV-1 Other_B
IIIB Other_M
replication Other_E
in NE
phytohemagglutinin NE
-stimulated NE
peripheral NE
blood NE
lymphocyte NE
cultures NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

C/EBP Protein_family_or_group_B
activators Protein_family_or_group_E
are NE
required NE
for NE
HIV-1 Other_B
replication Other_E
and NE
proviral NE
induction NE
in NE
monocytic NE
cell NE
lines NE
. NE

Previous NE
work NE
has NE
shown NE
that NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
and NE
C/EBP Protein_family_or_group_B
transcriptional Protein_family_or_group_M
activators Protein_family_or_group_E
are NE
necessary NE
for NE
HIV-1 Other_B
LTR Other_M
activity Other_E
in NE
monocytes/macrophages NE
. NE

We NE
have NE
investigated NE
the NE
role NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
play NE
in NE
induction NE
and NE
replication NE
of NE
HIV-1 Virus
. NE

Ectopic NE
expression NE
of NE
the NE
dominant NE
negative NE
C/EBP NE
protein NE
LIP NE
inhibited NE
HIV-1 NE
mRNA NE
and NE
virus NE
production NE
in NE
activated NE
U1 NE
cells NE
, NE
demonstrating NE
that NE
C/EBP NE
proteins NE
are NE
required NE
for NE
provirus NE
induction NE
. NE

U1 Cell_cultured_B
lines Cell_cultured_E
overexpressing NE
C/EBP Protein_family_or_group_B
activator Protein_family_or_group_E
NF-IL-6 Protein_molecule
produced NE
more NE
viral RNA_family_or_group_B
mRNA RNA_family_or_group_E
and NE
virus Virus_B
particles Virus_E
following NE
cellular Other_B
activation Other_E
than NE
control Cell_cultured_B
lines Cell_cultured_E
, NE
demonstrating NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
are NE
limiting NE
for NE
virus Other_B
transcription Other_E
. NE

HIV-1 Virus
harboring NE
mutations NE
within NE
two NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
were NE
crippled NE
in NE
their NE
ability NE
to NE
replicate NE
in NE
U937 Cell_cultured_B
promonocytic Cell_cultured_M
cells Cell_cultured_E
, NE
indicating NE
that NE
these NE
sites NE
are NE
required NE
for NE
replication NE
. NE

These NE
data NE
identify NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
as NE
regulators NE
of NE
HIV-1 Other_B
expression Other_E
in NE
monocytes/macrophages NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

A NE
novel NE
mitogen NE
-inducible NE
gene NE
product NE
related NE
to NE
p50/p105-NF-kappa NE
B NE
participates NE
in NE
transactivation NE
through NE
a NE
kappa NE
B NE
site NE
. NE

A NE
Rel-related NE
, NE
mitogen NE
-inducible NE
, NE
kappa NE
B NE
-binding NE
protein NE
has NE
been NE
cloned NE
as NE
an NE
immediate-early NE
activation NE
gene NE
of NE
human NE
peripheral NE
blood NE
T NE
cells NE
. NE

The NE
cDNA DNA_family_or_group
has NE
an NE
open DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
900 DNA_domain_or_region_B
amino DNA_domain_or_region_M
acids DNA_domain_or_region_E
capable NE
of NE
encoding NE
a NE
97-kDa Protein_molecule_B
protein Protein_molecule_E
. NE

This NE
protein NE
is NE
most NE
similar NE
to NE
the NE
105-kDa Peptide_B
precursor Peptide_M
polypeptide Peptide_E
of NE
p50-NF-kappa Protein_molecule_B
B Protein_molecule_E
. NE

Like NE
the NE
105-kDa NE
precursor NE
, NE
it NE
contains NE
an NE
amino-terminal Protein_domain_or_region_B
Rel-related Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
about NE
300 NE
amino NE
acids NE
and NE
a NE
carboxy-terminal Protein_domain_or_region_B
domain Protein_domain_or_region_E
containing NE
six NE
full Protein_substructure_B
cell Protein_substructure_M
cycle Protein_substructure_E
or NE
ankyrin Protein_substructure_B
repeats Protein_substructure_E
. NE

In NE
vitro-translated NE
proteins NE
, NE
truncated NE
downstream NE
of NE
the NE
Rel NE
domain NE
and NE
excluding NE
the NE
repeats NE
, NE
bind NE
kappa NE
B NE
sites NE
. NE

We NE
refer NE
to NE
the NE
kappa NE
B NE
-binding NE
, NE
truncated NE
protein NE
as NE
p50B NE
by NE
analogy NE
with NE
p50-NF-kappa NE
B NE
and NE
to NE
the NE
full-length NE
protein NE
as NE
p97 NE
. NE

p50B Protein_molecule
is NE
able NE
to NE
form NE
heteromeric NE
kappa NE
B NE
-binding NE
complexes NE
with NE
RelB NE
, NE
as NE
well NE
as NE
with NE
p65 NE
and NE
p50 NE
, NE
the NE
two NE
subunits NE
of NE
NF-kappa NE
B NE
. NE

Transient-transfection NE
experiments NE
in NE
embryonal Cell_cultured_B
carcinoma Cell_cultured_M
cells Cell_cultured_E
demonstrate NE
a NE
functional NE
cooperation NE
between NE
p50B Protein_molecule
and NE
RelB Protein_molecule
or NE
p65 Protein_molecule
in NE
transactivation NE
of NE
a NE
reporter DNA_molecule_B
plasmid DNA_molecule_E
dependent NE
on NE
a NE
kappa DNA_domain_or_region_B
B DNA_domain_or_region_M
site DNA_domain_or_region_E
. NE

The NE
data NE
imply NE
the NE
existence NE
of NE
a NE
complex NE
family NE
of NE
NF-kappa NE
B NE
-like NE
transcription NE
factors NE
. NE

A NE
novel DNA_domain_or_region_B
SP-1 DNA_domain_or_region_M
site DNA_domain_or_region_E
in NE
the NE
human NE
interleukin-1 NE
beta NE
promoter NE
confers NE
preferential NE
transcriptional NE
activity NE
in NE
keratinocytes NE
. NE

To NE
investigate NE
the NE
mechanisms NE
of NE
transcriptional Other_B
activation Other_E
of NE
interleukin-1beta Protein_molecule
( NE
IL-1beta Protein_molecule
) NE
in NE
non-monocytic NE
cells NE
, NE
we NE
constructed NE
a NE
series NE
of NE
reporter NE
plasmids NE
with NE
the NE
bacterial NE
chloramphenicol NE
acetyltransferase NE
gene NE
linked NE
to NE
various NE
parts NE
of NE
the NE
human DNA_domain_or_region_B
IL-1beta DNA_domain_or_region_M
promoter DNA_domain_or_region_E
and NE
performed NE
transient NE
transfection NE
experiments NE
. NE

We NE
identified NE
a NE
promoter NE
segment NE
that NE
activates NE
transcription NE
most NE
efficiently NE
in NE
keratinocytes Cell_natural
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
( NE
EMSA Other
) NE
with NE
a NE
43-mer DNA_domain_or_region_B
oligonucleotide DNA_domain_or_region_E
derived NE
from NE
the NE
functionally NE
identified NE
cis-acting DNA_domain_or_region_B
element DNA_domain_or_region_E
revealed NE
specific NE
complexes NE
. NE

By NE
competition NE
analysis NE
with NE
transcription DNA_family_or_group_B
factor DNA_family_or_group_M
consensus DNA_family_or_group_M
sequence DNA_family_or_group_M
oligonucleotides DNA_family_or_group_E
and NE
by NE
immunosupershift Other
, NE
transcription Protein_molecule_B
factor Protein_molecule_M
SP-1 Protein_molecule_E
or NE
a NE
closely NE
related NE
protein NE
was NE
shown NE
to NE
bind NE
to NE
this NE
regulatory DNA_domain_or_region_B
element DNA_domain_or_region_E
. NE

The NE
closest NE
match NE
to NE
the NE
known NE
SP-1 DNA_domain_or_region_B
consensus DNA_domain_or_region_M
sequence DNA_domain_or_region_E
within NE
the NE
respective NE
region NE
is NE
a NE
TCCCCTCCCCT NE
motif NE
. NE

Mutation NE
of NE
this NE
motif NE
almost NE
completely NE
, NE
and NE
specifically NE
, NE
abolished NE
the NE
binding NE
of NE
two NE
low-mobility NE
complexes NE
and NE
led NE
to NE
a NE
95% NE
decrease NE
of NE
constitutive NE
transcriptional NE
activation NE
of NE
a NE
reporter NE
construct NE
IL-1beta NE
(-170/+108) NE
. NE

Likewise NE
, NE
activation NE
of NE
this NE
reporter NE
construct NE
by NE
tumor Protein_molecule_B
necrosis Protein_molecule_M
factor-alpha Protein_molecule_E
depended NE
on NE
the NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
. NE

These NE
observations NE
suggest NE
that NE
a NE
so-far-unrecognized NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
human NE
IL-1beta NE
promoter NE
may NE
participate NE
in NE
the NE
transcriptional NE
regulation NE
of NE
this NE
gene NE
in NE
keratinocytes NE
. NE

Regulation NE
of NE
the NE
beta-globin DNA_domain_or_region_B
locus DNA_domain_or_region_E
. NE

Transcription NE
of NE
the NE
human DNA_domain_or_region_B
beta-globin DNA_domain_or_region_M
gene DNA_domain_or_region_M
cluster DNA_domain_or_region_E
depends NE
upon NE
upstream DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
sequences DNA_domain_or_region_E
, NE
which NE
are NE
collectively NE
termed NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
. NE

Recent NE
studies NE
have NE
provided NE
new NE
insights NE
into NE
how NE
the NE
individual NE
genes NE
of NE
the NE
cluster NE
are NE
regulated NE
through NE
development NE
. NE

The NE
crux NE
of NE
transcriptional Other_B
activation Other_E
is NE
how NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
communicates NE
with NE
the NE
gene-proximal DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
elements DNA_domain_or_region_E
. NE

Inhibition NE
of NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
by NE
dehydroepiandrosterone NE
( NE
DHEA NE
) NE
and NE
an NE
analog NE
of NE
DHEA NE
. NE

The NE
initial NE
infection NE
with NE
human Virus_B
immunodeficiency Virus_M
virus Virus_M
type Virus_M
1 Virus_E
( NE
HIV-1 Virus
) NE
in NE
most NE
individuals NE
usually NE
results NE
in NE
the NE
establishment NE
of NE
a NE
latent NE
or NE
chronic Other_B
infection Other_E
before NE
eventual NE
progression NE
toward NE
acquired Other_B
immunodeficiency Other_M
syndrome Other_E
. NE

HIV-1 Virus
can NE
also NE
establish NE
a NE
latent NE
or NE
persistent NE
infection NE
in NE
some NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
that NE
show NE
minimal NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

However NE
, NE
activation NE
of NE
the NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
leading NE
to NE
enhanced NE
HIV-1 Virus
replication NE
can NE
be NE
induced NE
by NE
antigens Protein_family_or_group
, NE
mitogens Other
, NE
and NE
cytokines Protein_family_or_group
( NE
tumor Protein_family_or_group_B
necrosis Protein_family_or_group_M
factor Protein_family_or_group_M
alpha Protein_family_or_group_E
[ NE
TNF-alpha Protein_molecule
] NE
, NE
interleukin Protein_molecule_B
1 Protein_molecule_E
, NE
and NE
interleukin-2 Protein_molecule
) NE
. NE

Various NE
gene NE
products NE
from NE
other NE
viruses NE
( NE
HTLV-1 Virus
, NE
HSV Virus
, NE
EBV Virus
, NE
CMV Virus
, NE
HBV Virus
, NE
and NE
HHV-6 Virus
) NE
can NE
also NE
enhance NE
HIV-1 NE
long NE
terminal NE
repeat NE
( NE
LTR NE
)-driven NE
reporter NE
gene NE
activity NE
. NE

On NE
the NE
basis NE
of NE
these NE
observations NE
, NE
it NE
has NE
been NE
proposed NE
that NE
reactivation NE
of NE
latent NE
HIV-1 Virus
harbored NE
in NE
chronically Cell_natural_B
infected Cell_natural_M
T Cell_natural_M
lymphocytes Cell_natural_E
, NE
monocytes Cell_natural
, NE
or NE
macrophages Cell_natural
plays NE
an NE
important NE
role NE
in NE
the NE
pathogenesis NE
of NE
AIDS Other
. NE

So NE
far NE
, NE
there NE
are NE
no NE
drugs NE
or NE
therapy NE
available NE
that NE
can NE
provide NE
protection NE
against NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
. NE

ACH-2 Cell_cultured
, NE
derived NE
from NE
a NE
human Cell_cultured_B
T Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
( NE
CEM Cell_cultured
) NE
, NE
is NE
chronically NE
infected NE
with NE
HIV-1 Virus
, NE
with NE
low NE
levels NE
of NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

ACH-2 Cell_cultured
can NE
be NE
converted NE
to NE
productive NE
infection NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
12-O-tetradecanoylphorbol-13-acetate Organic_compound_other
( NE
TPA Organic_compound_other
) NE
, NE
mitogen Organic_compound_other
or NE
cytokines Protein_family_or_group
( NE
TNF-alpha Protein_molecule
) NE
, NE
or NE
infection NE
with NE
HSV Virus
. NE

Therefore NE
the NE
ACH-2 Cell_cultured
cell NE
line NE
is NE
a NE
good NE
candidate NE
for NE
studying NE
the NE
effects NE
of NE
drugs NE
on NE
HIV-1 Virus
activation NE
. NE

Previously NE
, NE
we NE
have NE
reported NE
that NE
DHEA Lipid
and NE
synthetic NE
analogs NE
of NE
DHEA NE
can NE
be NE
modest NE
inhibitors NE
of NE
HIV-1 Other_B
IIIB Other_M
replication Other_E
in NE
phytohemagglutinin NE
-stimulated NE
peripheral NE
blood NE
lymphocyte NE
cultures NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

C/EBP Protein_family_or_group_B
activators Protein_family_or_group_E
are NE
required NE
for NE
HIV-1 Other_B
replication Other_E
and NE
proviral NE
induction NE
in NE
monocytic NE
cell NE
lines NE
. NE

Previous NE
work NE
has NE
shown NE
that NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
and NE
C/EBP Protein_family_or_group_B
transcriptional Protein_family_or_group_M
activators Protein_family_or_group_E
are NE
necessary NE
for NE
HIV-1 Other_B
LTR Other_M
activity Other_E
in NE
monocytes/macrophages NE
. NE

We NE
have NE
investigated NE
the NE
role NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
play NE
in NE
induction NE
and NE
replication NE
of NE
HIV-1 Virus
. NE

Ectopic NE
expression NE
of NE
the NE
dominant NE
negative NE
C/EBP NE
protein NE
LIP NE
inhibited NE
HIV-1 NE
mRNA NE
and NE
virus NE
production NE
in NE
activated NE
U1 NE
cells NE
, NE
demonstrating NE
that NE
C/EBP NE
proteins NE
are NE
required NE
for NE
provirus NE
induction NE
. NE

U1 Cell_cultured_B
lines Cell_cultured_E
overexpressing NE
C/EBP Protein_family_or_group_B
activator Protein_family_or_group_E
NF-IL-6 Protein_molecule
produced NE
more NE
viral RNA_family_or_group_B
mRNA RNA_family_or_group_E
and NE
virus Virus_B
particles Virus_E
following NE
cellular Other_B
activation Other_E
than NE
control Cell_cultured_B
lines Cell_cultured_E
, NE
demonstrating NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
are NE
limiting NE
for NE
virus Other_B
transcription Other_E
. NE

HIV-1 Virus
harboring NE
mutations NE
within NE
two NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
were NE
crippled NE
in NE
their NE
ability NE
to NE
replicate NE
in NE
U937 Cell_cultured_B
promonocytic Cell_cultured_M
cells Cell_cultured_E
, NE
indicating NE
that NE
these NE
sites NE
are NE
required NE
for NE
replication NE
. NE

These NE
data NE
identify NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
as NE
regulators NE
of NE
HIV-1 Other_B
expression Other_E
in NE
monocytes/macrophages NE
. NE

IL-10 Protein_molecule
inhibits NE
nuclear Other_B
factor-kappa Other_M
B/Rel Other_M
nuclear Other_M
activity Other_E
in NE
CD3 NE
-stimulated NE
human NE
peripheral NE
T NE
lymphocytes NE
. NE

IL-10 Protein_molecule
markedly NE
reduces NE
nuclear NE
factor NE
(NF)-kappa Other_B
B/Rel Other_M
nuclear Other_M
activity Other_E
induced NE
in NE
PBMC NE
by NE
stimulation NE
with NE
the NE
anti-CD3 NE
mAb NE
OKT3 NE
. NE

The NE
inhibition NE
is NE
exerted NE
specifically NE
on NE
the NE
NF-kappa Other_B
B/Rel Other_M
activation Other_E
induced NE
by NE
mAb NE
OKT3 NE
, NE
and NE
not NE
that NE
produced NE
by NE
PMA NE
. NE

As NE
judged NE
by NE
supershifting NE
the NE
DNA-protein NE
complexes NE
with NE
Abs NE
recognizing NE
specific NE
components NE
of NE
the NE
NF-kappa NE
B/Rel NE
protein NE
family NE
, NE
the NE
p50/p65 NE
( NE
Rel NE
A NE
) NE
heterodimeric NE
form NE
of NE
NF-kappa NE
B NE
is NE
primarily NE
affected NE
. NE

The NE
maximal NE
effect NE
is NE
observed NE
at NE
the NE
IL-10 Other_B
concentration Other_E
of NE
20 NE
U/ml NE
. NE

IL-10 Protein_molecule
inhibitory NE
activity NE
is NE
exerted NE
on NE
T Cell_natural_B
lymphocytes Cell_natural_E
and NE
is NE
mediated NE
by NE
monocytes Cell_natural
. NE

Indeed NE
, NE
monocytes Cell_natural
pretreated NE
with NE
IL-10 Protein_molecule
are NE
able NE
so NE
inhibit NE
NF-kappa Protein_complex_B
B Protein_complex_E
nuclear NE
activity NE
in NE
purified NE
T Cell_natural_B
lymphocytes Cell_natural_E
stimulated NE
with NE
OKT3 Protein_molecule
. NE

Soluble NE
factors NE
do NE
not NE
appear NE
to NE
be NE
involved NE
in NE
the NE
mechanism NE
of NE
inhibition NE
. NE

On NE
the NE
other NE
hand NE
, NE
the NE
up-regulation NE
of NE
CD80 Protein_molecule_B
Ag Protein_molecule_E
, NE
found NE
on NE
monocytes Cell_natural
obtained NE
from NE
PBMC Cell_natural
incubated NE
with NE
OKT3 Protein_molecule
, NE
is NE
not NE
detected NE
after NE
addition NE
of NE
IL-10 Protein_molecule
, NE
and NE
the NE
anti-CD28 Protein_family_or_group_B
mAb Protein_family_or_group_E
CLB-CD28/1 Protein_molecule
restores NE
the NE
NF-kappa Element_B
B/Rel Element_M
nuclear Element_M
activity Element_E
in NE
IL-10 NE
-inhibited NE
lymphocytes NE
. NE

Therefore NE
, NE
the NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
inhibition NE
might NE
be NE
ascribed NE
to NE
a NE
lack NE
of NE
cooperation NE
between NE
accessory NE
cells NE
and NE
T Cell_natural_B
lymphocytes Cell_natural_E
, NE
resulting NE
from NE
down-regulation NE
of NE
a NE
costimulatory NE
molecule NE
, NE
such NE
as NE
CD80 Protein_molecule
, NE
produced NE
by NE
IL-10 Protein_molecule
on NE
activated NE
monocytes Cell_natural
. NE

Our NE
results NE
demonstrate NE
that NE
IL-10 Protein_molecule
can NE
inhibit NE
the NE
induction NE
of NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
nuclear NE
activity NE
in NE
CD3 NE
-stimulated NE
T NE
lymphocytes NE
. NE

Since NE
inappropriate NE
activation NE
of NE
kappa DNA_family_or_group_B
B-driven DNA_family_or_group_M
genes DNA_family_or_group_E
has NE
a NE
physiopathologic NE
role NE
in NE
a NE
number NE
of NE
diseases NE
, NE
such NE
as NE
HIV Other_B
infection Other_E
, NE
our NE
findings NE
support NE
the NE
possibility NE
of NE
using NE
this NE
cytokine NE
to NE
suppress NE
an NE
undesirable NE
activation NE
of NE
these NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

A NE
novel NE
mitogen NE
-inducible NE
gene NE
product NE
related NE
to NE
p50/p105-NF-kappa NE
B NE
participates NE
in NE
transactivation NE
through NE
a NE
kappa NE
B NE
site NE
. NE

A NE
Rel-related NE
, NE
mitogen NE
-inducible NE
, NE
kappa NE
B NE
-binding NE
protein NE
has NE
been NE
cloned NE
as NE
an NE
immediate-early NE
activation NE
gene NE
of NE
human NE
peripheral NE
blood NE
T NE
cells NE
. NE

The NE
cDNA DNA_family_or_group
has NE
an NE
open DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
900 DNA_domain_or_region_B
amino DNA_domain_or_region_M
acids DNA_domain_or_region_E
capable NE
of NE
encoding NE
a NE
97-kDa Protein_molecule_B
protein Protein_molecule_E
. NE

This NE
protein NE
is NE
most NE
similar NE
to NE
the NE
105-kDa Peptide_B
precursor Peptide_M
polypeptide Peptide_E
of NE
p50-NF-kappa Protein_molecule_B
B Protein_molecule_E
. NE

Like NE
the NE
105-kDa NE
precursor NE
, NE
it NE
contains NE
an NE
amino-terminal Protein_domain_or_region_B
Rel-related Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
about NE
300 NE
amino NE
acids NE
and NE
a NE
carboxy-terminal Protein_domain_or_region_B
domain Protein_domain_or_region_E
containing NE
six NE
full Protein_substructure_B
cell Protein_substructure_M
cycle Protein_substructure_E
or NE
ankyrin Protein_substructure_B
repeats Protein_substructure_E
. NE

In NE
vitro-translated NE
proteins NE
, NE
truncated NE
downstream NE
of NE
the NE
Rel NE
domain NE
and NE
excluding NE
the NE
repeats NE
, NE
bind NE
kappa NE
B NE
sites NE
. NE

We NE
refer NE
to NE
the NE
kappa NE
B NE
-binding NE
, NE
truncated NE
protein NE
as NE
p50B NE
by NE
analogy NE
with NE
p50-NF-kappa NE
B NE
and NE
to NE
the NE
full-length NE
protein NE
as NE
p97 NE
. NE

p50B Protein_molecule
is NE
able NE
to NE
form NE
heteromeric NE
kappa NE
B NE
-binding NE
complexes NE
with NE
RelB NE
, NE
as NE
well NE
as NE
with NE
p65 NE
and NE
p50 NE
, NE
the NE
two NE
subunits NE
of NE
NF-kappa NE
B NE
. NE

Transient-transfection NE
experiments NE
in NE
embryonal Cell_cultured_B
carcinoma Cell_cultured_M
cells Cell_cultured_E
demonstrate NE
a NE
functional NE
cooperation NE
between NE
p50B Protein_molecule
and NE
RelB Protein_molecule
or NE
p65 Protein_molecule
in NE
transactivation NE
of NE
a NE
reporter DNA_molecule_B
plasmid DNA_molecule_E
dependent NE
on NE
a NE
kappa DNA_domain_or_region_B
B DNA_domain_or_region_M
site DNA_domain_or_region_E
. NE

The NE
data NE
imply NE
the NE
existence NE
of NE
a NE
complex NE
family NE
of NE
NF-kappa NE
B NE
-like NE
transcription NE
factors NE
. NE

A NE
novel DNA_domain_or_region_B
SP-1 DNA_domain_or_region_M
site DNA_domain_or_region_E
in NE
the NE
human NE
interleukin-1 NE
beta NE
promoter NE
confers NE
preferential NE
transcriptional NE
activity NE
in NE
keratinocytes NE
. NE

To NE
investigate NE
the NE
mechanisms NE
of NE
transcriptional Other_B
activation Other_E
of NE
interleukin-1beta Protein_molecule
( NE
IL-1beta Protein_molecule
) NE
in NE
non-monocytic NE
cells NE
, NE
we NE
constructed NE
a NE
series NE
of NE
reporter NE
plasmids NE
with NE
the NE
bacterial NE
chloramphenicol NE
acetyltransferase NE
gene NE
linked NE
to NE
various NE
parts NE
of NE
the NE
human DNA_domain_or_region_B
IL-1beta DNA_domain_or_region_M
promoter DNA_domain_or_region_E
and NE
performed NE
transient NE
transfection NE
experiments NE
. NE

We NE
identified NE
a NE
promoter NE
segment NE
that NE
activates NE
transcription NE
most NE
efficiently NE
in NE
keratinocytes Cell_natural
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
( NE
EMSA Other
) NE
with NE
a NE
43-mer DNA_domain_or_region_B
oligonucleotide DNA_domain_or_region_E
derived NE
from NE
the NE
functionally NE
identified NE
cis-acting DNA_domain_or_region_B
element DNA_domain_or_region_E
revealed NE
specific NE
complexes NE
. NE

By NE
competition NE
analysis NE
with NE
transcription DNA_family_or_group_B
factor DNA_family_or_group_M
consensus DNA_family_or_group_M
sequence DNA_family_or_group_M
oligonucleotides DNA_family_or_group_E
and NE
by NE
immunosupershift Other
, NE
transcription Protein_molecule_B
factor Protein_molecule_M
SP-1 Protein_molecule_E
or NE
a NE
closely NE
related NE
protein NE
was NE
shown NE
to NE
bind NE
to NE
this NE
regulatory DNA_domain_or_region_B
element DNA_domain_or_region_E
. NE

The NE
closest NE
match NE
to NE
the NE
known NE
SP-1 DNA_domain_or_region_B
consensus DNA_domain_or_region_M
sequence DNA_domain_or_region_E
within NE
the NE
respective NE
region NE
is NE
a NE
TCCCCTCCCCT NE
motif NE
. NE

Mutation NE
of NE
this NE
motif NE
almost NE
completely NE
, NE
and NE
specifically NE
, NE
abolished NE
the NE
binding NE
of NE
two NE
low-mobility NE
complexes NE
and NE
led NE
to NE
a NE
95% NE
decrease NE
of NE
constitutive NE
transcriptional NE
activation NE
of NE
a NE
reporter NE
construct NE
IL-1beta NE
(-170/+108) NE
. NE

Likewise NE
, NE
activation NE
of NE
this NE
reporter NE
construct NE
by NE
tumor Protein_molecule_B
necrosis Protein_molecule_M
factor-alpha Protein_molecule_E
depended NE
on NE
the NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
. NE

These NE
observations NE
suggest NE
that NE
a NE
so-far-unrecognized NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
human NE
IL-1beta NE
promoter NE
may NE
participate NE
in NE
the NE
transcriptional NE
regulation NE
of NE
this NE
gene NE
in NE
keratinocytes NE
. NE

Regulation NE
of NE
the NE
beta-globin DNA_domain_or_region_B
locus DNA_domain_or_region_E
. NE

Transcription NE
of NE
the NE
human DNA_domain_or_region_B
beta-globin DNA_domain_or_region_M
gene DNA_domain_or_region_M
cluster DNA_domain_or_region_E
depends NE
upon NE
upstream DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
sequences DNA_domain_or_region_E
, NE
which NE
are NE
collectively NE
termed NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
. NE

Recent NE
studies NE
have NE
provided NE
new NE
insights NE
into NE
how NE
the NE
individual NE
genes NE
of NE
the NE
cluster NE
are NE
regulated NE
through NE
development NE
. NE

The NE
crux NE
of NE
transcriptional Other_B
activation Other_E
is NE
how NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
communicates NE
with NE
the NE
gene-proximal DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
elements DNA_domain_or_region_E
. NE

Inhibition NE
of NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
by NE
dehydroepiandrosterone NE
( NE
DHEA NE
) NE
and NE
an NE
analog NE
of NE
DHEA NE
. NE

The NE
initial NE
infection NE
with NE
human Virus_B
immunodeficiency Virus_M
virus Virus_M
type Virus_M
1 Virus_E
( NE
HIV-1 Virus
) NE
in NE
most NE
individuals NE
usually NE
results NE
in NE
the NE
establishment NE
of NE
a NE
latent NE
or NE
chronic Other_B
infection Other_E
before NE
eventual NE
progression NE
toward NE
acquired Other_B
immunodeficiency Other_M
syndrome Other_E
. NE

HIV-1 Virus
can NE
also NE
establish NE
a NE
latent NE
or NE
persistent NE
infection NE
in NE
some NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
that NE
show NE
minimal NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

However NE
, NE
activation NE
of NE
the NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
leading NE
to NE
enhanced NE
HIV-1 Virus
replication NE
can NE
be NE
induced NE
by NE
antigens Protein_family_or_group
, NE
mitogens Other
, NE
and NE
cytokines Protein_family_or_group
( NE
tumor Protein_family_or_group_B
necrosis Protein_family_or_group_M
factor Protein_family_or_group_M
alpha Protein_family_or_group_E
[ NE
TNF-alpha Protein_molecule
] NE
, NE
interleukin Protein_molecule_B
1 Protein_molecule_E
, NE
and NE
interleukin-2 Protein_molecule
) NE
. NE

Various NE
gene NE
products NE
from NE
other NE
viruses NE
( NE
HTLV-1 Virus
, NE
HSV Virus
, NE
EBV Virus
, NE
CMV Virus
, NE
HBV Virus
, NE
and NE
HHV-6 Virus
) NE
can NE
also NE
enhance NE
HIV-1 NE
long NE
terminal NE
repeat NE
( NE
LTR NE
)-driven NE
reporter NE
gene NE
activity NE
. NE

On NE
the NE
basis NE
of NE
these NE
observations NE
, NE
it NE
has NE
been NE
proposed NE
that NE
reactivation NE
of NE
latent NE
HIV-1 Virus
harbored NE
in NE
chronically Cell_natural_B
infected Cell_natural_M
T Cell_natural_M
lymphocytes Cell_natural_E
, NE
monocytes Cell_natural
, NE
or NE
macrophages Cell_natural
plays NE
an NE
important NE
role NE
in NE
the NE
pathogenesis NE
of NE
AIDS Other
. NE

So NE
far NE
, NE
there NE
are NE
no NE
drugs NE
or NE
therapy NE
available NE
that NE
can NE
provide NE
protection NE
against NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
. NE

ACH-2 Cell_cultured
, NE
derived NE
from NE
a NE
human Cell_cultured_B
T Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
( NE
CEM Cell_cultured
) NE
, NE
is NE
chronically NE
infected NE
with NE
HIV-1 Virus
, NE
with NE
low NE
levels NE
of NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

ACH-2 Cell_cultured
can NE
be NE
converted NE
to NE
productive NE
infection NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
12-O-tetradecanoylphorbol-13-acetate Organic_compound_other
( NE
TPA Organic_compound_other
) NE
, NE
mitogen Organic_compound_other
or NE
cytokines Protein_family_or_group
( NE
TNF-alpha Protein_molecule
) NE
, NE
or NE
infection NE
with NE
HSV Virus
. NE

Therefore NE
the NE
ACH-2 Cell_cultured
cell NE
line NE
is NE
a NE
good NE
candidate NE
for NE
studying NE
the NE
effects NE
of NE
drugs NE
on NE
HIV-1 Virus
activation NE
. NE

Previously NE
, NE
we NE
have NE
reported NE
that NE
DHEA Lipid
and NE
synthetic NE
analogs NE
of NE
DHEA NE
can NE
be NE
modest NE
inhibitors NE
of NE
HIV-1 Other_B
IIIB Other_M
replication Other_E
in NE
phytohemagglutinin NE
-stimulated NE
peripheral NE
blood NE
lymphocyte NE
cultures NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

C/EBP Protein_family_or_group_B
activators Protein_family_or_group_E
are NE
required NE
for NE
HIV-1 Other_B
replication Other_E
and NE
proviral NE
induction NE
in NE
monocytic NE
cell NE
lines NE
. NE

Previous NE
work NE
has NE
shown NE
that NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
and NE
C/EBP Protein_family_or_group_B
transcriptional Protein_family_or_group_M
activators Protein_family_or_group_E
are NE
necessary NE
for NE
HIV-1 Other_B
LTR Other_M
activity Other_E
in NE
monocytes/macrophages NE
. NE

We NE
have NE
investigated NE
the NE
role NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
play NE
in NE
induction NE
and NE
replication NE
of NE
HIV-1 Virus
. NE

Ectopic NE
expression NE
of NE
the NE
dominant NE
negative NE
C/EBP NE
protein NE
LIP NE
inhibited NE
HIV-1 NE
mRNA NE
and NE
virus NE
production NE
in NE
activated NE
U1 NE
cells NE
, NE
demonstrating NE
that NE
C/EBP NE
proteins NE
are NE
required NE
for NE
provirus NE
induction NE
. NE

U1 Cell_cultured_B
lines Cell_cultured_E
overexpressing NE
C/EBP Protein_family_or_group_B
activator Protein_family_or_group_E
NF-IL-6 Protein_molecule
produced NE
more NE
viral RNA_family_or_group_B
mRNA RNA_family_or_group_E
and NE
virus Virus_B
particles Virus_E
following NE
cellular Other_B
activation Other_E
than NE
control Cell_cultured_B
lines Cell_cultured_E
, NE
demonstrating NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
are NE
limiting NE
for NE
virus Other_B
transcription Other_E
. NE

HIV-1 Virus
harboring NE
mutations NE
within NE
two NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
were NE
crippled NE
in NE
their NE
ability NE
to NE
replicate NE
in NE
U937 Cell_cultured_B
promonocytic Cell_cultured_M
cells Cell_cultured_E
, NE
indicating NE
that NE
these NE
sites NE
are NE
required NE
for NE
replication NE
. NE

These NE
data NE
identify NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
as NE
regulators NE
of NE
HIV-1 Other_B
expression Other_E
in NE
monocytes/macrophages NE
. NE

IL-10 Protein_molecule
inhibits NE
nuclear Other_B
factor-kappa Other_M
B/Rel Other_M
nuclear Other_M
activity Other_E
in NE
CD3 NE
-stimulated NE
human NE
peripheral NE
T NE
lymphocytes NE
. NE

IL-10 Protein_molecule
markedly NE
reduces NE
nuclear NE
factor NE
(NF)-kappa Other_B
B/Rel Other_M
nuclear Other_M
activity Other_E
induced NE
in NE
PBMC NE
by NE
stimulation NE
with NE
the NE
anti-CD3 NE
mAb NE
OKT3 NE
. NE

The NE
inhibition NE
is NE
exerted NE
specifically NE
on NE
the NE
NF-kappa Other_B
B/Rel Other_M
activation Other_E
induced NE
by NE
mAb NE
OKT3 NE
, NE
and NE
not NE
that NE
produced NE
by NE
PMA NE
. NE

As NE
judged NE
by NE
supershifting NE
the NE
DNA-protein NE
complexes NE
with NE
Abs NE
recognizing NE
specific NE
components NE
of NE
the NE
NF-kappa NE
B/Rel NE
protein NE
family NE
, NE
the NE
p50/p65 NE
( NE
Rel NE
A NE
) NE
heterodimeric NE
form NE
of NE
NF-kappa NE
B NE
is NE
primarily NE
affected NE
. NE

The NE
maximal NE
effect NE
is NE
observed NE
at NE
the NE
IL-10 Other_B
concentration Other_E
of NE
20 NE
U/ml NE
. NE

IL-10 Protein_molecule
inhibitory NE
activity NE
is NE
exerted NE
on NE
T Cell_natural_B
lymphocytes Cell_natural_E
and NE
is NE
mediated NE
by NE
monocytes Cell_natural
. NE

Indeed NE
, NE
monocytes Cell_natural
pretreated NE
with NE
IL-10 Protein_molecule
are NE
able NE
so NE
inhibit NE
NF-kappa Protein_complex_B
B Protein_complex_E
nuclear NE
activity NE
in NE
purified NE
T Cell_natural_B
lymphocytes Cell_natural_E
stimulated NE
with NE
OKT3 Protein_molecule
. NE

Soluble NE
factors NE
do NE
not NE
appear NE
to NE
be NE
involved NE
in NE
the NE
mechanism NE
of NE
inhibition NE
. NE

On NE
the NE
other NE
hand NE
, NE
the NE
up-regulation NE
of NE
CD80 Protein_molecule_B
Ag Protein_molecule_E
, NE
found NE
on NE
monocytes Cell_natural
obtained NE
from NE
PBMC Cell_natural
incubated NE
with NE
OKT3 Protein_molecule
, NE
is NE
not NE
detected NE
after NE
addition NE
of NE
IL-10 Protein_molecule
, NE
and NE
the NE
anti-CD28 Protein_family_or_group_B
mAb Protein_family_or_group_E
CLB-CD28/1 Protein_molecule
restores NE
the NE
NF-kappa Element_B
B/Rel Element_M
nuclear Element_M
activity Element_E
in NE
IL-10 NE
-inhibited NE
lymphocytes NE
. NE

Therefore NE
, NE
the NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
inhibition NE
might NE
be NE
ascribed NE
to NE
a NE
lack NE
of NE
cooperation NE
between NE
accessory NE
cells NE
and NE
T Cell_natural_B
lymphocytes Cell_natural_E
, NE
resulting NE
from NE
down-regulation NE
of NE
a NE
costimulatory NE
molecule NE
, NE
such NE
as NE
CD80 Protein_molecule
, NE
produced NE
by NE
IL-10 Protein_molecule
on NE
activated NE
monocytes Cell_natural
. NE

Our NE
results NE
demonstrate NE
that NE
IL-10 Protein_molecule
can NE
inhibit NE
the NE
induction NE
of NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
nuclear NE
activity NE
in NE
CD3 NE
-stimulated NE
T NE
lymphocytes NE
. NE

Since NE
inappropriate NE
activation NE
of NE
kappa DNA_family_or_group_B
B-driven DNA_family_or_group_M
genes DNA_family_or_group_E
has NE
a NE
physiopathologic NE
role NE
in NE
a NE
number NE
of NE
diseases NE
, NE
such NE
as NE
HIV Other_B
infection Other_E
, NE
our NE
findings NE
support NE
the NE
possibility NE
of NE
using NE
this NE
cytokine NE
to NE
suppress NE
an NE
undesirable NE
activation NE
of NE
these NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
. NE

Multiple NE
prolactin NE
-responsive NE
elements NE
mediate NE
G1 NE
and NE
S NE
phase NE
expression NE
of NE
the NE
interferon NE
regulatory NE
factor-1 NE
gene NE
. NE

The NE
interferon NE
regulatory NE
factor-1 NE
( NE
IRF-1 NE
) NE
gene NE
is NE
both NE
an NE
immediate-early NE
G1 NE
phase NE
gene NE
and NE
an NE
S NE
phase NE
gene NE
inducible NE
by NE
PRL NE
in NE
rat NE
Nb2 NE
T NE
lymphocytes NE
. NE

To NE
understand NE
the NE
mechanism NE
by NE
which NE
PRL Protein_molecule
regulates NE
the NE
biphasic NE
expression NE
of NE
IRF-1 Protein_molecule
, NE
we NE
cloned NE
the NE
rat DNA_domain_or_region_B
IRF-1 DNA_domain_or_region_M
gene DNA_domain_or_region_E
and NE
functionally NE
characterized NE
the NE
IRF-1 NE
promoter NE
. NE

Upon NE
transfection NE
into NE
Nb2 Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
, NE
1.7 NE
kilobases NE
(kb) NE
of NE
IRF-1 NE
5'-flanking NE
DNA NE
linked NE
to NE
a NE
chloramphenicol NE
acetyl NE
transferase NE
( NE
CAT NE
) NE
reporter NE
gene NE
mediated NE
a NE
30-fold NE
induction NE
of NE
CAT Other_B
enzyme Other_M
activity Other_E
in NE
response NE
to NE
24 NE
h NE
of NE
PRL NE
stimulation NE
. NE

Deletion NE
mutants NE
containing NE
1.3 NE
, NE
0.6 NE
, NE
and NE
0.2 NE
kb NE
5'-flanking NE
DNA NE
were NE
incrementally NE
less NE
transcriptionally NE
active NE
, NE
although NE
0.2 NE
kb NE
still NE
mediated NE
a NE
12-fold NE
induction NE
by NE
PRL NE
. NE

The NE
sequence NE
between NE
-1.7 NE
and NE
-0.2 NE
kb NE
linked NE
to NE
a NE
heterologous NE
thymidine NE
kinase NE
promoter NE
failed NE
to NE
respond NE
to NE
PRL Protein_molecule
stimulation NE
, NE
suggesting NE
that NE
the NE
activity NE
of NE
upstream DNA_family_or_group_B
PRL DNA_family_or_group_M
response DNA_family_or_group_M
elements DNA_family_or_group_E
may NE
require NE
an NE
interaction NE
with NE
promoter-proximal NE
elements NE
. NE

By NE
assaying NE
CAT Other_B
enzyme Other_M
activity Other_E
across NE
a NE
24-h NE
PRL NE
induction NE
time NE
course NE
, NE
we NE
were NE
able NE
to NE
assign NE
G1 NE
vs NE
. NE
S NE
phase NE
PRL NE
responses NE
of NE
the NE
IRF-1 NE
gene NE
to NE
different NE
regions NE
of NE
the NE
IRF-1 NE
5'-flanking NE
and NE
promoter NE
DNA NE
. NE

The NE
0.2-kb NE
IRF- NE
CAT NE
construct NE
was NE
induced NE
by NE
PRL NE
stimulation NE
during NE
the NE
G1 NE
phase NE
of NE
the NE
cell NE
cycle NE
. NE

In NE
contrast NE
, NE
the NE
1.7-kb NE
IRF- NE
CAT NE
construct NE
was NE
inducible NE
by NE
PRL Protein_molecule
during NE
both NE
G1 NE
and NE
S NE
phase NE
of NE
the NE
cell NE
cycle NE
. NE

Hence NE
, NE
the NE
PRL Protein_molecule
-induced NE
biphasic NE
expression NE
of NE
the NE
IRF-1 DNA_domain_or_region_B
gene DNA_domain_or_region_E
appears NE
to NE
be NE
controlled NE
by NE
separate NE
PRL NE
-responsive NE
elements NE
: NE
elements NE
in NE
the NE
first NE
0.2 NE
kb NE
of NE
the NE
IRF-1 NE
promoter NE
region NE
act NE
during NE
early NE
activation NE
, NE
and NE
elements NE
between NE
0.2 NE
and NE
1.7 NE
kb NE
act NE
in NE
concert NE
with NE
the NE
proximal NE
0.2-kb NE
region NE
during NE
S NE
phase NE
progression NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

A NE
novel NE
mitogen NE
-inducible NE
gene NE
product NE
related NE
to NE
p50/p105-NF-kappa NE
B NE
participates NE
in NE
transactivation NE
through NE
a NE
kappa NE
B NE
site NE
. NE

A NE
Rel-related NE
, NE
mitogen NE
-inducible NE
, NE
kappa NE
B NE
-binding NE
protein NE
has NE
been NE
cloned NE
as NE
an NE
immediate-early NE
activation NE
gene NE
of NE
human NE
peripheral NE
blood NE
T NE
cells NE
. NE

The NE
cDNA DNA_family_or_group
has NE
an NE
open DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
900 DNA_domain_or_region_B
amino DNA_domain_or_region_M
acids DNA_domain_or_region_E
capable NE
of NE
encoding NE
a NE
97-kDa Protein_molecule_B
protein Protein_molecule_E
. NE

This NE
protein NE
is NE
most NE
similar NE
to NE
the NE
105-kDa Peptide_B
precursor Peptide_M
polypeptide Peptide_E
of NE
p50-NF-kappa Protein_molecule_B
B Protein_molecule_E
. NE

Like NE
the NE
105-kDa NE
precursor NE
, NE
it NE
contains NE
an NE
amino-terminal Protein_domain_or_region_B
Rel-related Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
about NE
300 NE
amino NE
acids NE
and NE
a NE
carboxy-terminal Protein_domain_or_region_B
domain Protein_domain_or_region_E
containing NE
six NE
full Protein_substructure_B
cell Protein_substructure_M
cycle Protein_substructure_E
or NE
ankyrin Protein_substructure_B
repeats Protein_substructure_E
. NE

In NE
vitro-translated NE
proteins NE
, NE
truncated NE
downstream NE
of NE
the NE
Rel NE
domain NE
and NE
excluding NE
the NE
repeats NE
, NE
bind NE
kappa NE
B NE
sites NE
. NE

We NE
refer NE
to NE
the NE
kappa NE
B NE
-binding NE
, NE
truncated NE
protein NE
as NE
p50B NE
by NE
analogy NE
with NE
p50-NF-kappa NE
B NE
and NE
to NE
the NE
full-length NE
protein NE
as NE
p97 NE
. NE

p50B Protein_molecule
is NE
able NE
to NE
form NE
heteromeric NE
kappa NE
B NE
-binding NE
complexes NE
with NE
RelB NE
, NE
as NE
well NE
as NE
with NE
p65 NE
and NE
p50 NE
, NE
the NE
two NE
subunits NE
of NE
NF-kappa NE
B NE
. NE

Transient-transfection NE
experiments NE
in NE
embryonal Cell_cultured_B
carcinoma Cell_cultured_M
cells Cell_cultured_E
demonstrate NE
a NE
functional NE
cooperation NE
between NE
p50B Protein_molecule
and NE
RelB Protein_molecule
or NE
p65 Protein_molecule
in NE
transactivation NE
of NE
a NE
reporter DNA_molecule_B
plasmid DNA_molecule_E
dependent NE
on NE
a NE
kappa DNA_domain_or_region_B
B DNA_domain_or_region_M
site DNA_domain_or_region_E
. NE

The NE
data NE
imply NE
the NE
existence NE
of NE
a NE
complex NE
family NE
of NE
NF-kappa NE
B NE
-like NE
transcription NE
factors NE
. NE

A NE
novel DNA_domain_or_region_B
SP-1 DNA_domain_or_region_M
site DNA_domain_or_region_E
in NE
the NE
human NE
interleukin-1 NE
beta NE
promoter NE
confers NE
preferential NE
transcriptional NE
activity NE
in NE
keratinocytes NE
. NE

To NE
investigate NE
the NE
mechanisms NE
of NE
transcriptional Other_B
activation Other_E
of NE
interleukin-1beta Protein_molecule
( NE
IL-1beta Protein_molecule
) NE
in NE
non-monocytic NE
cells NE
, NE
we NE
constructed NE
a NE
series NE
of NE
reporter NE
plasmids NE
with NE
the NE
bacterial NE
chloramphenicol NE
acetyltransferase NE
gene NE
linked NE
to NE
various NE
parts NE
of NE
the NE
human DNA_domain_or_region_B
IL-1beta DNA_domain_or_region_M
promoter DNA_domain_or_region_E
and NE
performed NE
transient NE
transfection NE
experiments NE
. NE

We NE
identified NE
a NE
promoter NE
segment NE
that NE
activates NE
transcription NE
most NE
efficiently NE
in NE
keratinocytes Cell_natural
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
( NE
EMSA Other
) NE
with NE
a NE
43-mer DNA_domain_or_region_B
oligonucleotide DNA_domain_or_region_E
derived NE
from NE
the NE
functionally NE
identified NE
cis-acting DNA_domain_or_region_B
element DNA_domain_or_region_E
revealed NE
specific NE
complexes NE
. NE

By NE
competition NE
analysis NE
with NE
transcription DNA_family_or_group_B
factor DNA_family_or_group_M
consensus DNA_family_or_group_M
sequence DNA_family_or_group_M
oligonucleotides DNA_family_or_group_E
and NE
by NE
immunosupershift Other
, NE
transcription Protein_molecule_B
factor Protein_molecule_M
SP-1 Protein_molecule_E
or NE
a NE
closely NE
related NE
protein NE
was NE
shown NE
to NE
bind NE
to NE
this NE
regulatory DNA_domain_or_region_B
element DNA_domain_or_region_E
. NE

The NE
closest NE
match NE
to NE
the NE
known NE
SP-1 DNA_domain_or_region_B
consensus DNA_domain_or_region_M
sequence DNA_domain_or_region_E
within NE
the NE
respective NE
region NE
is NE
a NE
TCCCCTCCCCT NE
motif NE
. NE

Mutation NE
of NE
this NE
motif NE
almost NE
completely NE
, NE
and NE
specifically NE
, NE
abolished NE
the NE
binding NE
of NE
two NE
low-mobility NE
complexes NE
and NE
led NE
to NE
a NE
95% NE
decrease NE
of NE
constitutive NE
transcriptional NE
activation NE
of NE
a NE
reporter NE
construct NE
IL-1beta NE
(-170/+108) NE
. NE

Likewise NE
, NE
activation NE
of NE
this NE
reporter NE
construct NE
by NE
tumor Protein_molecule_B
necrosis Protein_molecule_M
factor-alpha Protein_molecule_E
depended NE
on NE
the NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
. NE

These NE
observations NE
suggest NE
that NE
a NE
so-far-unrecognized NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
human NE
IL-1beta NE
promoter NE
may NE
participate NE
in NE
the NE
transcriptional NE
regulation NE
of NE
this NE
gene NE
in NE
keratinocytes NE
. NE

Regulation NE
of NE
the NE
beta-globin DNA_domain_or_region_B
locus DNA_domain_or_region_E
. NE

Transcription NE
of NE
the NE
human DNA_domain_or_region_B
beta-globin DNA_domain_or_region_M
gene DNA_domain_or_region_M
cluster DNA_domain_or_region_E
depends NE
upon NE
upstream DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
sequences DNA_domain_or_region_E
, NE
which NE
are NE
collectively NE
termed NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
. NE

Recent NE
studies NE
have NE
provided NE
new NE
insights NE
into NE
how NE
the NE
individual NE
genes NE
of NE
the NE
cluster NE
are NE
regulated NE
through NE
development NE
. NE

The NE
crux NE
of NE
transcriptional Other_B
activation Other_E
is NE
how NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
communicates NE
with NE
the NE
gene-proximal DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
elements DNA_domain_or_region_E
. NE

Inhibition NE
of NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
by NE
dehydroepiandrosterone NE
( NE
DHEA NE
) NE
and NE
an NE
analog NE
of NE
DHEA NE
. NE

The NE
initial NE
infection NE
with NE
human Virus_B
immunodeficiency Virus_M
virus Virus_M
type Virus_M
1 Virus_E
( NE
HIV-1 Virus
) NE
in NE
most NE
individuals NE
usually NE
results NE
in NE
the NE
establishment NE
of NE
a NE
latent NE
or NE
chronic Other_B
infection Other_E
before NE
eventual NE
progression NE
toward NE
acquired Other_B
immunodeficiency Other_M
syndrome Other_E
. NE

HIV-1 Virus
can NE
also NE
establish NE
a NE
latent NE
or NE
persistent NE
infection NE
in NE
some NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
that NE
show NE
minimal NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

However NE
, NE
activation NE
of NE
the NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
leading NE
to NE
enhanced NE
HIV-1 Virus
replication NE
can NE
be NE
induced NE
by NE
antigens Protein_family_or_group
, NE
mitogens Other
, NE
and NE
cytokines Protein_family_or_group
( NE
tumor Protein_family_or_group_B
necrosis Protein_family_or_group_M
factor Protein_family_or_group_M
alpha Protein_family_or_group_E
[ NE
TNF-alpha Protein_molecule
] NE
, NE
interleukin Protein_molecule_B
1 Protein_molecule_E
, NE
and NE
interleukin-2 Protein_molecule
) NE
. NE

Various NE
gene NE
products NE
from NE
other NE
viruses NE
( NE
HTLV-1 Virus
, NE
HSV Virus
, NE
EBV Virus
, NE
CMV Virus
, NE
HBV Virus
, NE
and NE
HHV-6 Virus
) NE
can NE
also NE
enhance NE
HIV-1 NE
long NE
terminal NE
repeat NE
( NE
LTR NE
)-driven NE
reporter NE
gene NE
activity NE
. NE

On NE
the NE
basis NE
of NE
these NE
observations NE
, NE
it NE
has NE
been NE
proposed NE
that NE
reactivation NE
of NE
latent NE
HIV-1 Virus
harbored NE
in NE
chronically Cell_natural_B
infected Cell_natural_M
T Cell_natural_M
lymphocytes Cell_natural_E
, NE
monocytes Cell_natural
, NE
or NE
macrophages Cell_natural
plays NE
an NE
important NE
role NE
in NE
the NE
pathogenesis NE
of NE
AIDS Other
. NE

So NE
far NE
, NE
there NE
are NE
no NE
drugs NE
or NE
therapy NE
available NE
that NE
can NE
provide NE
protection NE
against NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
. NE

ACH-2 Cell_cultured
, NE
derived NE
from NE
a NE
human Cell_cultured_B
T Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
( NE
CEM Cell_cultured
) NE
, NE
is NE
chronically NE
infected NE
with NE
HIV-1 Virus
, NE
with NE
low NE
levels NE
of NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

ACH-2 Cell_cultured
can NE
be NE
converted NE
to NE
productive NE
infection NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
12-O-tetradecanoylphorbol-13-acetate Organic_compound_other
( NE
TPA Organic_compound_other
) NE
, NE
mitogen Organic_compound_other
or NE
cytokines Protein_family_or_group
( NE
TNF-alpha Protein_molecule
) NE
, NE
or NE
infection NE
with NE
HSV Virus
. NE

Therefore NE
the NE
ACH-2 Cell_cultured
cell NE
line NE
is NE
a NE
good NE
candidate NE
for NE
studying NE
the NE
effects NE
of NE
drugs NE
on NE
HIV-1 Virus
activation NE
. NE

Previously NE
, NE
we NE
have NE
reported NE
that NE
DHEA Lipid
and NE
synthetic NE
analogs NE
of NE
DHEA NE
can NE
be NE
modest NE
inhibitors NE
of NE
HIV-1 Other_B
IIIB Other_M
replication Other_E
in NE
phytohemagglutinin NE
-stimulated NE
peripheral NE
blood NE
lymphocyte NE
cultures NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

C/EBP Protein_family_or_group_B
activators Protein_family_or_group_E
are NE
required NE
for NE
HIV-1 Other_B
replication Other_E
and NE
proviral NE
induction NE
in NE
monocytic NE
cell NE
lines NE
. NE

Previous NE
work NE
has NE
shown NE
that NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
and NE
C/EBP Protein_family_or_group_B
transcriptional Protein_family_or_group_M
activators Protein_family_or_group_E
are NE
necessary NE
for NE
HIV-1 Other_B
LTR Other_M
activity Other_E
in NE
monocytes/macrophages NE
. NE

We NE
have NE
investigated NE
the NE
role NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
play NE
in NE
induction NE
and NE
replication NE
of NE
HIV-1 Virus
. NE

Ectopic NE
expression NE
of NE
the NE
dominant NE
negative NE
C/EBP NE
protein NE
LIP NE
inhibited NE
HIV-1 NE
mRNA NE
and NE
virus NE
production NE
in NE
activated NE
U1 NE
cells NE
, NE
demonstrating NE
that NE
C/EBP NE
proteins NE
are NE
required NE
for NE
provirus NE
induction NE
. NE

U1 Cell_cultured_B
lines Cell_cultured_E
overexpressing NE
C/EBP Protein_family_or_group_B
activator Protein_family_or_group_E
NF-IL-6 Protein_molecule
produced NE
more NE
viral RNA_family_or_group_B
mRNA RNA_family_or_group_E
and NE
virus Virus_B
particles Virus_E
following NE
cellular Other_B
activation Other_E
than NE
control Cell_cultured_B
lines Cell_cultured_E
, NE
demonstrating NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
are NE
limiting NE
for NE
virus Other_B
transcription Other_E
. NE

HIV-1 Virus
harboring NE
mutations NE
within NE
two NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
were NE
crippled NE
in NE
their NE
ability NE
to NE
replicate NE
in NE
U937 Cell_cultured_B
promonocytic Cell_cultured_M
cells Cell_cultured_E
, NE
indicating NE
that NE
these NE
sites NE
are NE
required NE
for NE
replication NE
. NE

These NE
data NE
identify NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
as NE
regulators NE
of NE
HIV-1 Other_B
expression Other_E
in NE
monocytes/macrophages NE
. NE

IL-10 Protein_molecule
inhibits NE
nuclear Other_B
factor-kappa Other_M
B/Rel Other_M
nuclear Other_M
activity Other_E
in NE
CD3 NE
-stimulated NE
human NE
peripheral NE
T NE
lymphocytes NE
. NE

IL-10 Protein_molecule
markedly NE
reduces NE
nuclear NE
factor NE
(NF)-kappa Other_B
B/Rel Other_M
nuclear Other_M
activity Other_E
induced NE
in NE
PBMC NE
by NE
stimulation NE
with NE
the NE
anti-CD3 NE
mAb NE
OKT3 NE
. NE

The NE
inhibition NE
is NE
exerted NE
specifically NE
on NE
the NE
NF-kappa Other_B
B/Rel Other_M
activation Other_E
induced NE
by NE
mAb NE
OKT3 NE
, NE
and NE
not NE
that NE
produced NE
by NE
PMA NE
. NE

As NE
judged NE
by NE
supershifting NE
the NE
DNA-protein NE
complexes NE
with NE
Abs NE
recognizing NE
specific NE
components NE
of NE
the NE
NF-kappa NE
B/Rel NE
protein NE
family NE
, NE
the NE
p50/p65 NE
( NE
Rel NE
A NE
) NE
heterodimeric NE
form NE
of NE
NF-kappa NE
B NE
is NE
primarily NE
affected NE
. NE

The NE
maximal NE
effect NE
is NE
observed NE
at NE
the NE
IL-10 Other_B
concentration Other_E
of NE
20 NE
U/ml NE
. NE

IL-10 Protein_molecule
inhibitory NE
activity NE
is NE
exerted NE
on NE
T Cell_natural_B
lymphocytes Cell_natural_E
and NE
is NE
mediated NE
by NE
monocytes Cell_natural
. NE

Indeed NE
, NE
monocytes Cell_natural
pretreated NE
with NE
IL-10 Protein_molecule
are NE
able NE
so NE
inhibit NE
NF-kappa Protein_complex_B
B Protein_complex_E
nuclear NE
activity NE
in NE
purified NE
T Cell_natural_B
lymphocytes Cell_natural_E
stimulated NE
with NE
OKT3 Protein_molecule
. NE

Soluble NE
factors NE
do NE
not NE
appear NE
to NE
be NE
involved NE
in NE
the NE
mechanism NE
of NE
inhibition NE
. NE

On NE
the NE
other NE
hand NE
, NE
the NE
up-regulation NE
of NE
CD80 Protein_molecule_B
Ag Protein_molecule_E
, NE
found NE
on NE
monocytes Cell_natural
obtained NE
from NE
PBMC Cell_natural
incubated NE
with NE
OKT3 Protein_molecule
, NE
is NE
not NE
detected NE
after NE
addition NE
of NE
IL-10 Protein_molecule
, NE
and NE
the NE
anti-CD28 Protein_family_or_group_B
mAb Protein_family_or_group_E
CLB-CD28/1 Protein_molecule
restores NE
the NE
NF-kappa Element_B
B/Rel Element_M
nuclear Element_M
activity Element_E
in NE
IL-10 NE
-inhibited NE
lymphocytes NE
. NE

Therefore NE
, NE
the NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
inhibition NE
might NE
be NE
ascribed NE
to NE
a NE
lack NE
of NE
cooperation NE
between NE
accessory NE
cells NE
and NE
T Cell_natural_B
lymphocytes Cell_natural_E
, NE
resulting NE
from NE
down-regulation NE
of NE
a NE
costimulatory NE
molecule NE
, NE
such NE
as NE
CD80 Protein_molecule
, NE
produced NE
by NE
IL-10 Protein_molecule
on NE
activated NE
monocytes Cell_natural
. NE

Our NE
results NE
demonstrate NE
that NE
IL-10 Protein_molecule
can NE
inhibit NE
the NE
induction NE
of NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
nuclear NE
activity NE
in NE
CD3 NE
-stimulated NE
T NE
lymphocytes NE
. NE

Since NE
inappropriate NE
activation NE
of NE
kappa DNA_family_or_group_B
B-driven DNA_family_or_group_M
genes DNA_family_or_group_E
has NE
a NE
physiopathologic NE
role NE
in NE
a NE
number NE
of NE
diseases NE
, NE
such NE
as NE
HIV Other_B
infection Other_E
, NE
our NE
findings NE
support NE
the NE
possibility NE
of NE
using NE
this NE
cytokine NE
to NE
suppress NE
an NE
undesirable NE
activation NE
of NE
these NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
. NE

Multiple NE
prolactin NE
-responsive NE
elements NE
mediate NE
G1 NE
and NE
S NE
phase NE
expression NE
of NE
the NE
interferon NE
regulatory NE
factor-1 NE
gene NE
. NE

The NE
interferon NE
regulatory NE
factor-1 NE
( NE
IRF-1 NE
) NE
gene NE
is NE
both NE
an NE
immediate-early NE
G1 NE
phase NE
gene NE
and NE
an NE
S NE
phase NE
gene NE
inducible NE
by NE
PRL NE
in NE
rat NE
Nb2 NE
T NE
lymphocytes NE
. NE

To NE
understand NE
the NE
mechanism NE
by NE
which NE
PRL Protein_molecule
regulates NE
the NE
biphasic NE
expression NE
of NE
IRF-1 Protein_molecule
, NE
we NE
cloned NE
the NE
rat DNA_domain_or_region_B
IRF-1 DNA_domain_or_region_M
gene DNA_domain_or_region_E
and NE
functionally NE
characterized NE
the NE
IRF-1 NE
promoter NE
. NE

Upon NE
transfection NE
into NE
Nb2 Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
, NE
1.7 NE
kilobases NE
(kb) NE
of NE
IRF-1 NE
5'-flanking NE
DNA NE
linked NE
to NE
a NE
chloramphenicol NE
acetyl NE
transferase NE
( NE
CAT NE
) NE
reporter NE
gene NE
mediated NE
a NE
30-fold NE
induction NE
of NE
CAT Other_B
enzyme Other_M
activity Other_E
in NE
response NE
to NE
24 NE
h NE
of NE
PRL NE
stimulation NE
. NE

Deletion NE
mutants NE
containing NE
1.3 NE
, NE
0.6 NE
, NE
and NE
0.2 NE
kb NE
5'-flanking NE
DNA NE
were NE
incrementally NE
less NE
transcriptionally NE
active NE
, NE
although NE
0.2 NE
kb NE
still NE
mediated NE
a NE
12-fold NE
induction NE
by NE
PRL NE
. NE

The NE
sequence NE
between NE
-1.7 NE
and NE
-0.2 NE
kb NE
linked NE
to NE
a NE
heterologous NE
thymidine NE
kinase NE
promoter NE
failed NE
to NE
respond NE
to NE
PRL Protein_molecule
stimulation NE
, NE
suggesting NE
that NE
the NE
activity NE
of NE
upstream DNA_family_or_group_B
PRL DNA_family_or_group_M
response DNA_family_or_group_M
elements DNA_family_or_group_E
may NE
require NE
an NE
interaction NE
with NE
promoter-proximal NE
elements NE
. NE

By NE
assaying NE
CAT Other_B
enzyme Other_M
activity Other_E
across NE
a NE
24-h NE
PRL NE
induction NE
time NE
course NE
, NE
we NE
were NE
able NE
to NE
assign NE
G1 NE
vs NE
. NE
S NE
phase NE
PRL NE
responses NE
of NE
the NE
IRF-1 NE
gene NE
to NE
different NE
regions NE
of NE
the NE
IRF-1 NE
5'-flanking NE
and NE
promoter NE
DNA NE
. NE

The NE
0.2-kb NE
IRF- NE
CAT NE
construct NE
was NE
induced NE
by NE
PRL NE
stimulation NE
during NE
the NE
G1 NE
phase NE
of NE
the NE
cell NE
cycle NE
. NE

In NE
contrast NE
, NE
the NE
1.7-kb NE
IRF- NE
CAT NE
construct NE
was NE
inducible NE
by NE
PRL Protein_molecule
during NE
both NE
G1 NE
and NE
S NE
phase NE
of NE
the NE
cell NE
cycle NE
. NE

Hence NE
, NE
the NE
PRL Protein_molecule
-induced NE
biphasic NE
expression NE
of NE
the NE
IRF-1 DNA_domain_or_region_B
gene DNA_domain_or_region_E
appears NE
to NE
be NE
controlled NE
by NE
separate NE
PRL NE
-responsive NE
elements NE
: NE
elements NE
in NE
the NE
first NE
0.2 NE
kb NE
of NE
the NE
IRF-1 NE
promoter NE
region NE
act NE
during NE
early NE
activation NE
, NE
and NE
elements NE
between NE
0.2 NE
and NE
1.7 NE
kb NE
act NE
in NE
concert NE
with NE
the NE
proximal NE
0.2-kb NE
region NE
during NE
S NE
phase NE
progression NE
. NE

Triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
CR1 Protein_molecule
( NE
CD35 Protein_molecule
) NE
and NE
CR3 Protein_molecule
( NE
CD11b/CD18 Protein_molecule
) NE
induces NE
nuclear Other_B
translocation Other_E
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50/p65 Protein_molecule
) NE
in NE
human Cell_natural_B
monocytes Cell_natural_E
and NE
enhances NE
viral Other_B
replication Other_E
in NE
HIV NE
-infected NE
monocytic NE
cells NE
. NE

Monocyte NE
/ NE
macrophages NE
may NE
harbor NE
HIV NE
in NE
a NE
nonproductive NE
fashion NE
for NE
prolonged NE
periods NE
of NE
time NE
. NE

Viral Other_B
gene Other_M
expression Other_E
may NE
be NE
reactivated NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
LPS Lipid
or NE
cytokines Protein_family_or_group
such NE
as NE
TNF-alpha Protein_molecule
in NE
vitro NE
. NE

The NE
effect NE
of NE
LPS Lipid
and NE
TNF-alpha Protein_molecule
is NE
mediated NE
by NE
their NE
ability NE
to NE
induce NE
nuclear Other_B
translocation Other_E
of NE
the NE
DNA-binding Protein_family_or_group_B
heterodimer Protein_family_or_group_E
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50/p65 Protein_molecule
) NE
, NE
which NE
binds NE
to NE
a NE
specific NE
sequence NE
in NE
the NE
HIV-long DNA_domain_or_region_B
terminal DNA_domain_or_region_M
repeat DNA_domain_or_region_E
. NE

The NE
present NE
study NE
demonstrates NE
that NE
triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
CR1 Protein_molecule
( NE
CD35 Protein_molecule
) NE
and NE
CR3 Protein_molecule
( NE
CD11b/CD18 Protein_molecule
) NE
enhances NE
viral Other_B
replication Other_E
in NE
HIV NE
-infected NE
human NE
monocytic NE
cells NE
. NE

Monocytic Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
and NE
normal NE
peripheral NE
blood NE
monocytes NE
were NE
infected NE
with NE
HIV-1 Virus
in NE
vitro NE
and NE
cultured NE
in NE
the NE
presence NE
or NE
absence NE
of NE
F(ab')2 Protein_molecule_B
fragments Protein_molecule_E
of NE
monoclonal NE
anti- NE
CR1 NE
or NE
anti- NE
CR3 NE
Abs NE
or NE
with NE
C3 NE
fragments NE
. NE

Stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
induces NE
a NE
two- NE
to NE
fourfold NE
increase NE
in NE
the NE
amount NE
of NE
cell-associated NE
and NE
released NE
p24 Protein_molecule_B
Ag Protein_molecule_E
in NE
cell Cell_cultured_B
cultures Cell_cultured_E
that NE
was NE
equivalent NE
to NE
that NE
observed NE
in NE
control Cell_cultured_B
cultures Cell_cultured_E
triggered NE
with NE
LPS Lipid
. NE

We NE
further NE
observed NE
that NE
stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
induces NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
in NE
infected Cell_natural_B
cells Cell_natural_E
. NE

Translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
was NE
also NE
observed NE
following NE
stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
of NE
uninfected NE
peripheral NE
blood NE
monocytes NE
from NE
HIV-seronegative NE
donors NE
. NE

The NE
amount NE
of NE
protein NE
translocated NE
was NE
similar NE
to NE
that NE
observed NE
when NE
cells NE
were NE
stimulated NE
with NE
rhTNF-alpha Protein_molecule
. NE

TNF-alpha Protein_molecule
did NE
not NE
mediate NE
the NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
induced NE
by NE
triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
. NE

Taken NE
together NE
, NE
these NE
observations NE
suggest NE
that NE
HIV Other_B
gene Other_M
expression Other_E
may NE
be NE
activated NE
in NE
infected Cell_natural_B
monocytes Cell_natural_E
through NE
interaction NE
of NE
the NE
cells NE
with NE
complement-opsonized Protein_family_or_group_B
particles Protein_family_or_group_E
and NE
that NE
enhanced NE
viral Other_B
replication Other_E
is NE
associated NE
with NE
C3 Protein_family_or_group_B
receptor Protein_family_or_group_E
-mediated NE
nuclear Other_B
translocation Other_E
of NE
the NE
NF-kappa Protein_complex_B
B Protein_complex_M
complex Protein_complex_E
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

A NE
novel NE
mitogen NE
-inducible NE
gene NE
product NE
related NE
to NE
p50/p105-NF-kappa NE
B NE
participates NE
in NE
transactivation NE
through NE
a NE
kappa NE
B NE
site NE
. NE

A NE
Rel-related NE
, NE
mitogen NE
-inducible NE
, NE
kappa NE
B NE
-binding NE
protein NE
has NE
been NE
cloned NE
as NE
an NE
immediate-early NE
activation NE
gene NE
of NE
human NE
peripheral NE
blood NE
T NE
cells NE
. NE

The NE
cDNA DNA_family_or_group
has NE
an NE
open DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
900 DNA_domain_or_region_B
amino DNA_domain_or_region_M
acids DNA_domain_or_region_E
capable NE
of NE
encoding NE
a NE
97-kDa Protein_molecule_B
protein Protein_molecule_E
. NE

This NE
protein NE
is NE
most NE
similar NE
to NE
the NE
105-kDa Peptide_B
precursor Peptide_M
polypeptide Peptide_E
of NE
p50-NF-kappa Protein_molecule_B
B Protein_molecule_E
. NE

Like NE
the NE
105-kDa NE
precursor NE
, NE
it NE
contains NE
an NE
amino-terminal Protein_domain_or_region_B
Rel-related Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
about NE
300 NE
amino NE
acids NE
and NE
a NE
carboxy-terminal Protein_domain_or_region_B
domain Protein_domain_or_region_E
containing NE
six NE
full Protein_substructure_B
cell Protein_substructure_M
cycle Protein_substructure_E
or NE
ankyrin Protein_substructure_B
repeats Protein_substructure_E
. NE

In NE
vitro-translated NE
proteins NE
, NE
truncated NE
downstream NE
of NE
the NE
Rel NE
domain NE
and NE
excluding NE
the NE
repeats NE
, NE
bind NE
kappa NE
B NE
sites NE
. NE

We NE
refer NE
to NE
the NE
kappa NE
B NE
-binding NE
, NE
truncated NE
protein NE
as NE
p50B NE
by NE
analogy NE
with NE
p50-NF-kappa NE
B NE
and NE
to NE
the NE
full-length NE
protein NE
as NE
p97 NE
. NE

p50B Protein_molecule
is NE
able NE
to NE
form NE
heteromeric NE
kappa NE
B NE
-binding NE
complexes NE
with NE
RelB NE
, NE
as NE
well NE
as NE
with NE
p65 NE
and NE
p50 NE
, NE
the NE
two NE
subunits NE
of NE
NF-kappa NE
B NE
. NE

Transient-transfection NE
experiments NE
in NE
embryonal Cell_cultured_B
carcinoma Cell_cultured_M
cells Cell_cultured_E
demonstrate NE
a NE
functional NE
cooperation NE
between NE
p50B Protein_molecule
and NE
RelB Protein_molecule
or NE
p65 Protein_molecule
in NE
transactivation NE
of NE
a NE
reporter DNA_molecule_B
plasmid DNA_molecule_E
dependent NE
on NE
a NE
kappa DNA_domain_or_region_B
B DNA_domain_or_region_M
site DNA_domain_or_region_E
. NE

The NE
data NE
imply NE
the NE
existence NE
of NE
a NE
complex NE
family NE
of NE
NF-kappa NE
B NE
-like NE
transcription NE
factors NE
. NE

A NE
novel DNA_domain_or_region_B
SP-1 DNA_domain_or_region_M
site DNA_domain_or_region_E
in NE
the NE
human NE
interleukin-1 NE
beta NE
promoter NE
confers NE
preferential NE
transcriptional NE
activity NE
in NE
keratinocytes NE
. NE

To NE
investigate NE
the NE
mechanisms NE
of NE
transcriptional Other_B
activation Other_E
of NE
interleukin-1beta Protein_molecule
( NE
IL-1beta Protein_molecule
) NE
in NE
non-monocytic NE
cells NE
, NE
we NE
constructed NE
a NE
series NE
of NE
reporter NE
plasmids NE
with NE
the NE
bacterial NE
chloramphenicol NE
acetyltransferase NE
gene NE
linked NE
to NE
various NE
parts NE
of NE
the NE
human DNA_domain_or_region_B
IL-1beta DNA_domain_or_region_M
promoter DNA_domain_or_region_E
and NE
performed NE
transient NE
transfection NE
experiments NE
. NE

We NE
identified NE
a NE
promoter NE
segment NE
that NE
activates NE
transcription NE
most NE
efficiently NE
in NE
keratinocytes Cell_natural
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
( NE
EMSA Other
) NE
with NE
a NE
43-mer DNA_domain_or_region_B
oligonucleotide DNA_domain_or_region_E
derived NE
from NE
the NE
functionally NE
identified NE
cis-acting DNA_domain_or_region_B
element DNA_domain_or_region_E
revealed NE
specific NE
complexes NE
. NE

By NE
competition NE
analysis NE
with NE
transcription DNA_family_or_group_B
factor DNA_family_or_group_M
consensus DNA_family_or_group_M
sequence DNA_family_or_group_M
oligonucleotides DNA_family_or_group_E
and NE
by NE
immunosupershift Other
, NE
transcription Protein_molecule_B
factor Protein_molecule_M
SP-1 Protein_molecule_E
or NE
a NE
closely NE
related NE
protein NE
was NE
shown NE
to NE
bind NE
to NE
this NE
regulatory DNA_domain_or_region_B
element DNA_domain_or_region_E
. NE

The NE
closest NE
match NE
to NE
the NE
known NE
SP-1 DNA_domain_or_region_B
consensus DNA_domain_or_region_M
sequence DNA_domain_or_region_E
within NE
the NE
respective NE
region NE
is NE
a NE
TCCCCTCCCCT NE
motif NE
. NE

Mutation NE
of NE
this NE
motif NE
almost NE
completely NE
, NE
and NE
specifically NE
, NE
abolished NE
the NE
binding NE
of NE
two NE
low-mobility NE
complexes NE
and NE
led NE
to NE
a NE
95% NE
decrease NE
of NE
constitutive NE
transcriptional NE
activation NE
of NE
a NE
reporter NE
construct NE
IL-1beta NE
(-170/+108) NE
. NE

Likewise NE
, NE
activation NE
of NE
this NE
reporter NE
construct NE
by NE
tumor Protein_molecule_B
necrosis Protein_molecule_M
factor-alpha Protein_molecule_E
depended NE
on NE
the NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
. NE

These NE
observations NE
suggest NE
that NE
a NE
so-far-unrecognized NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
human NE
IL-1beta NE
promoter NE
may NE
participate NE
in NE
the NE
transcriptional NE
regulation NE
of NE
this NE
gene NE
in NE
keratinocytes NE
. NE

Regulation NE
of NE
the NE
beta-globin DNA_domain_or_region_B
locus DNA_domain_or_region_E
. NE

Transcription NE
of NE
the NE
human DNA_domain_or_region_B
beta-globin DNA_domain_or_region_M
gene DNA_domain_or_region_M
cluster DNA_domain_or_region_E
depends NE
upon NE
upstream DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
sequences DNA_domain_or_region_E
, NE
which NE
are NE
collectively NE
termed NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
. NE

Recent NE
studies NE
have NE
provided NE
new NE
insights NE
into NE
how NE
the NE
individual NE
genes NE
of NE
the NE
cluster NE
are NE
regulated NE
through NE
development NE
. NE

The NE
crux NE
of NE
transcriptional Other_B
activation Other_E
is NE
how NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
communicates NE
with NE
the NE
gene-proximal DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
elements DNA_domain_or_region_E
. NE

Inhibition NE
of NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
by NE
dehydroepiandrosterone NE
( NE
DHEA NE
) NE
and NE
an NE
analog NE
of NE
DHEA NE
. NE

The NE
initial NE
infection NE
with NE
human Virus_B
immunodeficiency Virus_M
virus Virus_M
type Virus_M
1 Virus_E
( NE
HIV-1 Virus
) NE
in NE
most NE
individuals NE
usually NE
results NE
in NE
the NE
establishment NE
of NE
a NE
latent NE
or NE
chronic Other_B
infection Other_E
before NE
eventual NE
progression NE
toward NE
acquired Other_B
immunodeficiency Other_M
syndrome Other_E
. NE

HIV-1 Virus
can NE
also NE
establish NE
a NE
latent NE
or NE
persistent NE
infection NE
in NE
some NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
that NE
show NE
minimal NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

However NE
, NE
activation NE
of NE
the NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
leading NE
to NE
enhanced NE
HIV-1 Virus
replication NE
can NE
be NE
induced NE
by NE
antigens Protein_family_or_group
, NE
mitogens Other
, NE
and NE
cytokines Protein_family_or_group
( NE
tumor Protein_family_or_group_B
necrosis Protein_family_or_group_M
factor Protein_family_or_group_M
alpha Protein_family_or_group_E
[ NE
TNF-alpha Protein_molecule
] NE
, NE
interleukin Protein_molecule_B
1 Protein_molecule_E
, NE
and NE
interleukin-2 Protein_molecule
) NE
. NE

Various NE
gene NE
products NE
from NE
other NE
viruses NE
( NE
HTLV-1 Virus
, NE
HSV Virus
, NE
EBV Virus
, NE
CMV Virus
, NE
HBV Virus
, NE
and NE
HHV-6 Virus
) NE
can NE
also NE
enhance NE
HIV-1 NE
long NE
terminal NE
repeat NE
( NE
LTR NE
)-driven NE
reporter NE
gene NE
activity NE
. NE

On NE
the NE
basis NE
of NE
these NE
observations NE
, NE
it NE
has NE
been NE
proposed NE
that NE
reactivation NE
of NE
latent NE
HIV-1 Virus
harbored NE
in NE
chronically Cell_natural_B
infected Cell_natural_M
T Cell_natural_M
lymphocytes Cell_natural_E
, NE
monocytes Cell_natural
, NE
or NE
macrophages Cell_natural
plays NE
an NE
important NE
role NE
in NE
the NE
pathogenesis NE
of NE
AIDS Other
. NE

So NE
far NE
, NE
there NE
are NE
no NE
drugs NE
or NE
therapy NE
available NE
that NE
can NE
provide NE
protection NE
against NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
. NE

ACH-2 Cell_cultured
, NE
derived NE
from NE
a NE
human Cell_cultured_B
T Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
( NE
CEM Cell_cultured
) NE
, NE
is NE
chronically NE
infected NE
with NE
HIV-1 Virus
, NE
with NE
low NE
levels NE
of NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

ACH-2 Cell_cultured
can NE
be NE
converted NE
to NE
productive NE
infection NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
12-O-tetradecanoylphorbol-13-acetate Organic_compound_other
( NE
TPA Organic_compound_other
) NE
, NE
mitogen Organic_compound_other
or NE
cytokines Protein_family_or_group
( NE
TNF-alpha Protein_molecule
) NE
, NE
or NE
infection NE
with NE
HSV Virus
. NE

Therefore NE
the NE
ACH-2 Cell_cultured
cell NE
line NE
is NE
a NE
good NE
candidate NE
for NE
studying NE
the NE
effects NE
of NE
drugs NE
on NE
HIV-1 Virus
activation NE
. NE

Previously NE
, NE
we NE
have NE
reported NE
that NE
DHEA Lipid
and NE
synthetic NE
analogs NE
of NE
DHEA NE
can NE
be NE
modest NE
inhibitors NE
of NE
HIV-1 Other_B
IIIB Other_M
replication Other_E
in NE
phytohemagglutinin NE
-stimulated NE
peripheral NE
blood NE
lymphocyte NE
cultures NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

C/EBP Protein_family_or_group_B
activators Protein_family_or_group_E
are NE
required NE
for NE
HIV-1 Other_B
replication Other_E
and NE
proviral NE
induction NE
in NE
monocytic NE
cell NE
lines NE
. NE

Previous NE
work NE
has NE
shown NE
that NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
and NE
C/EBP Protein_family_or_group_B
transcriptional Protein_family_or_group_M
activators Protein_family_or_group_E
are NE
necessary NE
for NE
HIV-1 Other_B
LTR Other_M
activity Other_E
in NE
monocytes/macrophages NE
. NE

We NE
have NE
investigated NE
the NE
role NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
play NE
in NE
induction NE
and NE
replication NE
of NE
HIV-1 Virus
. NE

Ectopic NE
expression NE
of NE
the NE
dominant NE
negative NE
C/EBP NE
protein NE
LIP NE
inhibited NE
HIV-1 NE
mRNA NE
and NE
virus NE
production NE
in NE
activated NE
U1 NE
cells NE
, NE
demonstrating NE
that NE
C/EBP NE
proteins NE
are NE
required NE
for NE
provirus NE
induction NE
. NE

U1 Cell_cultured_B
lines Cell_cultured_E
overexpressing NE
C/EBP Protein_family_or_group_B
activator Protein_family_or_group_E
NF-IL-6 Protein_molecule
produced NE
more NE
viral RNA_family_or_group_B
mRNA RNA_family_or_group_E
and NE
virus Virus_B
particles Virus_E
following NE
cellular Other_B
activation Other_E
than NE
control Cell_cultured_B
lines Cell_cultured_E
, NE
demonstrating NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
are NE
limiting NE
for NE
virus Other_B
transcription Other_E
. NE

HIV-1 Virus
harboring NE
mutations NE
within NE
two NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
were NE
crippled NE
in NE
their NE
ability NE
to NE
replicate NE
in NE
U937 Cell_cultured_B
promonocytic Cell_cultured_M
cells Cell_cultured_E
, NE
indicating NE
that NE
these NE
sites NE
are NE
required NE
for NE
replication NE
. NE

These NE
data NE
identify NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
as NE
regulators NE
of NE
HIV-1 Other_B
expression Other_E
in NE
monocytes/macrophages NE
. NE

IL-10 Protein_molecule
inhibits NE
nuclear Other_B
factor-kappa Other_M
B/Rel Other_M
nuclear Other_M
activity Other_E
in NE
CD3 NE
-stimulated NE
human NE
peripheral NE
T NE
lymphocytes NE
. NE

IL-10 Protein_molecule
markedly NE
reduces NE
nuclear NE
factor NE
(NF)-kappa Other_B
B/Rel Other_M
nuclear Other_M
activity Other_E
induced NE
in NE
PBMC NE
by NE
stimulation NE
with NE
the NE
anti-CD3 NE
mAb NE
OKT3 NE
. NE

The NE
inhibition NE
is NE
exerted NE
specifically NE
on NE
the NE
NF-kappa Other_B
B/Rel Other_M
activation Other_E
induced NE
by NE
mAb NE
OKT3 NE
, NE
and NE
not NE
that NE
produced NE
by NE
PMA NE
. NE

As NE
judged NE
by NE
supershifting NE
the NE
DNA-protein NE
complexes NE
with NE
Abs NE
recognizing NE
specific NE
components NE
of NE
the NE
NF-kappa NE
B/Rel NE
protein NE
family NE
, NE
the NE
p50/p65 NE
( NE
Rel NE
A NE
) NE
heterodimeric NE
form NE
of NE
NF-kappa NE
B NE
is NE
primarily NE
affected NE
. NE

The NE
maximal NE
effect NE
is NE
observed NE
at NE
the NE
IL-10 Other_B
concentration Other_E
of NE
20 NE
U/ml NE
. NE

IL-10 Protein_molecule
inhibitory NE
activity NE
is NE
exerted NE
on NE
T Cell_natural_B
lymphocytes Cell_natural_E
and NE
is NE
mediated NE
by NE
monocytes Cell_natural
. NE

Indeed NE
, NE
monocytes Cell_natural
pretreated NE
with NE
IL-10 Protein_molecule
are NE
able NE
so NE
inhibit NE
NF-kappa Protein_complex_B
B Protein_complex_E
nuclear NE
activity NE
in NE
purified NE
T Cell_natural_B
lymphocytes Cell_natural_E
stimulated NE
with NE
OKT3 Protein_molecule
. NE

Soluble NE
factors NE
do NE
not NE
appear NE
to NE
be NE
involved NE
in NE
the NE
mechanism NE
of NE
inhibition NE
. NE

On NE
the NE
other NE
hand NE
, NE
the NE
up-regulation NE
of NE
CD80 Protein_molecule_B
Ag Protein_molecule_E
, NE
found NE
on NE
monocytes Cell_natural
obtained NE
from NE
PBMC Cell_natural
incubated NE
with NE
OKT3 Protein_molecule
, NE
is NE
not NE
detected NE
after NE
addition NE
of NE
IL-10 Protein_molecule
, NE
and NE
the NE
anti-CD28 Protein_family_or_group_B
mAb Protein_family_or_group_E
CLB-CD28/1 Protein_molecule
restores NE
the NE
NF-kappa Element_B
B/Rel Element_M
nuclear Element_M
activity Element_E
in NE
IL-10 NE
-inhibited NE
lymphocytes NE
. NE

Therefore NE
, NE
the NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
inhibition NE
might NE
be NE
ascribed NE
to NE
a NE
lack NE
of NE
cooperation NE
between NE
accessory NE
cells NE
and NE
T Cell_natural_B
lymphocytes Cell_natural_E
, NE
resulting NE
from NE
down-regulation NE
of NE
a NE
costimulatory NE
molecule NE
, NE
such NE
as NE
CD80 Protein_molecule
, NE
produced NE
by NE
IL-10 Protein_molecule
on NE
activated NE
monocytes Cell_natural
. NE

Our NE
results NE
demonstrate NE
that NE
IL-10 Protein_molecule
can NE
inhibit NE
the NE
induction NE
of NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
nuclear NE
activity NE
in NE
CD3 NE
-stimulated NE
T NE
lymphocytes NE
. NE

Since NE
inappropriate NE
activation NE
of NE
kappa DNA_family_or_group_B
B-driven DNA_family_or_group_M
genes DNA_family_or_group_E
has NE
a NE
physiopathologic NE
role NE
in NE
a NE
number NE
of NE
diseases NE
, NE
such NE
as NE
HIV Other_B
infection Other_E
, NE
our NE
findings NE
support NE
the NE
possibility NE
of NE
using NE
this NE
cytokine NE
to NE
suppress NE
an NE
undesirable NE
activation NE
of NE
these NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
. NE

Multiple NE
prolactin NE
-responsive NE
elements NE
mediate NE
G1 NE
and NE
S NE
phase NE
expression NE
of NE
the NE
interferon NE
regulatory NE
factor-1 NE
gene NE
. NE

The NE
interferon NE
regulatory NE
factor-1 NE
( NE
IRF-1 NE
) NE
gene NE
is NE
both NE
an NE
immediate-early NE
G1 NE
phase NE
gene NE
and NE
an NE
S NE
phase NE
gene NE
inducible NE
by NE
PRL NE
in NE
rat NE
Nb2 NE
T NE
lymphocytes NE
. NE

To NE
understand NE
the NE
mechanism NE
by NE
which NE
PRL Protein_molecule
regulates NE
the NE
biphasic NE
expression NE
of NE
IRF-1 Protein_molecule
, NE
we NE
cloned NE
the NE
rat DNA_domain_or_region_B
IRF-1 DNA_domain_or_region_M
gene DNA_domain_or_region_E
and NE
functionally NE
characterized NE
the NE
IRF-1 NE
promoter NE
. NE

Upon NE
transfection NE
into NE
Nb2 Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
, NE
1.7 NE
kilobases NE
(kb) NE
of NE
IRF-1 NE
5'-flanking NE
DNA NE
linked NE
to NE
a NE
chloramphenicol NE
acetyl NE
transferase NE
( NE
CAT NE
) NE
reporter NE
gene NE
mediated NE
a NE
30-fold NE
induction NE
of NE
CAT Other_B
enzyme Other_M
activity Other_E
in NE
response NE
to NE
24 NE
h NE
of NE
PRL NE
stimulation NE
. NE

Deletion NE
mutants NE
containing NE
1.3 NE
, NE
0.6 NE
, NE
and NE
0.2 NE
kb NE
5'-flanking NE
DNA NE
were NE
incrementally NE
less NE
transcriptionally NE
active NE
, NE
although NE
0.2 NE
kb NE
still NE
mediated NE
a NE
12-fold NE
induction NE
by NE
PRL NE
. NE

The NE
sequence NE
between NE
-1.7 NE
and NE
-0.2 NE
kb NE
linked NE
to NE
a NE
heterologous NE
thymidine NE
kinase NE
promoter NE
failed NE
to NE
respond NE
to NE
PRL Protein_molecule
stimulation NE
, NE
suggesting NE
that NE
the NE
activity NE
of NE
upstream DNA_family_or_group_B
PRL DNA_family_or_group_M
response DNA_family_or_group_M
elements DNA_family_or_group_E
may NE
require NE
an NE
interaction NE
with NE
promoter-proximal NE
elements NE
. NE

By NE
assaying NE
CAT Other_B
enzyme Other_M
activity Other_E
across NE
a NE
24-h NE
PRL NE
induction NE
time NE
course NE
, NE
we NE
were NE
able NE
to NE
assign NE
G1 NE
vs NE
. NE
S NE
phase NE
PRL NE
responses NE
of NE
the NE
IRF-1 NE
gene NE
to NE
different NE
regions NE
of NE
the NE
IRF-1 NE
5'-flanking NE
and NE
promoter NE
DNA NE
. NE

The NE
0.2-kb NE
IRF- NE
CAT NE
construct NE
was NE
induced NE
by NE
PRL NE
stimulation NE
during NE
the NE
G1 NE
phase NE
of NE
the NE
cell NE
cycle NE
. NE

In NE
contrast NE
, NE
the NE
1.7-kb NE
IRF- NE
CAT NE
construct NE
was NE
inducible NE
by NE
PRL Protein_molecule
during NE
both NE
G1 NE
and NE
S NE
phase NE
of NE
the NE
cell NE
cycle NE
. NE

Hence NE
, NE
the NE
PRL Protein_molecule
-induced NE
biphasic NE
expression NE
of NE
the NE
IRF-1 DNA_domain_or_region_B
gene DNA_domain_or_region_E
appears NE
to NE
be NE
controlled NE
by NE
separate NE
PRL NE
-responsive NE
elements NE
: NE
elements NE
in NE
the NE
first NE
0.2 NE
kb NE
of NE
the NE
IRF-1 NE
promoter NE
region NE
act NE
during NE
early NE
activation NE
, NE
and NE
elements NE
between NE
0.2 NE
and NE
1.7 NE
kb NE
act NE
in NE
concert NE
with NE
the NE
proximal NE
0.2-kb NE
region NE
during NE
S NE
phase NE
progression NE
. NE

Triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
CR1 Protein_molecule
( NE
CD35 Protein_molecule
) NE
and NE
CR3 Protein_molecule
( NE
CD11b/CD18 Protein_molecule
) NE
induces NE
nuclear Other_B
translocation Other_E
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50/p65 Protein_molecule
) NE
in NE
human Cell_natural_B
monocytes Cell_natural_E
and NE
enhances NE
viral Other_B
replication Other_E
in NE
HIV NE
-infected NE
monocytic NE
cells NE
. NE

Monocyte NE
/ NE
macrophages NE
may NE
harbor NE
HIV NE
in NE
a NE
nonproductive NE
fashion NE
for NE
prolonged NE
periods NE
of NE
time NE
. NE

Viral Other_B
gene Other_M
expression Other_E
may NE
be NE
reactivated NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
LPS Lipid
or NE
cytokines Protein_family_or_group
such NE
as NE
TNF-alpha Protein_molecule
in NE
vitro NE
. NE

The NE
effect NE
of NE
LPS Lipid
and NE
TNF-alpha Protein_molecule
is NE
mediated NE
by NE
their NE
ability NE
to NE
induce NE
nuclear Other_B
translocation Other_E
of NE
the NE
DNA-binding Protein_family_or_group_B
heterodimer Protein_family_or_group_E
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50/p65 Protein_molecule
) NE
, NE
which NE
binds NE
to NE
a NE
specific NE
sequence NE
in NE
the NE
HIV-long DNA_domain_or_region_B
terminal DNA_domain_or_region_M
repeat DNA_domain_or_region_E
. NE

The NE
present NE
study NE
demonstrates NE
that NE
triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
CR1 Protein_molecule
( NE
CD35 Protein_molecule
) NE
and NE
CR3 Protein_molecule
( NE
CD11b/CD18 Protein_molecule
) NE
enhances NE
viral Other_B
replication Other_E
in NE
HIV NE
-infected NE
human NE
monocytic NE
cells NE
. NE

Monocytic Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
and NE
normal NE
peripheral NE
blood NE
monocytes NE
were NE
infected NE
with NE
HIV-1 Virus
in NE
vitro NE
and NE
cultured NE
in NE
the NE
presence NE
or NE
absence NE
of NE
F(ab')2 Protein_molecule_B
fragments Protein_molecule_E
of NE
monoclonal NE
anti- NE
CR1 NE
or NE
anti- NE
CR3 NE
Abs NE
or NE
with NE
C3 NE
fragments NE
. NE

Stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
induces NE
a NE
two- NE
to NE
fourfold NE
increase NE
in NE
the NE
amount NE
of NE
cell-associated NE
and NE
released NE
p24 Protein_molecule_B
Ag Protein_molecule_E
in NE
cell Cell_cultured_B
cultures Cell_cultured_E
that NE
was NE
equivalent NE
to NE
that NE
observed NE
in NE
control Cell_cultured_B
cultures Cell_cultured_E
triggered NE
with NE
LPS Lipid
. NE

We NE
further NE
observed NE
that NE
stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
induces NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
in NE
infected Cell_natural_B
cells Cell_natural_E
. NE

Translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
was NE
also NE
observed NE
following NE
stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
of NE
uninfected NE
peripheral NE
blood NE
monocytes NE
from NE
HIV-seronegative NE
donors NE
. NE

The NE
amount NE
of NE
protein NE
translocated NE
was NE
similar NE
to NE
that NE
observed NE
when NE
cells NE
were NE
stimulated NE
with NE
rhTNF-alpha Protein_molecule
. NE

TNF-alpha Protein_molecule
did NE
not NE
mediate NE
the NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
induced NE
by NE
triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
. NE

Taken NE
together NE
, NE
these NE
observations NE
suggest NE
that NE
HIV Other_B
gene Other_M
expression Other_E
may NE
be NE
activated NE
in NE
infected Cell_natural_B
monocytes Cell_natural_E
through NE
interaction NE
of NE
the NE
cells NE
with NE
complement-opsonized Protein_family_or_group_B
particles Protein_family_or_group_E
and NE
that NE
enhanced NE
viral Other_B
replication Other_E
is NE
associated NE
with NE
C3 Protein_family_or_group_B
receptor Protein_family_or_group_E
-mediated NE
nuclear Other_B
translocation Other_E
of NE
the NE
NF-kappa Protein_complex_B
B Protein_complex_M
complex Protein_complex_E
. NE

Genes NE
encoding NE
general Protein_family_or_group_B
initiation Protein_family_or_group_M
factors Protein_family_or_group_E
for NE
RNA Protein_molecule_B
polymerase Protein_molecule_M
II Protein_molecule_E
transcription NE
are NE
dispersed NE
in NE
the NE
human DNA_family_or_group_B
genome DNA_family_or_group_E
. NE

General Protein_family_or_group_B
transcription Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
required NE
for NE
accurate NE
initiation NE
of NE
transcription NE
by NE
RNA NE
polymerase NE
II NE
. NE

Human DNA_family_or_group_B
cDNAs DNA_family_or_group_E
encoding NE
subunits NE
of NE
these NE
factors NE
have NE
been NE
cloned NE
and NE
sequenced NE
. NE

Using NE
fluorescence Other_B
in Other_M
situ Other_M
hybridization Other_E
( NE
FISH Other
) NE
, NE
we NE
show NE
here NE
that NE
the NE
genes DNA_family_or_group
encoding NE
the NE
TATA-box Protein_family_or_group_B
binding Protein_family_or_group_M
protein Protein_family_or_group_E
( NE
TBP Protein_family_or_group
) NE
, NE
TFIIB Protein_molecule
, NE
TFIIE Protein_molecule_B
alpha Protein_molecule_E
, NE
TFIIE Protein_molecule_B
beta Protein_molecule_E
, NE
RAP30 Protein_molecule
, NE
RAP74 Protein_molecule
and NE
the NE
62 Protein_molecule_B
kDa Protein_molecule_M
subunit Protein_molecule_E
, NE
of NE
TFIIH Protein_molecule
are NE
located NE
at NE
the NE
human NE
chromosomal NE
bands NE
6q26-27 NE
, NE
1p21-22 NE
, NE
3q21-24 NE
, NE
8p12 NE
, NE
13q14 NE
, NE
19p13.3 NE
and NE
11p14-15.1 NE
, NE
respectively NE
. NE

This NE
dispersed NE
localization NE
of NE
a NE
group NE
of NE
functionally NE
related NE
gene NE
provides NE
insights NE
into NE
the NE
molecular Other_B
mechanism Other_E
of NE
human Other_B
genome Other_M
evolution Other_E
and NE
their NE
possible NE
involvement NE
in NE
human NE
diseases NE
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

A NE
novel NE
mitogen NE
-inducible NE
gene NE
product NE
related NE
to NE
p50/p105-NF-kappa NE
B NE
participates NE
in NE
transactivation NE
through NE
a NE
kappa NE
B NE
site NE
. NE

A NE
Rel-related NE
, NE
mitogen NE
-inducible NE
, NE
kappa NE
B NE
-binding NE
protein NE
has NE
been NE
cloned NE
as NE
an NE
immediate-early NE
activation NE
gene NE
of NE
human NE
peripheral NE
blood NE
T NE
cells NE
. NE

The NE
cDNA DNA_family_or_group
has NE
an NE
open DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
900 DNA_domain_or_region_B
amino DNA_domain_or_region_M
acids DNA_domain_or_region_E
capable NE
of NE
encoding NE
a NE
97-kDa Protein_molecule_B
protein Protein_molecule_E
. NE

This NE
protein NE
is NE
most NE
similar NE
to NE
the NE
105-kDa Peptide_B
precursor Peptide_M
polypeptide Peptide_E
of NE
p50-NF-kappa Protein_molecule_B
B Protein_molecule_E
. NE

Like NE
the NE
105-kDa NE
precursor NE
, NE
it NE
contains NE
an NE
amino-terminal Protein_domain_or_region_B
Rel-related Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
about NE
300 NE
amino NE
acids NE
and NE
a NE
carboxy-terminal Protein_domain_or_region_B
domain Protein_domain_or_region_E
containing NE
six NE
full Protein_substructure_B
cell Protein_substructure_M
cycle Protein_substructure_E
or NE
ankyrin Protein_substructure_B
repeats Protein_substructure_E
. NE

In NE
vitro-translated NE
proteins NE
, NE
truncated NE
downstream NE
of NE
the NE
Rel NE
domain NE
and NE
excluding NE
the NE
repeats NE
, NE
bind NE
kappa NE
B NE
sites NE
. NE

We NE
refer NE
to NE
the NE
kappa NE
B NE
-binding NE
, NE
truncated NE
protein NE
as NE
p50B NE
by NE
analogy NE
with NE
p50-NF-kappa NE
B NE
and NE
to NE
the NE
full-length NE
protein NE
as NE
p97 NE
. NE

p50B Protein_molecule
is NE
able NE
to NE
form NE
heteromeric NE
kappa NE
B NE
-binding NE
complexes NE
with NE
RelB NE
, NE
as NE
well NE
as NE
with NE
p65 NE
and NE
p50 NE
, NE
the NE
two NE
subunits NE
of NE
NF-kappa NE
B NE
. NE

Transient-transfection NE
experiments NE
in NE
embryonal Cell_cultured_B
carcinoma Cell_cultured_M
cells Cell_cultured_E
demonstrate NE
a NE
functional NE
cooperation NE
between NE
p50B Protein_molecule
and NE
RelB Protein_molecule
or NE
p65 Protein_molecule
in NE
transactivation NE
of NE
a NE
reporter DNA_molecule_B
plasmid DNA_molecule_E
dependent NE
on NE
a NE
kappa DNA_domain_or_region_B
B DNA_domain_or_region_M
site DNA_domain_or_region_E
. NE

The NE
data NE
imply NE
the NE
existence NE
of NE
a NE
complex NE
family NE
of NE
NF-kappa NE
B NE
-like NE
transcription NE
factors NE
. NE

A NE
novel DNA_domain_or_region_B
SP-1 DNA_domain_or_region_M
site DNA_domain_or_region_E
in NE
the NE
human NE
interleukin-1 NE
beta NE
promoter NE
confers NE
preferential NE
transcriptional NE
activity NE
in NE
keratinocytes NE
. NE

To NE
investigate NE
the NE
mechanisms NE
of NE
transcriptional Other_B
activation Other_E
of NE
interleukin-1beta Protein_molecule
( NE
IL-1beta Protein_molecule
) NE
in NE
non-monocytic NE
cells NE
, NE
we NE
constructed NE
a NE
series NE
of NE
reporter NE
plasmids NE
with NE
the NE
bacterial NE
chloramphenicol NE
acetyltransferase NE
gene NE
linked NE
to NE
various NE
parts NE
of NE
the NE
human DNA_domain_or_region_B
IL-1beta DNA_domain_or_region_M
promoter DNA_domain_or_region_E
and NE
performed NE
transient NE
transfection NE
experiments NE
. NE

We NE
identified NE
a NE
promoter NE
segment NE
that NE
activates NE
transcription NE
most NE
efficiently NE
in NE
keratinocytes Cell_natural
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
( NE
EMSA Other
) NE
with NE
a NE
43-mer DNA_domain_or_region_B
oligonucleotide DNA_domain_or_region_E
derived NE
from NE
the NE
functionally NE
identified NE
cis-acting DNA_domain_or_region_B
element DNA_domain_or_region_E
revealed NE
specific NE
complexes NE
. NE

By NE
competition NE
analysis NE
with NE
transcription DNA_family_or_group_B
factor DNA_family_or_group_M
consensus DNA_family_or_group_M
sequence DNA_family_or_group_M
oligonucleotides DNA_family_or_group_E
and NE
by NE
immunosupershift Other
, NE
transcription Protein_molecule_B
factor Protein_molecule_M
SP-1 Protein_molecule_E
or NE
a NE
closely NE
related NE
protein NE
was NE
shown NE
to NE
bind NE
to NE
this NE
regulatory DNA_domain_or_region_B
element DNA_domain_or_region_E
. NE

The NE
closest NE
match NE
to NE
the NE
known NE
SP-1 DNA_domain_or_region_B
consensus DNA_domain_or_region_M
sequence DNA_domain_or_region_E
within NE
the NE
respective NE
region NE
is NE
a NE
TCCCCTCCCCT NE
motif NE
. NE

Mutation NE
of NE
this NE
motif NE
almost NE
completely NE
, NE
and NE
specifically NE
, NE
abolished NE
the NE
binding NE
of NE
two NE
low-mobility NE
complexes NE
and NE
led NE
to NE
a NE
95% NE
decrease NE
of NE
constitutive NE
transcriptional NE
activation NE
of NE
a NE
reporter NE
construct NE
IL-1beta NE
(-170/+108) NE
. NE

Likewise NE
, NE
activation NE
of NE
this NE
reporter NE
construct NE
by NE
tumor Protein_molecule_B
necrosis Protein_molecule_M
factor-alpha Protein_molecule_E
depended NE
on NE
the NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
. NE

These NE
observations NE
suggest NE
that NE
a NE
so-far-unrecognized NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
human NE
IL-1beta NE
promoter NE
may NE
participate NE
in NE
the NE
transcriptional NE
regulation NE
of NE
this NE
gene NE
in NE
keratinocytes NE
. NE

Regulation NE
of NE
the NE
beta-globin DNA_domain_or_region_B
locus DNA_domain_or_region_E
. NE

Transcription NE
of NE
the NE
human DNA_domain_or_region_B
beta-globin DNA_domain_or_region_M
gene DNA_domain_or_region_M
cluster DNA_domain_or_region_E
depends NE
upon NE
upstream DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
sequences DNA_domain_or_region_E
, NE
which NE
are NE
collectively NE
termed NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
. NE

Recent NE
studies NE
have NE
provided NE
new NE
insights NE
into NE
how NE
the NE
individual NE
genes NE
of NE
the NE
cluster NE
are NE
regulated NE
through NE
development NE
. NE

The NE
crux NE
of NE
transcriptional Other_B
activation Other_E
is NE
how NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
communicates NE
with NE
the NE
gene-proximal DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
elements DNA_domain_or_region_E
. NE

Inhibition NE
of NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
by NE
dehydroepiandrosterone NE
( NE
DHEA NE
) NE
and NE
an NE
analog NE
of NE
DHEA NE
. NE

The NE
initial NE
infection NE
with NE
human Virus_B
immunodeficiency Virus_M
virus Virus_M
type Virus_M
1 Virus_E
( NE
HIV-1 Virus
) NE
in NE
most NE
individuals NE
usually NE
results NE
in NE
the NE
establishment NE
of NE
a NE
latent NE
or NE
chronic Other_B
infection Other_E
before NE
eventual NE
progression NE
toward NE
acquired Other_B
immunodeficiency Other_M
syndrome Other_E
. NE

HIV-1 Virus
can NE
also NE
establish NE
a NE
latent NE
or NE
persistent NE
infection NE
in NE
some NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
that NE
show NE
minimal NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

However NE
, NE
activation NE
of NE
the NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
leading NE
to NE
enhanced NE
HIV-1 Virus
replication NE
can NE
be NE
induced NE
by NE
antigens Protein_family_or_group
, NE
mitogens Other
, NE
and NE
cytokines Protein_family_or_group
( NE
tumor Protein_family_or_group_B
necrosis Protein_family_or_group_M
factor Protein_family_or_group_M
alpha Protein_family_or_group_E
[ NE
TNF-alpha Protein_molecule
] NE
, NE
interleukin Protein_molecule_B
1 Protein_molecule_E
, NE
and NE
interleukin-2 Protein_molecule
) NE
. NE

Various NE
gene NE
products NE
from NE
other NE
viruses NE
( NE
HTLV-1 Virus
, NE
HSV Virus
, NE
EBV Virus
, NE
CMV Virus
, NE
HBV Virus
, NE
and NE
HHV-6 Virus
) NE
can NE
also NE
enhance NE
HIV-1 NE
long NE
terminal NE
repeat NE
( NE
LTR NE
)-driven NE
reporter NE
gene NE
activity NE
. NE

On NE
the NE
basis NE
of NE
these NE
observations NE
, NE
it NE
has NE
been NE
proposed NE
that NE
reactivation NE
of NE
latent NE
HIV-1 Virus
harbored NE
in NE
chronically Cell_natural_B
infected Cell_natural_M
T Cell_natural_M
lymphocytes Cell_natural_E
, NE
monocytes Cell_natural
, NE
or NE
macrophages Cell_natural
plays NE
an NE
important NE
role NE
in NE
the NE
pathogenesis NE
of NE
AIDS Other
. NE

So NE
far NE
, NE
there NE
are NE
no NE
drugs NE
or NE
therapy NE
available NE
that NE
can NE
provide NE
protection NE
against NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
. NE

ACH-2 Cell_cultured
, NE
derived NE
from NE
a NE
human Cell_cultured_B
T Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
( NE
CEM Cell_cultured
) NE
, NE
is NE
chronically NE
infected NE
with NE
HIV-1 Virus
, NE
with NE
low NE
levels NE
of NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

ACH-2 Cell_cultured
can NE
be NE
converted NE
to NE
productive NE
infection NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
12-O-tetradecanoylphorbol-13-acetate Organic_compound_other
( NE
TPA Organic_compound_other
) NE
, NE
mitogen Organic_compound_other
or NE
cytokines Protein_family_or_group
( NE
TNF-alpha Protein_molecule
) NE
, NE
or NE
infection NE
with NE
HSV Virus
. NE

Therefore NE
the NE
ACH-2 Cell_cultured
cell NE
line NE
is NE
a NE
good NE
candidate NE
for NE
studying NE
the NE
effects NE
of NE
drugs NE
on NE
HIV-1 Virus
activation NE
. NE

Previously NE
, NE
we NE
have NE
reported NE
that NE
DHEA Lipid
and NE
synthetic NE
analogs NE
of NE
DHEA NE
can NE
be NE
modest NE
inhibitors NE
of NE
HIV-1 Other_B
IIIB Other_M
replication Other_E
in NE
phytohemagglutinin NE
-stimulated NE
peripheral NE
blood NE
lymphocyte NE
cultures NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

C/EBP Protein_family_or_group_B
activators Protein_family_or_group_E
are NE
required NE
for NE
HIV-1 Other_B
replication Other_E
and NE
proviral NE
induction NE
in NE
monocytic NE
cell NE
lines NE
. NE

Previous NE
work NE
has NE
shown NE
that NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
and NE
C/EBP Protein_family_or_group_B
transcriptional Protein_family_or_group_M
activators Protein_family_or_group_E
are NE
necessary NE
for NE
HIV-1 Other_B
LTR Other_M
activity Other_E
in NE
monocytes/macrophages NE
. NE

We NE
have NE
investigated NE
the NE
role NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
play NE
in NE
induction NE
and NE
replication NE
of NE
HIV-1 Virus
. NE

Ectopic NE
expression NE
of NE
the NE
dominant NE
negative NE
C/EBP NE
protein NE
LIP NE
inhibited NE
HIV-1 NE
mRNA NE
and NE
virus NE
production NE
in NE
activated NE
U1 NE
cells NE
, NE
demonstrating NE
that NE
C/EBP NE
proteins NE
are NE
required NE
for NE
provirus NE
induction NE
. NE

U1 Cell_cultured_B
lines Cell_cultured_E
overexpressing NE
C/EBP Protein_family_or_group_B
activator Protein_family_or_group_E
NF-IL-6 Protein_molecule
produced NE
more NE
viral RNA_family_or_group_B
mRNA RNA_family_or_group_E
and NE
virus Virus_B
particles Virus_E
following NE
cellular Other_B
activation Other_E
than NE
control Cell_cultured_B
lines Cell_cultured_E
, NE
demonstrating NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
are NE
limiting NE
for NE
virus Other_B
transcription Other_E
. NE

HIV-1 Virus
harboring NE
mutations NE
within NE
two NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
were NE
crippled NE
in NE
their NE
ability NE
to NE
replicate NE
in NE
U937 Cell_cultured_B
promonocytic Cell_cultured_M
cells Cell_cultured_E
, NE
indicating NE
that NE
these NE
sites NE
are NE
required NE
for NE
replication NE
. NE

These NE
data NE
identify NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
as NE
regulators NE
of NE
HIV-1 Other_B
expression Other_E
in NE
monocytes/macrophages NE
. NE

IL-10 Protein_molecule
inhibits NE
nuclear Other_B
factor-kappa Other_M
B/Rel Other_M
nuclear Other_M
activity Other_E
in NE
CD3 NE
-stimulated NE
human NE
peripheral NE
T NE
lymphocytes NE
. NE

IL-10 Protein_molecule
markedly NE
reduces NE
nuclear NE
factor NE
(NF)-kappa Other_B
B/Rel Other_M
nuclear Other_M
activity Other_E
induced NE
in NE
PBMC NE
by NE
stimulation NE
with NE
the NE
anti-CD3 NE
mAb NE
OKT3 NE
. NE

The NE
inhibition NE
is NE
exerted NE
specifically NE
on NE
the NE
NF-kappa Other_B
B/Rel Other_M
activation Other_E
induced NE
by NE
mAb NE
OKT3 NE
, NE
and NE
not NE
that NE
produced NE
by NE
PMA NE
. NE

As NE
judged NE
by NE
supershifting NE
the NE
DNA-protein NE
complexes NE
with NE
Abs NE
recognizing NE
specific NE
components NE
of NE
the NE
NF-kappa NE
B/Rel NE
protein NE
family NE
, NE
the NE
p50/p65 NE
( NE
Rel NE
A NE
) NE
heterodimeric NE
form NE
of NE
NF-kappa NE
B NE
is NE
primarily NE
affected NE
. NE

The NE
maximal NE
effect NE
is NE
observed NE
at NE
the NE
IL-10 Other_B
concentration Other_E
of NE
20 NE
U/ml NE
. NE

IL-10 Protein_molecule
inhibitory NE
activity NE
is NE
exerted NE
on NE
T Cell_natural_B
lymphocytes Cell_natural_E
and NE
is NE
mediated NE
by NE
monocytes Cell_natural
. NE

Indeed NE
, NE
monocytes Cell_natural
pretreated NE
with NE
IL-10 Protein_molecule
are NE
able NE
so NE
inhibit NE
NF-kappa Protein_complex_B
B Protein_complex_E
nuclear NE
activity NE
in NE
purified NE
T Cell_natural_B
lymphocytes Cell_natural_E
stimulated NE
with NE
OKT3 Protein_molecule
. NE

Soluble NE
factors NE
do NE
not NE
appear NE
to NE
be NE
involved NE
in NE
the NE
mechanism NE
of NE
inhibition NE
. NE

On NE
the NE
other NE
hand NE
, NE
the NE
up-regulation NE
of NE
CD80 Protein_molecule_B
Ag Protein_molecule_E
, NE
found NE
on NE
monocytes Cell_natural
obtained NE
from NE
PBMC Cell_natural
incubated NE
with NE
OKT3 Protein_molecule
, NE
is NE
not NE
detected NE
after NE
addition NE
of NE
IL-10 Protein_molecule
, NE
and NE
the NE
anti-CD28 Protein_family_or_group_B
mAb Protein_family_or_group_E
CLB-CD28/1 Protein_molecule
restores NE
the NE
NF-kappa Element_B
B/Rel Element_M
nuclear Element_M
activity Element_E
in NE
IL-10 NE
-inhibited NE
lymphocytes NE
. NE

Therefore NE
, NE
the NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
inhibition NE
might NE
be NE
ascribed NE
to NE
a NE
lack NE
of NE
cooperation NE
between NE
accessory NE
cells NE
and NE
T Cell_natural_B
lymphocytes Cell_natural_E
, NE
resulting NE
from NE
down-regulation NE
of NE
a NE
costimulatory NE
molecule NE
, NE
such NE
as NE
CD80 Protein_molecule
, NE
produced NE
by NE
IL-10 Protein_molecule
on NE
activated NE
monocytes Cell_natural
. NE

Our NE
results NE
demonstrate NE
that NE
IL-10 Protein_molecule
can NE
inhibit NE
the NE
induction NE
of NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
nuclear NE
activity NE
in NE
CD3 NE
-stimulated NE
T NE
lymphocytes NE
. NE

Since NE
inappropriate NE
activation NE
of NE
kappa DNA_family_or_group_B
B-driven DNA_family_or_group_M
genes DNA_family_or_group_E
has NE
a NE
physiopathologic NE
role NE
in NE
a NE
number NE
of NE
diseases NE
, NE
such NE
as NE
HIV Other_B
infection Other_E
, NE
our NE
findings NE
support NE
the NE
possibility NE
of NE
using NE
this NE
cytokine NE
to NE
suppress NE
an NE
undesirable NE
activation NE
of NE
these NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
. NE

Multiple NE
prolactin NE
-responsive NE
elements NE
mediate NE
G1 NE
and NE
S NE
phase NE
expression NE
of NE
the NE
interferon NE
regulatory NE
factor-1 NE
gene NE
. NE

The NE
interferon NE
regulatory NE
factor-1 NE
( NE
IRF-1 NE
) NE
gene NE
is NE
both NE
an NE
immediate-early NE
G1 NE
phase NE
gene NE
and NE
an NE
S NE
phase NE
gene NE
inducible NE
by NE
PRL NE
in NE
rat NE
Nb2 NE
T NE
lymphocytes NE
. NE

To NE
understand NE
the NE
mechanism NE
by NE
which NE
PRL Protein_molecule
regulates NE
the NE
biphasic NE
expression NE
of NE
IRF-1 Protein_molecule
, NE
we NE
cloned NE
the NE
rat DNA_domain_or_region_B
IRF-1 DNA_domain_or_region_M
gene DNA_domain_or_region_E
and NE
functionally NE
characterized NE
the NE
IRF-1 NE
promoter NE
. NE

Upon NE
transfection NE
into NE
Nb2 Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
, NE
1.7 NE
kilobases NE
(kb) NE
of NE
IRF-1 NE
5'-flanking NE
DNA NE
linked NE
to NE
a NE
chloramphenicol NE
acetyl NE
transferase NE
( NE
CAT NE
) NE
reporter NE
gene NE
mediated NE
a NE
30-fold NE
induction NE
of NE
CAT Other_B
enzyme Other_M
activity Other_E
in NE
response NE
to NE
24 NE
h NE
of NE
PRL NE
stimulation NE
. NE

Deletion NE
mutants NE
containing NE
1.3 NE
, NE
0.6 NE
, NE
and NE
0.2 NE
kb NE
5'-flanking NE
DNA NE
were NE
incrementally NE
less NE
transcriptionally NE
active NE
, NE
although NE
0.2 NE
kb NE
still NE
mediated NE
a NE
12-fold NE
induction NE
by NE
PRL NE
. NE

The NE
sequence NE
between NE
-1.7 NE
and NE
-0.2 NE
kb NE
linked NE
to NE
a NE
heterologous NE
thymidine NE
kinase NE
promoter NE
failed NE
to NE
respond NE
to NE
PRL Protein_molecule
stimulation NE
, NE
suggesting NE
that NE
the NE
activity NE
of NE
upstream DNA_family_or_group_B
PRL DNA_family_or_group_M
response DNA_family_or_group_M
elements DNA_family_or_group_E
may NE
require NE
an NE
interaction NE
with NE
promoter-proximal NE
elements NE
. NE

By NE
assaying NE
CAT Other_B
enzyme Other_M
activity Other_E
across NE
a NE
24-h NE
PRL NE
induction NE
time NE
course NE
, NE
we NE
were NE
able NE
to NE
assign NE
G1 NE
vs NE
. NE
S NE
phase NE
PRL NE
responses NE
of NE
the NE
IRF-1 NE
gene NE
to NE
different NE
regions NE
of NE
the NE
IRF-1 NE
5'-flanking NE
and NE
promoter NE
DNA NE
. NE

The NE
0.2-kb NE
IRF- NE
CAT NE
construct NE
was NE
induced NE
by NE
PRL NE
stimulation NE
during NE
the NE
G1 NE
phase NE
of NE
the NE
cell NE
cycle NE
. NE

In NE
contrast NE
, NE
the NE
1.7-kb NE
IRF- NE
CAT NE
construct NE
was NE
inducible NE
by NE
PRL Protein_molecule
during NE
both NE
G1 NE
and NE
S NE
phase NE
of NE
the NE
cell NE
cycle NE
. NE

Hence NE
, NE
the NE
PRL Protein_molecule
-induced NE
biphasic NE
expression NE
of NE
the NE
IRF-1 DNA_domain_or_region_B
gene DNA_domain_or_region_E
appears NE
to NE
be NE
controlled NE
by NE
separate NE
PRL NE
-responsive NE
elements NE
: NE
elements NE
in NE
the NE
first NE
0.2 NE
kb NE
of NE
the NE
IRF-1 NE
promoter NE
region NE
act NE
during NE
early NE
activation NE
, NE
and NE
elements NE
between NE
0.2 NE
and NE
1.7 NE
kb NE
act NE
in NE
concert NE
with NE
the NE
proximal NE
0.2-kb NE
region NE
during NE
S NE
phase NE
progression NE
. NE

Triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
CR1 Protein_molecule
( NE
CD35 Protein_molecule
) NE
and NE
CR3 Protein_molecule
( NE
CD11b/CD18 Protein_molecule
) NE
induces NE
nuclear Other_B
translocation Other_E
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50/p65 Protein_molecule
) NE
in NE
human Cell_natural_B
monocytes Cell_natural_E
and NE
enhances NE
viral Other_B
replication Other_E
in NE
HIV NE
-infected NE
monocytic NE
cells NE
. NE

Monocyte NE
/ NE
macrophages NE
may NE
harbor NE
HIV NE
in NE
a NE
nonproductive NE
fashion NE
for NE
prolonged NE
periods NE
of NE
time NE
. NE

Viral Other_B
gene Other_M
expression Other_E
may NE
be NE
reactivated NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
LPS Lipid
or NE
cytokines Protein_family_or_group
such NE
as NE
TNF-alpha Protein_molecule
in NE
vitro NE
. NE

The NE
effect NE
of NE
LPS Lipid
and NE
TNF-alpha Protein_molecule
is NE
mediated NE
by NE
their NE
ability NE
to NE
induce NE
nuclear Other_B
translocation Other_E
of NE
the NE
DNA-binding Protein_family_or_group_B
heterodimer Protein_family_or_group_E
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50/p65 Protein_molecule
) NE
, NE
which NE
binds NE
to NE
a NE
specific NE
sequence NE
in NE
the NE
HIV-long DNA_domain_or_region_B
terminal DNA_domain_or_region_M
repeat DNA_domain_or_region_E
. NE

The NE
present NE
study NE
demonstrates NE
that NE
triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
CR1 Protein_molecule
( NE
CD35 Protein_molecule
) NE
and NE
CR3 Protein_molecule
( NE
CD11b/CD18 Protein_molecule
) NE
enhances NE
viral Other_B
replication Other_E
in NE
HIV NE
-infected NE
human NE
monocytic NE
cells NE
. NE

Monocytic Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
and NE
normal NE
peripheral NE
blood NE
monocytes NE
were NE
infected NE
with NE
HIV-1 Virus
in NE
vitro NE
and NE
cultured NE
in NE
the NE
presence NE
or NE
absence NE
of NE
F(ab')2 Protein_molecule_B
fragments Protein_molecule_E
of NE
monoclonal NE
anti- NE
CR1 NE
or NE
anti- NE
CR3 NE
Abs NE
or NE
with NE
C3 NE
fragments NE
. NE

Stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
induces NE
a NE
two- NE
to NE
fourfold NE
increase NE
in NE
the NE
amount NE
of NE
cell-associated NE
and NE
released NE
p24 Protein_molecule_B
Ag Protein_molecule_E
in NE
cell Cell_cultured_B
cultures Cell_cultured_E
that NE
was NE
equivalent NE
to NE
that NE
observed NE
in NE
control Cell_cultured_B
cultures Cell_cultured_E
triggered NE
with NE
LPS Lipid
. NE

We NE
further NE
observed NE
that NE
stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
induces NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
in NE
infected Cell_natural_B
cells Cell_natural_E
. NE

Translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
was NE
also NE
observed NE
following NE
stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
of NE
uninfected NE
peripheral NE
blood NE
monocytes NE
from NE
HIV-seronegative NE
donors NE
. NE

The NE
amount NE
of NE
protein NE
translocated NE
was NE
similar NE
to NE
that NE
observed NE
when NE
cells NE
were NE
stimulated NE
with NE
rhTNF-alpha Protein_molecule
. NE

TNF-alpha Protein_molecule
did NE
not NE
mediate NE
the NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
induced NE
by NE
triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
. NE

Taken NE
together NE
, NE
these NE
observations NE
suggest NE
that NE
HIV Other_B
gene Other_M
expression Other_E
may NE
be NE
activated NE
in NE
infected Cell_natural_B
monocytes Cell_natural_E
through NE
interaction NE
of NE
the NE
cells NE
with NE
complement-opsonized Protein_family_or_group_B
particles Protein_family_or_group_E
and NE
that NE
enhanced NE
viral Other_B
replication Other_E
is NE
associated NE
with NE
C3 Protein_family_or_group_B
receptor Protein_family_or_group_E
-mediated NE
nuclear Other_B
translocation Other_E
of NE
the NE
NF-kappa Protein_complex_B
B Protein_complex_M
complex Protein_complex_E
. NE

Genes NE
encoding NE
general Protein_family_or_group_B
initiation Protein_family_or_group_M
factors Protein_family_or_group_E
for NE
RNA Protein_molecule_B
polymerase Protein_molecule_M
II Protein_molecule_E
transcription NE
are NE
dispersed NE
in NE
the NE
human DNA_family_or_group_B
genome DNA_family_or_group_E
. NE

General Protein_family_or_group_B
transcription Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
required NE
for NE
accurate NE
initiation NE
of NE
transcription NE
by NE
RNA NE
polymerase NE
II NE
. NE

Human DNA_family_or_group_B
cDNAs DNA_family_or_group_E
encoding NE
subunits NE
of NE
these NE
factors NE
have NE
been NE
cloned NE
and NE
sequenced NE
. NE

Using NE
fluorescence Other_B
in Other_M
situ Other_M
hybridization Other_E
( NE
FISH Other
) NE
, NE
we NE
show NE
here NE
that NE
the NE
genes DNA_family_or_group
encoding NE
the NE
TATA-box Protein_family_or_group_B
binding Protein_family_or_group_M
protein Protein_family_or_group_E
( NE
TBP Protein_family_or_group
) NE
, NE
TFIIB Protein_molecule
, NE
TFIIE Protein_molecule_B
alpha Protein_molecule_E
, NE
TFIIE Protein_molecule_B
beta Protein_molecule_E
, NE
RAP30 Protein_molecule
, NE
RAP74 Protein_molecule
and NE
the NE
62 Protein_molecule_B
kDa Protein_molecule_M
subunit Protein_molecule_E
, NE
of NE
TFIIH Protein_molecule
are NE
located NE
at NE
the NE
human NE
chromosomal NE
bands NE
6q26-27 NE
, NE
1p21-22 NE
, NE
3q21-24 NE
, NE
8p12 NE
, NE
13q14 NE
, NE
19p13.3 NE
and NE
11p14-15.1 NE
, NE
respectively NE
. NE

This NE
dispersed NE
localization NE
of NE
a NE
group NE
of NE
functionally NE
related NE
gene NE
provides NE
insights NE
into NE
the NE
molecular Other_B
mechanism Other_E
of NE
human Other_B
genome Other_M
evolution Other_E
and NE
their NE
possible NE
involvement NE
in NE
human NE
diseases NE
. NE

Cell Cell_natural_B
type Cell_natural_M
specificity Cell_natural_E
and NE
activation NE
requirements NE
for NE
NFAT-1 Protein_molecule
( NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_E
of NE
activated Cell_natural_B
T-cells Cell_natural_E
) NE
transcriptional NE
activity NE
determined NE
by NE
a NE
new NE
method NE
using NE
transgenic Multicellular_organism_genetically_modified_B
mice Multicellular_organism_genetically_modified_E
to NE
assay NE
transcriptional Other_B
activity Other_E
of NE
an NE
individual NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_E
. NE

Nuclear Protein_family_or_group_B
factor Protein_family_or_group_E
of NE
activated Cell_natural_B
T-cells Cell_natural_E
( NE
NFAT-1 Protein_molecule
) NE
is NE
a NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
which NE
is NE
considered NE
to NE
be NE
an NE
important NE
regulator NE
in NE
early NE
T-cell Other_B
activation Other_E
. NE

We NE
have NE
developed NE
a NE
system NE
to NE
monitor NE
the NE
transcriptional Other_B
activity Other_E
of NE
NFAT-1 Protein_molecule
at NE
the NE
single Cell_natural_B
cell Cell_natural_M
level Cell_natural_E
in NE
whole Multicellular_organism_natural_B
animals Multicellular_organism_natural_E
. NE

The NE
system NE
is NE
based NE
on NE
the NE
use NE
of NE
an NE
oligomerized Polynucleotide_B
NFAT-1 Polynucleotide_M
binding Polynucleotide_M
motif Polynucleotide_E
that NE
directs NE
transcription NE
of NE
SV40 NE
T-antigen NE
in NE
transgenic NE
mice NE
. NE

This NE
report NE
represents NE
the NE
first NE
demonstration NE
that NE
a NE
multimerized Polynucleotide_B
short Polynucleotide_M
binding Polynucleotide_M
motif Polynucleotide_E
can NE
function NE
appropriately NE
in NE
transgenic Multicellular_organism_genetically_modified_B
mice Multicellular_organism_genetically_modified_E
. NE

NFAT-1 Protein_molecule
activity NE
had NE
previously NE
been NE
thought NE
to NE
be NE
confined NE
to NE
activated Cell_natural_B
T-lymphocytes Cell_natural_E
upon NE
release NE
of NE
intracellular NE
calcium NE
. NE

By NE
targeting NE
NFAT-1 Protein_molecule
-dependent NE
gene NE
expression NE
in NE
transgenic Multicellular_organism_genetically_modified_B
mice Multicellular_organism_genetically_modified_E
we NE
discovered NE
new NE
sites NE
of NE
NFAT-1 Other_B
activity Other_E
. NE

Besides NE
in NE
T-lymphocytes Cell_natural
NFAT-1 Other_B
activity Other_E
could NE
also NE
be NE
induced NE
in NE
T-lymphocyte NE
-depleted NE
spleen NE
cells NE
and NE
purified NE
B-lymphocytes NE
and NE
requires NE
agents NE
that NE
both NE
release NE
intracellular NE
calcium NE
and NE
activate NE
protein NE
kinase NE
C NE
. NE

A NE
difference NE
in NE
the NE
time NE
course NE
of NE
appearance NE
of NE
NFAT-1 Other_B
activity Other_E
between NE
T-lymphocytes NE
and NE
non-T-lymphocytes NE
was NE
revealed NE
. NE

Constitutive Other_B
expression Other_E
was NE
observed NE
in NE
a NE
small NE
population NE
of NE
cells NE
in NE
the NE
dermis Tissue_natural
and NE
some NE
mice NE
have NE
developed NE
skin Tissue_natural_B
lesions Tissue_natural_E
. NE

Interestingly NE
, NE
the NE
tissue NE
pattern NE
of NE
expression NE
of NE
the NE
NFAT-1 Protein_molecule
activity NE
resembles NE
the NE
expression NE
pattern NE
described NE
for NE
HIV-LTR/tat Multicellular_organism_natural_B
transgenic Multicellular_organism_natural_M
mice Multicellular_organism_natural_E
(Vogel NE
, NE
J. NE
, NE
Hinrichs NE
, NE
S NE
. NE
H. NE
, NE
Reynolds NE
, NE
R NE
. NE
K. NE
, NE
Luciw NE
, NE
P NE
. NE
A. NE
, NE
and NE
Jay NE
, NE
G NE
. NE
(1988) NE
Nature NE
335 NE
, NE
606-611) NE
. NE

This NE
similarity NE
in NE
expression NE
and NE
the NE
fact NE
that NE
NFAT-1 Protein_molecule
has NE
been NE
shown NE
to NE
bind NE
functional NE
sequences NE
in NE
HIV-LTR NE
suggest NE
a NE
role NE
for NE
NFAT-1 Protein_molecule
in NE
dermal Other_B
activation Other_E
of NE
the NE
HIV-LTR DNA_domain_or_region
. NE

Transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
activates NE
gene NE
expression NE
of NE
HTLV-I NE
. NE

The NE
HTLV-I DNA_domain_or_region_B
LTR DNA_domain_or_region_E
contains NE
three NE
conserved NE
regulatory DNA_domain_or_region_B
elements DNA_domain_or_region_E
known NE
as NE
21 DNA_domain_or_region_B
base DNA_domain_or_region_M
pair DNA_domain_or_region_M
repeats DNA_domain_or_region_E
which NE
are NE
required NE
for NE
stimulation NE
of NE
gene Other_B
expression Other_E
by NE
the NE
transactivator Protein_family_or_group_B
protein Protein_family_or_group_E
tax Protein_molecule
. NE

Mutagenesis Other
indicates NE
that NE
the NE
21 NE
bp NE
repeats NE
can NE
be NE
subdivided NE
into NE
three NE
motifs NE
, NE
A DNA_substructure
, NE
B DNA_substructure
and NE
C DNA_substructure
, NE
each NE
of NE
which NE
influences NE
the NE
level NE
of NE
tax Other_B
activation Other_E
. NE

The NE
A DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeat DNA_domain_or_region_E
has NE
strong NE
homology NE
with NE
previously NE
described NE
binding DNA_domain_or_region_B
sites DNA_domain_or_region_E
for NE
the NE
transcription Protein_molecule_B
factor Protein_molecule_M
AP-2 Protein_molecule_E
. NE

We NE
demonstrated NE
that NE
AP-2 RNA_molecule_B
mRNA RNA_molecule_E
was NE
present NE
in NE
T-lymphocytes Cell_natural
and NE
that NE
cellular NE
factors NE
from NE
both NE
non-transformed NE
and NE
transformed NE
T-lymphocytes Cell_natural
specifically NE
bound NE
to NE
the NE
consensus NE
motif NE
for NE
AP-2 NE
in NE
each NE
21 NE
bp NE
. NE

To NE
determine NE
the NE
role NE
of NE
AP-2 Protein_molecule
in NE
the NE
regulation NE
of NE
the NE
HTLV-I Other_B
LTR Other_M
gene Other_M
expression Other_E
, NE
we NE
used NE
an NE
AP-2 NE
cDNA NE
in NE
DNA NE
binding NE
and NE
transient NE
expression NE
assays NE
. NE

Gel Other_B
retardation Other_E
and NE
methylation Other_B
interference Other_E
studies NE
revealed NE
that NE
bacterially Protein_molecule_B
produced Protein_molecule_M
AP-2 Protein_molecule_E
bound NE
specifically NE
and NE
with NE
high NE
affinity NE
to NE
all NE
three NE
21 NE
bp NE
repeats NE
, NE
and NE
that NE
it NE
required NE
the NE
core NE
sequence NE
AGGC NE
for NE
specific NE
binding NE
. NE

Binding NE
of NE
AP-2 Protein_molecule
prevented NE
the NE
subsequent NE
binding NE
of NE
members NE
of NE
the NE
CREB/ATF Protein_family_or_group_B
family Protein_family_or_group_E
to NE
an NE
adjacent NE
regulatory NE
motif NE
in NE
the NE
21 NE
bp NE
repeat NE
. NE

Transfection NE
of NE
an NE
AP-2 DNA_molecule_B
expression DNA_molecule_M
construct DNA_molecule_E
into NE
T-lymphocytes NE
activated NE
gene NE
expression NE
from NE
the NE
HTLV-I NE
LTR NE
. NE

At NE
least NE
two NE
21 DNA_domain_or_region_B
bp DNA_domain_or_region_M
repeats DNA_domain_or_region_E
were NE
required NE
for NE
high NE
levels NE
of NE
AP-2 Protein_molecule
activation NE
and NE
mutagenesis NE
of NE
the NE
AP-2 NE
consensus NE
binding NE
sequences NE
in NE
the NE
21 NE
bp NE
repeats NE
eliminate NE
this NE
activation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Peripheral Cell_natural_B
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
isolated NE
from NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
show NE
increased NE
activation NE
of NE
the NE
oxidative-stress Protein_family_or_group_B
sensitive Protein_family_or_group_M
transcription Protein_family_or_group_M
factor Protein_family_or_group_E
NF-kappaB Protein_complex
. NE

Increased NE
oxidative Other_B
stress Other_E
and NE
subsequent NE
activation NE
of NE
the NE
transcription NE
factor NE
NF-kappaB Protein_complex
has NE
been NE
linked NE
to NE
the NE
development NE
of NE
late NE
diabetic Other_B
complications Other_E
. NE

To NE
determine NE
whether NE
oxidative Other_B
stress Other_E
dependent NE
NF-kappaB Protein_complex
activation NE
is NE
evident NE
in NE
patients Multicellular_organism_natural
with NE
diabetic Other_B
nephropathy Other_E
we NE
used NE
an NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assay Other_E
based NE
semiquantitative NE
detection NE
system NE
which NE
enabled NE
us NE
to NE
determine NE
NF-kappaB Other_B
activation Other_E
in NE
ex NE
vivo NE
isolated NE
peripheral NE
blood NE
mononuclear NE
cells NE
. NE

We NE
examined NE
33 NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
(Type NE
I NE
and NE
Type NE
II) NE
. NE

Patients NE
with NE
diabetic Other_B
nephropathy Other_E
showed NE
higher NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
Electrophoretic Other_B
Mobility Other_M
Shift Other_M
Assays Other_E
and NE
stronger NE
immunohistological NE
staining NE
for NE
activated NE
NF-kappaBp65 Protein_molecule
than NE
patients Multicellular_organism_natural
without NE
renal Other_B
complications Other_E
. NE

NF-kappaB Protein_complex
binding NE
activity NE
correlated NE
with NE
the NE
degree NE
of NE
albuminuria Other
(r NE
= NE
0.316) NE
and NE
with NE
thrombomodulin Other_B
plasma Other_M
concentrations Other_E
(r NE
= NE
0.33) NE
, NE
indicative NE
for NE
albuminuria NE
associated NE
endothelial NE
dysfunction NE
. NE

In NE
a NE
3 NE
day NE
intervention NE
study NE
in NE
which NE
600 NE
mg NE
of NE
the NE
antioxidant NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
per NE
day NE
were NE
given NE
to NE
nine NE
patients NE
with NE
diabetic NE
nephropathy NE
oxidative Other_B
stress Other_E
in NE
plasma NE
samples NE
was NE
decreased NE
by NE
48% NE
and NE
NF-kappaB Protein_complex
binding NE
activity NE
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
by NE
38% NE
. NE

In NE
conclusion NE
, NE
activation NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NF-kappaB Protein_complex
in NE
ex NE
vivo NE
isolated Cell_natural_B
peripheral Cell_natural_M
blood Cell_natural_M
mononuclear Cell_natural_M
cells Cell_natural_E
of NE
patients Multicellular_organism_natural
with NE
diabetes Other_B
mellitus Other_E
correlates NE
with NE
the NE
degree NE
of NE
diabetic Other_B
nephropathy Other_E
. NE

NF-kappaB Protein_complex
activation NE
is NE
at NE
least NE
in NE
part NE
dependent NE
on NE
oxidative Other_B
stress Other_E
since NE
thioctic Organic_compound_other_B
acid Organic_compound_other_E
( NE
alpha-lipoic Organic_compound_other_B
acid Organic_compound_other_E
) NE
reduced NE
NF-kappaB Other_B
binding Other_M
activity Other_E
. NE

The NE
human Other_B
toll Other_M
signaling Other_M
pathway Other_E
: NE
divergence NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
kappaB Protein_complex_E
and NE
JNK NE
/SAPK NE
activation NE
upstream NE
of NE
tumor NE
necrosis NE
factor NE
receptor-associated NE
factor NE
6 NE
( NE
TRAF6 NE
) NE
. NE

The NE
human NE
homologue NE
of NE
Drosophila Protein_molecule_B
Toll Protein_molecule_E
( NE
hToll Protein_molecule
) NE
is NE
a NE
recently NE
cloned NE
receptor NE
of NE
the NE
interleukin NE
1 NE
receptor NE
( NE
IL-1R NE
) NE
superfamily NE
, NE
and NE
has NE
been NE
implicated NE
in NE
the NE
activation NE
of NE
adaptive NE
immunity NE
. NE

Signaling NE
by NE
hToll Protein_molecule
is NE
shown NE
to NE
occur NE
through NE
sequential NE
recruitment NE
of NE
the NE
adapter Protein_family_or_group_B
molecule Protein_family_or_group_E
MyD88 Protein_molecule
and NE
the NE
IL-1R-associated Protein_molecule_B
kinase Protein_molecule_E
. NE

Tumor Protein_molecule_B
necrosis Protein_molecule_M
factor Protein_molecule_M
receptor-activated Protein_molecule_M
factor Protein_molecule_M
6 Protein_molecule_E
( NE
TRAF6 Protein_molecule
) NE
and NE
the NE
nuclear NE
factor NE
kappaB NE
( NE
NF-kappaB NE
)-inducing NE
kinase NE
( NE
NIK NE
) NE
are NE
both NE
involved NE
in NE
subsequent NE
steps NE
of NE
NF-kappaB NE
activation NE
. NE

Conversely NE
, NE
a NE
dominant NE
negative NE
version NE
of NE
TRAF6 NE
failed NE
to NE
block NE
hToll Protein_molecule
-induced NE
activation NE
of NE
stress-activated Protein_family_or_group_B
protein Protein_family_or_group_M
kinase/c-Jun Protein_family_or_group_M
NH2-terminal Protein_family_or_group_M
kinases Protein_family_or_group_E
, NE
thus NE
suggesting NE
an NE
early NE
divergence NE
of NE
the NE
two NE
pathways NE
. NE

Various NE
modes NE
of NE
basic NE
helix-loop-helix NE
protein NE
-mediated NE
regulation NE
of NE
murine NE
leukemia NE
virus NE
transcription NE
in NE
lymphoid NE
cell NE
lines NE
. NE

The NE
transcriptionally DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
regions DNA_domain_or_region_E
of NE
the NE
lymphomagenic NE
Akv NE
and NE
SL3-3 NE
murine NE
leukemia NE
retroviruses NE
( NE
MLVs NE
) NE
contain NE
two NE
types NE
of NE
E-box NE
consensus NE
motifs NE
, NE
CAGATG NE
. NE

One NE
type NE
, NE
EA/S DNA_domain_or_region
, NE
is NE
located NE
in NE
the NE
upstream DNA_domain_or_region_B
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
, NE
and NE
the NE
other NE
, NE
E(gre) DNA_domain_or_region
, NE
is NE
located NE
in NE
a NE
tandem DNA_domain_or_region_B
repeat DNA_domain_or_region_E
with NE
enhancer NE
properties NE
. NE

We NE
have NE
examined NE
the NE
requirements NE
of NE
the NE
individual NE
E-boxes NE
in NE
MLV NE
transcriptional NE
regulation NE
. NE

In NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
only NE
, NE
the NE
E(gre) NE
-binding NE
protein NE
complexes NE
included NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
basic NE
helix-loop-helix NE
proteins NE
. NE

Ectopic NE
ALF1 Protein_complex
and NE
E2A Protein_family_or_group_B
proteins Protein_family_or_group_E
required NE
intact NE
E(gre) DNA_domain_or_region_B
motifs DNA_domain_or_region_E
for NE
mediating NE
transcriptional NE
activation NE
. NE

ALF1 Other_B
transactivated Other_M
transcription Other_E
of NE
Akv NE
MLV NE
through NE
the NE
two NE
E(gre) NE
motifs NE
equally NE
, NE
whereas NE
E2A NE
protein NE
required NE
the NE
promoter-proximal NE
E(gre) NE
motif NE
. NE

In NE
T- NE
and NE
B- NE
cell NE
lines NE
, NE
the NE
E(gre) NE
motifs NE
were NE
of NE
major NE
importance NE
for NE
Akv NE
MLV NE
transcriptional NE
activity NE
, NE
while NE
the NE
EA/S NE
motif NE
had NE
some NE
effect NE
. NE

In NE
contrast NE
, NE
neither NE
E(gre) DNA_domain_or_region
nor NE
EA/S DNA_domain_or_region_B
motifs DNA_domain_or_region_E
contributed NE
pronouncedly NE
to NE
Akv NE
MLV NE
transcription NE
in NE
NIH NE
3T3 NE
cells NE
lacking NE
DNA NE
-binding NE
ALF1 NE
or NE
HEB NE
and NE
E2A NE
proteins NE
. NE

The NE
Id1 NE
protein NE
was NE
found NE
to NE
repress NE
ALF1 Other_B
activity Other_E
in NE
vitro NE
and NE
in NE
vivo NE
. NE

Moreover NE
, NE
ectopic Protein_molecule_B
Id1 Protein_molecule_E
repressed NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
but NE
not NE
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
E(gre)-directed Other_B
MLV Other_M
transcription Other_M
but Other_M
not Other_M
EA/S-directed Other_M
MLV Other_M
transcription Other_E
in NE
lymphoid Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
. NE

In NE
conclusion NE
, NE
E(gre) DNA_domain_or_region
motifs NE
and NE
interacting NE
basic Protein_family_or_group_B
helix-loop-helix Protein_family_or_group_M
proteins Protein_family_or_group_E
are NE
important NE
determinants NE
for NE
MLV Other_B
transcriptional Other_M
activity Other_E
in NE
lymphocytic NE
cell NE
lines NE
. NE

The NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
is NE
responsible NE
for NE
its NE
B NE
cell NE
-specific NE
activity NE
and NE
binds NE
to NE
a NE
B NE
cell NE
110-kDa NE
nuclear NE
protein NE
. NE

Expression NE
studies NE
as NE
well NE
as NE
the NE
use NE
of NE
transgenic Multicellular_organism_genetically_modified_B
animals Multicellular_organism_genetically_modified_E
have NE
demonstrated NE
that NE
the NE
A-MYB Protein_molecule
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
plays NE
central NE
and NE
specific NE
role NE
in NE
the NE
regulation NE
of NE
mature Other_B
B Other_M
cell Other_M
proliferation Other_E
and/or NE
differentiation NE
. NE

Furthermore NE
, NE
it NE
is NE
highly NE
expressed NE
in NE
Burkitt's Cell_cultured_B
lymphoma Cell_cultured_M
cells Cell_cultured_E
and NE
may NE
participate NE
in NE
the NE
pathogenesis NE
of NE
this NE
disease NE
. NE

We NE
have NE
therefore NE
investigated NE
the NE
transcriptional Other_B
activity Other_E
of NE
A-MYB Protein_molecule
and NE
its NE
regulation NE
in NE
several NE
human Cell_cultured_B
lymphoid Cell_cultured_M
cell Cell_cultured_M
lines Cell_cultured_E
using NE
co-transfection NE
assays NE
and NE
show NE
that NE
A-MYB Protein_molecule
is NE
transcriptionally NE
active NE
in NE
all NE
the NE
B Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
studied NE
, NE
but NE
not NE
in NE
T Cell_natural_B
cells Cell_natural_E
. NE

In NE
particular NE
the NE
best NE
responder Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_E
was NE
the NE
Burkitt's Cell_cultured_B
cell Cell_cultured_M
line Cell_cultured_M
Namalwa Cell_cultured_E
. NE

The NE
activity NE
of NE
A-MYB Protein_molecule
in NE
B NE
and NE
not NE
T NE
cells NE
was NE
observed NE
when NE
either NE
an NE
artificial NE
construct NE
or NE
the NE
c-MYC NE
promoter NE
was NE
used NE
as NE
a NE
reporter NE
. NE

Furthermore NE
, NE
the NE
functional Protein_domain_or_region_B
domains Protein_domain_or_region_E
responsible NE
for NE
DNA Other_B
binding Other_E
, NE
transactivation Other
, NE
and NE
negative Other_B
regulation Other_E
, NE
previously NE
characterized NE
in NE
a NE
fibroblast NE
context NE
, NE
were NE
found NE
to NE
have NE
similar NE
activity NE
in NE
B Cell_natural_B
cells Cell_natural_E
. NE

The NE
region NE
of NE
A-MYB NE
responsible NE
for NE
the NE
B Other_B
cell Other_M
specific Other_M
activity Other_E
was NE
defined NE
to NE
be NE
the NE
N-terminal Protein_domain_or_region_B
218 Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
containing NE
the NE
DNA Protein_domain_or_region_B
binding Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

Finally NE
, NE
a NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
has NE
been NE
identified NE
in NE
the NE
nuclei NE
of NE
all NE
the NE
B NE
, NE
but NE
not NE
T NE
, NE
cell NE
lines NE
that NE
specifically NE
binds NE
to NE
this NE
A-MYB NE
N-terminal NE
domain NE
. NE

We NE
hypothesize NE
that NE
this NE
110-kDa Protein_molecule_B
protein Protein_molecule_E
may NE
be NE
a NE
functionally NE
important NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
co-activator Protein_family_or_group_E
of NE
A-MYB Protein_molecule
. NE

Repression NE
by NE
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
is NE
mediated NE
through NE
histone NE
deacetylase NE
complexes NE
. NE

Here NE
we NE
show NE
that NE
the NE
lymphoid Protein_family_or_group_B
lineage-determining Protein_family_or_group_M
factors Protein_family_or_group_E
Ikaros Protein_molecule
and NE
Aiolos Protein_molecule
can NE
function NE
as NE
strong Protein_family_or_group_B
transcriptional Protein_family_or_group_M
repressors Protein_family_or_group_E
. NE

This NE
function NE
is NE
mediated NE
through NE
two NE
repression Protein_family_or_group_B
domains Protein_family_or_group_E
and NE
is NE
dependent NE
upon NE
the NE
promoter DNA_domain_or_region_B
context DNA_domain_or_region_E
and NE
cell Cell_natural_B
type Cell_natural_E
. NE

Repression NE
by NE
Ikaros Protein_family_or_group_B
proteins Protein_family_or_group_E
correlates NE
with NE
hypo-acetylation NE
of NE
core NE
histones NE
at NE
promoter NE
sites NE
and NE
is NE
relieved NE
by NE
histone NE
deacetylase NE
inhibitors NE
. NE

Consistent NE
with NE
these NE
findings NE
, NE
Ikaros Protein_molecule
and NE
its NE
repression Protein_domain_or_region_B
domains Protein_domain_or_region_E
can NE
interact NE
in NE
vivo NE
and NE
in NE
vitro NE
with NE
the NE
mSin3 NE
family NE
of NE
co-repressors NE
which NE
bind NE
to NE
histone Protein_family_or_group_B
deacetylases Protein_family_or_group_E
. NE

Based NE
on NE
these NE
and NE
our NE
recent NE
findings NE
of NE
associations NE
between NE
Ikaros Protein_molecule
and NE
Mi-2-HDAC Protein_molecule
, NE
we NE
propose NE
that NE
Ikaros Protein_family_or_group_B
family Protein_family_or_group_M
members Protein_family_or_group_E
modulate NE
gene NE
expression NE
during NE
lymphocyte NE
development NE
by NE
recruiting NE
distinct NE
histone NE
deacetylase NE
complexes NE
to NE
specific NE
promoters NE
. NE

Stimulation NE
of NE
neutrophil Cell_natural
interleukin-8 Other_B
production Other_E
by NE
eosinophil NE
granule NE
major NE
basic NE
protein NE
. NE

We NE
evaluated NE
the NE
ability NE
of NE
eosinophil Protein_molecule_B
granule Protein_molecule_M
major Protein_molecule_M
basic Protein_molecule_M
protein Protein_molecule_E
( NE
MBP Protein_molecule
) NE
to NE
stimulate NE
interleukin Other_B
(IL)-8 Other_M
production Other_E
by NE
neutrophils NE
. NE

MBP Protein_molecule
over NE
the NE
concentration NE
range NE
of NE
0.1 NE
to NE
10 NE
microM NE
stimulated NE
the NE
release NE
of NE
up NE
to NE
approximately NE
8 NE
ng/ml NE
IL-8 Protein_molecule
. NE

Incubation NE
with NE
2 NE
microM NE
MBP Protein_molecule
showed NE
that NE
, NE
after NE
a NE
1 NE
h NE
lag NE
, NE
the NE
level NE
of NE
IL-8 Protein_molecule
release NE
increased NE
with NE
time NE
for NE
approximately NE
10 NE
h NE
. NE

At NE
the NE
2 NE
microM NE
concentration NE
, NE
eosinophil Protein_molecule_B
cationic Protein_molecule_M
protein Protein_molecule_E
, NE
eosinophil-derived Organic_compound_other_B
neurotoxin Organic_compound_other_E
, NE
and NE
eosinophil Protein_molecule_B
peroxidase Protein_molecule_E
did NE
not NE
stimulate NE
significant NE
levels NE
of NE
IL-8 Other_B
production Other_E
. NE

MBP Protein_molecule
stimulated NE
2-fold NE
increases NE
in NE
IL-8 RNA_molecule_B
messenger RNA_molecule_M
RNA RNA_molecule_E
( NE
mRNA NE
) NE
after NE
1 NE
and NE
3 NE
h NE
of NE
incubation NE
, NE
which NE
were NE
blocked NE
by NE
pretreatment NE
with NE
actinomycin NE
D NE
. NE

However NE
, NE
stimulation NE
with NE
MBP Protein_molecule
did NE
not NE
produce NE
an NE
increase NE
in NE
the NE
binding NE
activity NE
of NE
nuclear Protein_complex_B
factor Protein_complex_M
(NF)-kappaB Protein_complex_E
or NE
activator Protein_molecule_B
protein-1 Protein_molecule_E
. NE

No NE
NF-IL-6 Other_B
binding Other_M
activity Other_E
was NE
detected NE
in NE
the NE
same NE
nuclear NE
extracts NE
. NE

In NE
addition NE
, NE
stimulation NE
with NE
MBP Protein_molecule
prolonged NE
the NE
stability NE
of NE
IL-8 RNA_molecule_B
mRNA RNA_molecule_E
. NE

MBP Protein_molecule
also NE
induced NE
transient NE
increases NE
in NE
mRNA RNA_family_or_group
for NE
macrophage Protein_molecule_B
inflammatory Protein_molecule_M
protein Protein_molecule_M
(MIP)-1alpha Protein_molecule_E
and NE
MIP-1beta Protein_molecule
, NE
but NE
did NE
not NE
stimulate NE
the NE
release NE
of NE
either NE
chemokine Protein_family_or_group
. NE

These NE
findings NE
indicate NE
that NE
MBP Protein_molecule
is NE
selective NE
among NE
the NE
eosinophil Protein_family_or_group_B
granule Protein_family_or_group_M
proteins Protein_family_or_group_E
as NE
a NE
stimulus NE
for NE
neutrophil Other_B
IL-8 Other_M
release Other_E
and NE
, NE
further NE
, NE
that NE
stimulation NE
of NE
neutrophil Other_B
IL-8 Other_M
release Other_E
by NE
MBP NE
involves NE
both NE
transcriptional NE
and NE
posttranscriptional NE
regulation NE
. NE

We NE
postulate NE
that NE
MBP NE
-induced NE
release NE
of NE
IL-8 NE
by NE
neutrophils NE
may NE
contribute NE
to NE
the NE
pathophysiology NE
of NE
acute NE
asthma NE
and NE
other NE
inflammatory NE
lung NE
diseases NE
. NE

IFN-gamma Protein_molecule
priming NE
of NE
monocytes Cell_natural
enhances NE
LPS NE
-induced NE
TNF NE
production NE
by NE
augmenting NE
both NE
transcription NE
and NE
MRNA NE
stability NE
. NE

The NE
induction NE
of NE
cytokine Other_B
expression Other_E
in NE
monocytes NE
/ NE
macrophages NE
by NE
bacterial NE
endotoxin NE
or NE
lipopolysaccharide NE
is NE
a NE
critical NE
, NE
highly NE
regulated NE
host NE
defence NE
response NE
. NE

The NE
augmentation NE
of NE
LPS Lipid
responses NE
by NE
interferon Protein_molecule_B
gamma Protein_molecule_E
( NE
IFN-gamma Protein_molecule
) NE
, NE
referred NE
to NE
as NE
priming NE
, NE
is NE
well NE
established NE
. NE

However NE
, NE
the NE
mechanism(s) NE
by NE
which NE
priming NE
occurs NE
is NE
poorly NE
defined NE
. NE

Using NE
tumour NE
necrosis NE
factor NE
( NE
TNF NE
) NE
induction NE
as NE
a NE
model NE
, NE
experiments NE
were NE
designed NE
to NE
analyse NE
in NE
detail NE
the NE
priming NE
effect NE
on NE
the NE
LPS NE
response NE
in NE
human NE
monocytes NE
. NE

Priming NE
by NE
IFN-gamma Protein_molecule
was NE
primarily NE
manifested NE
at NE
the NE
level NE
of NE
TNF Other_B
mRNA Other_M
accumulation Other_E
. NE

IFN-gamma Other_B
pre-treatment Other_E
affected NE
the NE
magnitude NE
rather NE
than NE
the NE
sensitivity NE
of NE
the NE
LPS NE
response NE
. NE

Priming NE
occurred NE
after NE
several NE
hours NE
of NE
treatment Other
, NE
and NE
the NE
primed Other_B
state Other_E
was NE
induced NE
by NE
either NE
IFN-gamma Protein_molecule
or NE
GM-CSF Protein_molecule
, NE
but NE
not NE
M-CSF Protein_molecule
. NE

Primed NE
monocytes Cell_natural
transcribed NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
at NE
a NE
higher NE
rate NE
than NE
freshly NE
isolated NE
monocytes NE
upon NE
activation NE
with NE
LPS NE
. NE

The NE
increased NE
transcriptional Other_B
rate Other_E
correlated NE
with NE
a NE
marked NE
increase NE
in NE
nuclear Other_B
factor-kappa Other_M
B Other_M
activity Other_E
in NE
these NE
cells NE
as NE
determined NE
by NE
electrophoretic NE
mobility NE
shift NE
assay NE
using NE
a NE
consensus NE
NF-kappa NE
B NE
oligonucleotide NE
. NE

An NE
additional NE
significant NE
finding NE
was NE
than NE
TNF RNA_family_or_group_B
mRNA RNA_family_or_group_E
induced NE
in NE
primed NE
cells NE
was NE
much NE
more NE
stable NE
than NE
in NE
unprimed NE
cells NE
(T1/2 NE
increased NE
6-8-fold) NE
. NE

Consistent NE
with NE
the NE
increased NE
mRNA Other_B
stability Other_E
, NE
the NE
duration NE
of NE
mRNA NE
accumulation NE
was NE
longer NE
following NE
LPS NE
stimulation NE
in NE
primed NE
monocytes NE
, NE
in NE
addition NE
to NE
being NE
of NE
greater NE
magnitude NE
. NE

Finally NE
, NE
primed NE
and NE
unprimed NE
cells NE
possessed NE
a NE
differential NE
sensitivity NE
to NE
the NE
kinase Organic_compound_other_B
inhibitor Organic_compound_other_M
H-89 Organic_compound_other_E
. NE

H-89 Organic_compound_other
substantially NE
suppressed NE
LPS NE
-induced NE
TNF NE
mRNA NE
accumulation NE
in NE
unprimed NE
cells NE
, NE
but NE
had NE
no NE
effect NE
on NE
primed NE
monocytes NE
following NE
LPS NE
stimulation NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

Two NE
distinct NE
pathways NE
of NE
interleukin-5 Other_B
synthesis Other_E
in NE
allergen-specific NE
human NE
T-cell NE
clones NE
are NE
suppressed NE
by NE
glucocorticoids NE
. NE

Glucocorticoids Lipid
( NE
GC Lipid
) NE
have NE
long NE
been NE
used NE
as NE
the NE
most NE
effective NE
agents NE
for NE
the NE
treatment NE
of NE
allergic Other_B
diseases Other_E
accompanied NE
by NE
eosinophilia Other
such NE
as NE
chronic Other_B
asthma Other_E
and NE
atopic Other_B
dermatitis Other_E
. NE

The NE
development NE
of NE
chronic Other_B
eosinophilic Other_M
inflammation Other_E
is NE
dependent NE
on NE
interleukin-5 Protein_molecule
( NE
IL-5 Protein_molecule
) NE
, NE
a NE
selective Protein_family_or_group_B
eosinophil-activating Protein_family_or_group_M
factor Protein_family_or_group_E
, NE
produced NE
by NE
helper Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
. NE

To NE
delineate NE
the NE
regulatory NE
mechanisms NE
of NE
human Other_B
IL-5 Other_M
synthesis Other_E
, NE
we NE
established NE
allergen-specific NE
CD4+ NE
T-cell NE
clones NE
from NE
asthmatic NE
patients NE
. NE

GC Lipid
efficiently NE
suppressed NE
IL-5 Other_B
synthesis Other_E
of NE
T-cell NE
clones NE
activated NE
via NE
either NE
T-cell NE
receptor NE
( NE
TCR NE
) NE
or NE
IL-2 NE
receptor NE
( NE
IL-2R NE
) NE
. NE

Induction NE
of NE
IL-5 RNA_molecule_B
mRNA RNA_molecule_E
upon NE
TCR NE
and NE
IL-2R NE
stimulation NE
was NE
totally NE
inhibited NE
by NE
dexamethasone NE
. NE

Human NE
IL-5 NE
promoter/enhancer-luciferase NE
gene NE
construct NE
transfected NE
to NE
T-cell Cell_cultured_B
clones Cell_cultured_E
was NE
transcribed NE
on NE
either NE
TCR Protein_family_or_group
or NE
IL-2R Other_B
stimulation Other_E
and NE
was NE
clearly NE
downregulated NE
by NE
dexamethasone NE
, NE
indicating NE
that NE
the NE
approximately NE
500-bp NE
human NE
IL-5 NE
gene NE
segment NE
located NE
5' NE
upstream NE
of NE
the NE
coding NE
region NE
contains NE
activation NE
-inducible NE
enhancer NE
elements NE
responsible NE
for NE
the NE
regulation NE
by NE
GC NE
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assay Other_M
analysis Other_E
suggested NE
that NE
AP-1 Protein_molecule
and NE
NF-kappaB Protein_complex
are NE
among NE
the NE
possible NE
targets NE
of NE
GC Other_B
actions Other_E
on NE
TCR NE
-stimulated NE
T NE
cells NE
. NE

NF-AT Protein_molecule
and NE
NF-kappaB Protein_complex
were NE
not NE
significantly NE
induced NE
by NE
IL-2 Other_B
stimulation Other_E
. NE

Our NE
results NE
showing NE
that NE
GC Lipid
suppressed NE
IL-5 Protein_molecule
production NE
by NE
human Cell_natural_B
CD4+ Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
activated NE
by NE
two NE
distinct NE
stimuli NE
, NE
TCR Protein_family_or_group
and NE
IL-2R Other_B
stimulation Other_E
, NE
underscore NE
the NE
efficacy NE
of NE
GC NE
in NE
the NE
treatment NE
of NE
allergic NE
diseases NE
via NE
suppression NE
of NE
T-cell NE
IL-5 NE
synthesis NE
. NE

Differential NE
expression NE
and NE
phosphorylation Other
of NE
CTCF Protein_molecule
, NE
a NE
c-myc NE
transcriptional NE
regulator NE
, NE
during NE
differentiation NE
of NE
human NE
myeloid NE
cells NE
. NE

CTCF Protein_molecule
is NE
a NE
transcriptional NE
repressor NE
of NE
the NE
c-myc NE
gene NE
. NE

Although NE
CTCF Protein_molecule
has NE
been NE
characterized NE
in NE
some NE
detail NE
, NE
there NE
is NE
very NE
little NE
information NE
about NE
the NE
regulation NE
of NE
CTCF Other_B
activity Other_E
. NE

Therefore NE
we NE
investigated NE
CTCF Other_B
expression Other_E
and NE
phosphorylation NE
during NE
induced NE
differentiation NE
of NE
human NE
myeloid NE
leukemia NE
cells NE
. NE

We NE
found NE
that NE
: NE
(i) NE
both NE
CTCF RNA_molecule_B
mRNA RNA_molecule_E
and NE
protein NE
are NE
down-regulated NE
during NE
terminal NE
differentiation NE
in NE
most NE
cell NE
lines NE
tested NE
; NE
(ii) NE
CTCF NE
down-regulation NE
is NE
retarded NE
and NE
less NE
pronounced NE
than NE
that NE
of NE
c-myc NE
; NE
(iii) NE
CTCF NE
protein NE
is NE
differentially NE
phosphorylated NE
and NE
the NE
phosphorylation NE
profiles NE
depend NE
on NE
the NE
differentiation NE
pathway NE
. NE

We NE
concluded NE
that NE
CTCF Other_B
expression Other_E
and NE
activity NE
is NE
controlled NE
at NE
transcriptional NE
and NE
post-transcriptional NE
levels NE
. NE

Role NE
of NE
IKK1 Protein_molecule
and NE
IKK2 Protein_molecule
in NE
lipopolysaccharide Other_B
signaling Other_E
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
. NE

Mononuclear Cell_natural_B
phagocytes Cell_natural_E
play NE
a NE
major NE
role NE
in NE
immune NE
and NE
inflammatory NE
responses NE
. NE

Bacterial Lipid_B
lipopolysaccharide Lipid_E
( NE
LPS Lipid
) NE
induces NE
monocytes Cell_natural
to NE
express NE
a NE
variety NE
of NE
genes NE
by NE
activating NE
the NE
NF-kappaB/Rel Protein_family_or_group_B
transcription Protein_family_or_group_M
factor Protein_family_or_group_M
family Protein_family_or_group_E
. NE

Recently NE
, NE
we NE
have NE
reported NE
that NE
the NE
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
tumor Other_B
necrosis Other_M
factor Other_M
signaling Other_M
pathway Other_M
and Other_M
interleukin Other_M
1 Other_M
signaling Other_M
pathway Other_E
IKK1 NE
and NE
IKK2 Protein_molecule
. NE

Phosphorylation NE
of NE
the NE
IkappaB Protein_family_or_group_B
cytoplasmic Protein_family_or_group_M
inhibitors Protein_family_or_group_E
, NE
IkappaBalpha NE
, NE
IkappaBbeta NE
, NE
and NE
IkappaBepsilon NE
, NE
by NE
these NE
kinases NE
triggers NE
proteolytic NE
degradation NE
and NE
the NE
release NE
of NE
NF-kappaB/Rel NE
proteins NE
into NE
the NE
nucleus NE
. NE

At NE
present NE
, NE
the NE
role NE
of NE
the NE
IKKs NE
in NE
LPS Lipid
signaling NE
has NE
not NE
been NE
investigated NE
. NE

Here NE
, NE
we NE
report NE
that NE
LPS Lipid
induces NE
IKK Other_B
activity Other_E
in NE
human NE
monocytes NE
and NE
THP-1 NE
monocytic NE
cells NE
. NE

The NE
kinetics NE
of NE
activation NE
of NE
kinase Other_B
activity Other_E
in NE
monocytic Cell_natural_B
cells Cell_natural_E
are NE
relatively NE
slow NE
with NE
maximal NE
activity NE
observed NE
at NE
60 NE
min NE
, NE
which NE
coincides NE
with NE
the NE
degradation NE
of NE
IkappaBs Protein_family_or_group
and NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappaB Protein_complex
. NE

In NE
transfection NE
experiments NE
, NE
overexpression NE
of NE
wild NE
type NE
IKK1 Protein_molecule
, NE
a NE
dominant Protein_molecule_B
negative Protein_molecule_M
mutant Protein_molecule_M
IKK1 Protein_molecule_E
( NE
K44M NE
) NE
, NE
or NE
wild NE
type NE
IKK2 NE
did NE
not NE
affect NE
LPS NE
-induced NE
kappaB NE
-dependent NE
transcription NE
in NE
monocytic NE
cells NE
. NE

In NE
contrast NE
, NE
a NE
dominant NE
negative NE
mutant NE
of NE
IKK2 Protein_molecule
inhibited NE
LPS Lipid
induction NE
of NE
kappaB Protein_molecule
-dependent NE
transcription NE
in NE
a NE
dose-dependent Other_B
manner Other_E
. NE

These NE
results NE
indicate NE
that NE
LPS Lipid
induction NE
of NE
kappaB NE
-dependent NE
gene NE
expression NE
in NE
human Cell_natural_B
monocytic Cell_natural_M
cells Cell_natural_E
requires NE
activation NE
of NE
IKK2 NE
. NE

OBF-1 Protein_molecule
, NE
a NE
novel Protein_family_or_group_B
B Protein_family_or_group_M
cell-specific Protein_family_or_group_M
coactivator Protein_family_or_group_E
that NE
stimulates NE
immunoglobulin Other_B
promoter Other_M
activity Other_E
through NE
association NE
with NE
octamer-binding NE
proteins NE
. NE

Recent NE
biochemical NE
and NE
genetic NE
studies NE
indicate NE
that NE
in NE
addition NE
to NE
the NE
octamer-binding Protein_family_or_group_B
proteins Protein_family_or_group_E
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
, NE
other NE
B Protein_family_or_group_B
cell Protein_family_or_group_M
components Protein_family_or_group_E
are NE
required NE
for NE
lymphoid-restricted NE
, NE
octamer NE
site NE
-mediated NE
immunoglobulin NE
gene NE
promoter NE
activity NE
. NE

Using NE
a NE
genetic NE
screen NE
in NE
yeast NE
, NE
we NE
have NE
isolated NE
B DNA_family_or_group_B
cell-derived DNA_family_or_group_M
cDNAs DNA_family_or_group_E
encoding NE
Oct-binding Protein_molecule_B
factor Protein_molecule_M
1 Protein_molecule_E
( NE
OBF-1 Protein_molecule
) NE
, NE
a NE
novel NE
protein NE
that NE
specifically NE
associates NE
with NE
Oct-1 Protein_molecule
and NE
Oct-2 Protein_molecule
. NE

Biochemical NE
studies NE
demonstrate NE
that NE
OBF-1 Protein_molecule
has NE
no NE
intrinsic NE
DNA NE
-binding NE
activity NE
and NE
recognizes NE
the NE
POU Protein_domain_or_region_B
domains Protein_domain_or_region_E
of NE
Oct-1 Protein_domain_or_region
and NE
Oct-2 Protein_domain_or_region
, NE
but NE
not NE
those NE
of NE
Oct-4 Protein_domain_or_region
and NE
Oct-6 Protein_domain_or_region
. NE

The NE
OBF-1 RNA_molecule_B
mRNA RNA_molecule_E
is NE
expressed NE
in NE
a NE
highly NE
cell-specific NE
manner NE
, NE
being NE
most NE
abundant NE
in NE
B NE
cells NE
and NE
essentially NE
absent NE
in NE
most NE
of NE
the NE
other NE
cells NE
or NE
tissues NE
tested NE
. NE

Furthermore NE
, NE
expression NE
of NE
OBF-1 Protein_molecule
in NE
HeLa Cell_cultured_B
cells Cell_cultured_E
selectively NE
stimulates NE
the NE
activity NE
of NE
a NE
natural NE
immunoglobulin DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
an NE
octamer NE
site NE
-dependent NE
manner NE
. NE

Thus NE
, NE
OBF-1 Protein_molecule
has NE
all NE
the NE
properties NE
expected NE
for NE
a NE
B Protein_family_or_group_B
cell-specific Protein_family_or_group_M
transcriptional Protein_family_or_group_M
coactivator Protein_family_or_group_M
protein Protein_family_or_group_E
. NE

Differential NE
utilization NE
of NE
Janus NE
kinase NE
-signal NE
transducer NE
activator NE
of NE
transcription NE
signaling NE
pathways NE
in NE
the NE
stimulation NE
of NE
human NE
natural NE
killer NE
cells NE
by NE
IL-2 NE
, NE
IL-12 NE
, NE
and NE
IFN-alpha NE
. NE

IL-2 NE
- NE
, NE
IL-12 NE
- NE
, NE
and NE
IFN-alpha NE
- NE
mediated NE
signaling NE
pathways NE
were NE
analyzed NE
in NE
primary NE
NK NE
cells NE
and NE
in NE
the NE
NK3.3 NE
cell NE
line NE
. NE

Gel Other_B
mobility Other_M
shift Other_E
and NE
immunoprecipitation NE
analyses NE
revealed NE
that NE
in NE
addition NE
to NE
activating NE
STAT3 NE
( NE
signal NE
transducer NE
and NE
activator NE
of NE
transcription-3 NE
) NE
and NE
STAT5 NE
, NE
IL-2 NE
induced NE
tyrosine NE
and NE
serine NE
phosphorylation NE
of NE
STAT1 NE
alpha NE
, NE
which NE
formed NE
IFN-gamma NE
-activated NE
sequence NE
-binding NE
complexes NE
by NE
itself NE
and NE
with NE
STAT3 NE
. NE

Although NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
and NE
STAT5 Protein_molecule
, NE
IL-2 Protein_molecule
predominantly NE
activated NE
STAT5 Protein_molecule
, NE
while NE
IFN-alpha Protein_molecule
predominantly NE
activated NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
. NE

IL-2 Protein_molecule
induced NE
less NE
STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
and NE
IFN-alpha Protein_molecule
induced NE
greater NE
STAT5 Other_B
activation Other_E
in NE
NK3.3 NE
cells NE
compared NE
with NE
preactivated NE
primary NE
NK NE
cells NE
. NE

In NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
, NE
IL-2 Protein_molecule
induced NE
comparable NE
formation NE
of NE
c-fos NE
promoter NE
sis-inducible NE
element NE
IFN-gamma-activated NE
sequence NE
-binding NE
complexes NE
containing NE
STAT3 NE
alone NE
with NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
, NE
while NE
in NE
preactivated Cell_cultured_B
primary Cell_cultured_M
NK Cell_cultured_M
cells Cell_cultured_E
, NE
it NE
preferentially NE
induced NE
complexes NE
containing NE
STAT3 NE
and NE
STAT1 NE
alpha NE
. NE

Thus NE
, NE
signaling NE
in NE
NK3.3 Cell_cultured_B
cells Cell_cultured_E
is NE
not NE
always NE
identical NE
with NE
that NE
in NE
primary Cell_natural_B
NK Cell_natural_M
cells Cell_natural_E
. NE

In NE
contrast NE
to NE
IL-2 Protein_molecule
and NE
IFN-alpha Protein_molecule
, NE
IL-12 Protein_molecule
induced NE
strong NE
tyrosine Other_B
phosphorylation Other_E
of NE
STAT4 NE
and NE
variable NE
weak NE
phosphorylation NE
of NE
STAT3 NE
. NE

However NE
, NE
supershift NE
analyses NE
using NE
the NE
c-fos DNA_molecule_B
promoter DNA_molecule_M
sis-inducible DNA_molecule_M
element DNA_molecule_M
probe DNA_molecule_E
showed NE
that NE
IL-12 NE
activated NE
STAT4 NE
, NE
STAT1 NE
alpha NE
, NE
and NE
STAT3 NE
, NE
and NE
induced NE
complexes NE
containing NE
STAT4 NE
only NE
, NE
STAT4 NE
with NE
STAT1 NE
alpha NE
, NE
STAT3 NE
with NE
STAT1 NE
alpha NE
, NE
or NE
STAT1 NE
alpha NE
only NE
in NE
preactivated NE
primary NE
NK NE
cells NE
. NE

STAT1 Protein_molecule_B
alpha Protein_molecule_E
activation NE
by NE
IL-12 Protein_molecule
correlated NE
with NE
increased NE
phosphorylation NE
of NE
serine Amino_acid_monomer
, NE
but NE
not NE
tyrosine Amino_acid_monomer
. NE

Finally NE
, NE
IL-2 Protein_molecule
induced NE
tyrosine Other_B
phosphorylation Other_E
of NE
JAK1 NE
and NE
JAK3 NE
, NE
while NE
IL-12 NE
induced NE
phosphorylation NE
of NE
JAK2 NE
and NE
TYK2 NE
in NE
both NE
preactivated NE
primary NE
NK NE
and NE
NK3.3 NE
cells NE
. NE

Differential Other_B
phosphorylation Other_E
and NE
consequent NE
differential Other_B
activation Other_E
of NE
both NE
separate NE
and NE
overlapping NE
STAT Protein_family_or_group_B
proteins Protein_family_or_group_E
by NE
IL-2 Protein_molecule
, NE
IL-12 Protein_molecule
, NE
and NE
IFN-alpha Protein_molecule
may NE
provide NE
a NE
molecular NE
basis NE
for NE
the NE
similarities NE
and NE
differences NE
in NE
the NE
actions NE
of NE
these NE
cytokines Protein_family_or_group
on NE
NK Cell_natural_B
cells Cell_natural_E
. NE

Sequence NE
analysis NE
and NE
expression NE
in NE
cultured Cell_natural_B
lymphocytes Cell_natural_E
of NE
the NE
human NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
( NE
G0S3 DNA_domain_or_region
) NE
. NE

G0S3 DNA_domain_or_region
is NE
a NE
member NE
of NE
a NE
set NE
of NE
putative DNA_family_or_group_B
G0/G1 DNA_family_or_group_M
switch DNA_family_or_group_M
regulatory DNA_family_or_group_M
genes DNA_family_or_group_E
( NE
G0S DNA_family_or_group_B
genes DNA_family_or_group_E
) NE
selected NE
by NE
screening NE
cDNA NE
libraries NE
prepared NE
from NE
human NE
blood NE
mononuclear NE
cells NE
cultured NE
for NE
2 NE
hr NE
with NE
lectin NE
and NE
cycloheximide NE
. NE

The NE
sequence NE
shows NE
high NE
homology NE
with NE
the NE
murine DNA_domain_or_region_B
FOSB DNA_domain_or_region_M
gene DNA_domain_or_region_E
, NE
which NE
encodes NE
a NE
component NE
of NE
the NE
AP1 NE
transcriptional NE
regulator NE
. NE

Comparison NE
of NE
cDNA DNA_family_or_group
and NE
genomic DNA_domain_or_region_B
sequences DNA_domain_or_region_E
reveals NE
a NE
4-exon DNA_domain_or_region_B
structure DNA_domain_or_region_E
characteristic NE
of NE
the NE
FOS DNA_family_or_group_B
family DNA_family_or_group_M
of DNA_family_or_group_M
genes DNA_family_or_group_E
. NE

Freshly NE
isolated NE
cells NE
show NE
high NE
levels NE
of NE
FOSB/G0S3 NE
and NE
FOS/G0S7 NE
mRNAs NE
, NE
which NE
decline NE
rapidly NE
during NE
incubation NE
in NE
culture NE
medium NE
. NE

The NE
kinetics NE
of NE
expression NE
suggest NE
that NE
the NE
high NE
initial NE
levels NE
are NE
caused NE
by NE
the NE
isolation NE
procedure NE
, NE
and NE
do NE
not NE
reflect NE
constitutive Other_B
expression Other_E
. NE

In NE
cells NE
preincubated NE
for NE
a NE
day NE
, NE
levels NE
of NE
FOS RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
20 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
3 NE
hr NE
. NE

Levels NE
of NE
FOSB RNA_molecule_B
mRNA RNA_molecule_E
reach NE
a NE
maximum NE
40 NE
min NE
after NE
the NE
addition NE
of NE
lectin Protein_family_or_group
and NE
decline NE
to NE
control NE
levels NE
over NE
the NE
next NE
6 NE
hr NE
. NE

In NE
freshly NE
isolated NE
cells NE
, NE
both NE
FOS NE
and NE
FOSB NE
mRNAs NE
increase NE
dramatically NE
in NE
response NE
to NE
the NE
protein NE
synthesis NE
inhibitor NE
cycloheximide NE
. NE

In NE
preincubated NE
cells NE
, NE
the NE
cycloheximide Organic_compound_other
response NE
is NE
decreased NE
, NE
especially NE
in NE
the NE
case NE
of NE
FOSB DNA_domain_or_region
. NE

These NE
differences NE
in NE
expression NE
of NE
FOS DNA_domain_or_region
and NE
FOSB DNA_domain_or_region
suggest NE
different NE
roles NE
and NE
regulation NE
. NE

Regions NE
of NE
low NE
base NE
order-dependent NE
stem-loop NE
potential NE
in NE
the NE
region NE
of NE
the NE
gene NE
are NE
defined NE
. NE

These NE
indicate NE
where NE
base NE
order NE
has NE
been NE
adapted NE
for NE
purposes NE
other NE
than NE
stem-loop Other_B
stability Other_E
(e.g. NE
, NE
encoding NE
proteins NE
or NE
gene Other_B
regulation Other_E
) NE
. NE

Regions NE
of NE
low NE
potential NE
in NE
a NE
68.5-kb NE
genomic NE
segment NE
containing NE
the NE
FOSB DNA_domain_or_region_B
gene DNA_domain_or_region_E
suggest NE
that NE
the NE
potential NE
may NE
help NE
locate NE
genes NE
in NE
uncharted NE
DNA NE
sequences NE
. NE

Alternative NE
splicing NE
of NE
RNA NE
transcripts NE
encoded NE
by NE
the NE
murine NE
p105 NE
NF-kappa NE
B NE
gene NE
generates NE
I NE
kappa NE
B NE
gamma NE
isoforms NE
with NE
different NE
inhibitory NE
activities NE
. NE

The NE
gene NE
encoding NE
the NE
105-kDa NE
protein NE
( NE
p105 NE
) NE
precursor NE
of NE
the NE
p50 NE
subunit NE
of NE
transcription NE
factor NE
NF-kappa NE
B NE
also NE
encodes NE
a NE
p70 NE
I NE
kappa NE
B NE
protein NE
, NE
I NE
kappa NE
B NE
gamma NE
, NE
which NE
is NE
identical NE
to NE
the NE
C-terminal NE
607 NE
amino NE
acids NE
of NE
p105 NE
. NE

Here NE
we NE
show NE
that NE
alternative NE
RNA Other_B
splicing Other_E
generates NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
with NE
properties NE
different NE
from NE
those NE
of NE
p70 NE
. NE

One NE
63-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
termed NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
, NE
which NE
lacks NE
59 Peptide_B
amino Peptide_M
acids Peptide_E
C-terminal NE
to NE
ankyrin Protein_domain_or_region_B
repeat Protein_domain_or_region_M
7 Protein_domain_or_region_E
, NE
has NE
a NE
novel NE
35-amino Protein_domain_or_region_B
acid Protein_domain_or_region_M
C Protein_domain_or_region_M
terminus Protein_domain_or_region_E
encoded NE
by NE
an NE
alternative DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
the NE
p105 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

A NE
55-kDa Protein_molecule_B
isoform Protein_molecule_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
, NE
lacks NE
the NE
190 Protein_domain_or_region_B
C-terminal Protein_domain_or_region_M
amino Protein_domain_or_region_M
acids Protein_domain_or_region_E
of NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
. NE

In NE
contrast NE
to NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
, NE
which NE
is NE
a NE
cytoplasmic Protein_family_or_group_B
protein Protein_family_or_group_E
, NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
is NE
found NE
in NE
both NE
the NE
cytoplasm Cell_component
and NE
nucleus NE
, NE
whereas NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
is NE
predominantly NE
nuclear NE
. NE

The NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
also NE
display NE
differences NE
in NE
specificity NE
and NE
affinity NE
for NE
Rel NE
/ NE
NF-kappa NE
B NE
proteins NE
. NE

While NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibits NE
p50 NE
- NE
, NE
p65 NE
- NE
, NE
and NE
c-Rel NE
-mediated NE
transactivation NE
and/or NE
DNA Other_B
binding Other_E
, NE
both NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
are NE
specific NE
for NE
p50 Protein_molecule
and NE
have NE
different NE
affinities NE
for NE
this NE
subunit NE
. NE

The NE
absence NE
in NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-1 Protein_molecule_E
and NE
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma-2 Protein_molecule_E
of NE
a NE
protein DNA_domain_or_region_B
kinase DNA_domain_or_region_M
A DNA_domain_or_region_M
site DNA_domain_or_region_E
whose NE
phosphorylation NE
modulates NE
p70 Protein_molecule
I Protein_molecule_B
kappa Protein_molecule_M
B Protein_molecule_M
gamma Protein_molecule_E
inhibitory NE
activity NE
suggests NE
that NE
alternative NE
RNA Other_B
splicing Other_E
may NE
be NE
used NE
to NE
generate NE
I Protein_family_or_group_B
kappa Protein_family_or_group_M
B Protein_family_or_group_M
gamma Protein_family_or_group_M
isoforms Protein_family_or_group_E
that NE
respond NE
differently NE
to NE
intracellular NE
signals NE
. NE

Ex NE
vivo NE
activation NE
of NE
tumor-draining Cell_natural_B
lymph Cell_natural_M
node Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
reverses NE
defects NE
in NE
signal NE
transduction NE
molecules NE
. NE

The NE
adoptive NE
transfer NE
of NE
tumor-draining Body_region_B
lymph Body_region_M
node Body_region_E
( NE
LN Body_region
) NE
T Cell_natural_B
cells Cell_natural_E
activated NE
ex NE
vivo NE
with NE
anti-CD3 Protein_molecule
and NE
interleukin Protein_molecule_B
2 Protein_molecule_E
( NE
IL-2 Protein_molecule
) NE
mediates NE
the NE
regression NE
of NE
the NE
poorly Tissue_natural_B
immunogenic Tissue_natural_M
murine Tissue_natural_M
melanoma Tissue_natural_M
D5 Tissue_natural_E
. NE

The NE
efficacy NE
of NE
the NE
activated NE
LN Cell_natural_B
cells Cell_natural_E
is NE
augmented NE
when NE
the NE
sensitizing NE
tumor NE
is NE
a NE
genetically Cell_cultured_B
modified Cell_cultured_M
variant Cell_cultured_E
(designated NE
D5G6 Cell_cultured
) NE
that NE
secretes NE
granulocyte/macrophage-colony-stimulating Protein_molecule_B
factor Protein_molecule_E
. NE

In NE
contrast NE
to NE
anti-CD3 NE
/ NE
IL-2 Protein_molecule
-activated NE
LN Cell_natural_B
cells Cell_natural_E
, NE
adoptive NE
transfer NE
of NE
freshly NE
isolated NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
has NE
no NE
therapeutic Other_B
activity Other_E
. NE

To NE
determine NE
whether NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
during NE
ex NE
vivo NE
activation NE
is NE
associated NE
with NE
modifications NE
in NE
signal Other_B
transduction Other_M
capacity Other_E
, NE
the NE
protein NE
tyrosine NE
kinases NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
and NE
proteins NE
of NE
the NE
NF-kappaB Protein_family_or_group_B
family Protein_family_or_group_E
were NE
analyzed NE
in NE
tumor-draining Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
. NE

The NE
levels NE
of NE
p56lck Protein_molecule
and NE
p59fyn Protein_molecule
were NE
lower NE
in NE
tumor-draining NE
than NE
in NE
normal Cell_natural_B
LN Cell_natural_M
T Cell_natural_M
cells Cell_natural_E
and NE
production NE
of NE
tyrosine NE
-phosphorylated NE
substrates NE
was NE
markedly NE
depressed NE
following NE
anti-CD3 NE
stimulation NE
. NE

After NE
5-day NE
anti-CD3 Protein_molecule
/IL-2 NE
activation NE
, NE
levels NE
of NE
p56lck NE
and NE
p59fyn NE
and NE
protein NE
tyrosine NE
kinase NE
activity NE
increased NE
. NE

Interestingly NE
, NE
the NE
levels NE
of NE
p56lck Protein_molecule
, NE
p59fyn Protein_molecule
, NE
and NE
tyrosine Other_B
kinase Other_M
activity Other_E
were NE
higher NE
in NE
activated NE
T NE
cells NE
derived NE
from NE
LN NE
that NE
drained NE
D5G6 NE
than NE
they NE
were NE
in NE
those NE
from NE
D5 NE
tumors NE
. NE

In NE
contrast NE
, NE
the NE
cytoplasmic Other_B
levels Other_E
of NE
c-Rel Protein_molecule
and NE
Rel Protein_molecule_B
A Protein_molecule_E
were NE
normal NE
in NE
freshly NE
isolated NE
tumor-draining Body_region_B
LN Body_region_E
, NE
as NE
was NE
nuclear NE
kappaB NE
DNA NE
-binding NE
activity NE
induced NE
by NE
anti-CD3 NE
mAb NE
or NE
phorbol NE
myristate NE
acetate NE
. NE

Stimulation NE
of NE
activated Cell_natural_B
LN Cell_natural_M
cells Cell_natural_E
with NE
D5 NE
tumor NE
cells NE
induced NE
the NE
nuclear NE
translocation NE
of NE
NF-kappaB NE
. NE

These NE
findings NE
indicate NE
that NE
the NE
recovery NE
of NE
proteins NE
mediating NE
signal NE
transduction NE
through NE
the NE
T Protein_complex_B
cell Protein_complex_M
receptor/CD3 Protein_complex_M
complex Protein_complex_E
in NE
LN Cell_natural_B
T Cell_natural_M
cells Cell_natural_E
activated NE
ex NE
vivo NE
was NE
associated NE
with NE
the NE
acquisition NE
of NE
antitumor Other_B
function Other_E
. NE

Effect NE
of NE
adenovirus Virus_B
2 Virus_E
on NE
cellular Other_B
gene Other_M
activation Other_E
in NE
blood-derived Cell_natural_B
monocytes Cell_natural_E
and NE
macrophages Cell_natural
. NE

We NE
have NE
investigated NE
the NE
effect NE
of NE
adenovirus NE
2 NE
( NE
Ad2 NE
) NE
infection NE
on NE
human NE
monocytes NE
and NE
monocyte-derived NE
macrophages NE
with NE
regard NE
to NE
expression NE
of NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
. NE

In NE
monocytes NE
, NE
the NE
virus NE
was NE
bound NE
to NE
the NE
surface NE
without NE
being NE
internalized NE
. NE

On NE
the NE
other NE
hand NE
, NE
Ad2 Virus
was NE
internalized NE
by NE
macrophages Cell_natural
. NE

No NE
virus NE
replication NE
and NE
no NE
transcription NE
of NE
the NE
Ad2 DNA_family_or_group_B
early DNA_family_or_group_M
genes DNA_family_or_group_E
was NE
observed NE
in NE
either NE
of NE
the NE
cells NE
. NE

Ad2 Other_B
infection Other_E
induced NE
transient NE
increase NE
in NE
the NE
mRNA NE
levels NE
for NE
TNF-alpha NE
and NE
IL-1 NE
beta NE
in NE
both NE
monocytes NE
and NE
in NE
macrophages NE
, NE
although NE
the NE
kinetics NE
of NE
the NE
transcription NE
was NE
slightly NE
different NE
. NE

The NE
production NE
of NE
both NE
cytokines Protein_family_or_group
, NE
measured NE
by NE
ELISA Other_B
tests Other_E
, NE
was NE
enhanced NE
in NE
monocytes Cell_natural
. NE

In NE
macrophages Cell_natural
, NE
a NE
slight NE
enhancement NE
of NE
TNF-alpha Other_B
production Other_E
was NE
seen NE
, NE
whereas NE
IL-1 NE
beta NE
was NE
not NE
detected NE
. NE

The NE
data NE
indicate NE
that NE
cellular DNA_family_or_group_B
genes DNA_family_or_group_E
might NE
be NE
activated NE
by NE
Ad2 Other_B
virus Other_M
infection Other_E
in NE
nonpermissive NE
cells NE
where NE
no NE
viral NE
gene NE
products NE
could NE
be NE
detected NE
. NE

Regulation NE
of NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
and NE
cytokine NE
gene Other_B
expression Other_E
in NE
myeloid Cell_natural_B
cells Cell_natural_E
by NE
NF-kappa NE
B NE
/Rel NE
transcription NE
factors NE
. NE

CD4+ Cell_cultured_B
macrophages Cell_cultured_E
in NE
tissues NE
such NE
as NE
lung Body_region
, NE
skin Body_region
, NE
and NE
lymph Body_region_B
nodes Body_region_E
, NE
promyelocytic Cell_natural_B
cells Cell_natural_E
in NE
bone Tissue_natural_B
marrow Tissue_natural_E
, NE
and NE
peripheral Cell_natural_B
blood Cell_natural_M
monocytes Cell_natural_E
serve NE
as NE
important NE
targets NE
and NE
reservoirs NE
for NE
human NE
immunodeficiency NE
virus NE
type NE
1 NE
( NE
HIV-1 NE
) NE
replication NE
. NE

HIV-1 Virus
-infected NE
myeloid Cell_natural_B
cells Cell_natural_E
are NE
often NE
diminished NE
in NE
their NE
ability NE
to NE
participate NE
in NE
chemotaxis Other
, NE
phagocytosis Other
, NE
and NE
intracellular Other_B
killing Other_E
. NE

HIV-1 Virus
infection NE
of NE
myeloid Cell_natural_B
cells Cell_natural_E
can NE
lead NE
to NE
the NE
expression NE
of NE
surface Protein_family_or_group_B
receptors Protein_family_or_group_E
associated NE
with NE
cellular Other_B
activation Other_E
and/or NE
differentiation Other
that NE
increase NE
the NE
responsiveness NE
of NE
these NE
cells NE
to NE
cytokines Protein_family_or_group
secreted NE
by NE
neighboring NE
cells NE
as NE
well NE
as NE
to NE
bacteria Unicellular_organism
or NE
other NE
pathogens NE
. NE

Enhancement NE
of NE
HIV-1 Other_B
replication Other_E
is NE
related NE
in NE
part NE
to NE
increased NE
DNA NE
-binding NE
activity NE
of NE
cellular NE
transcription NE
factors NE
such NE
as NE
NF-kappa NE
B NE
. NE

NF-kappa Protein_molecule_B
B Protein_molecule_E
binds NE
to NE
the NE
HIV-1 NE
enhancer NE
region NE
of NE
the NE
long NE
terminal NE
repeat NE
and NE
contributes NE
to NE
the NE
inducibility NE
of NE
HIV-1 NE
gene NE
expression NE
in NE
response NE
to NE
multiple NE
activating NE
agents NE
. NE

Phosphorylation Other
and NE
degradation Other
of NE
the NE
cytoplasmic Protein_family_or_group_B
inhibitor Protein_family_or_group_E
I NE
kappa NE
B NE
alpha NE
are NE
crucial NE
regulatory NE
events NE
in NE
the NE
activation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
DNA NE
-binding NE
activity NE
. NE

Both NE
N- NE
and NE
C- NE
terminal NE
residues NE
of NE
I NE
kappa NE
B NE
alpha NE
are NE
required NE
for NE
inducer-mediated NE
degradation NE
. NE

Chronic NE
HIV-1 Other_B
infection Other_E
of NE
myeloid NE
cells NE
leads NE
to NE
constitutive NE
NF-kappa NE
B NE
DNA NE
-binding NE
activity NE
and NE
provides NE
an NE
intranuclear NE
environment NE
capable NE
of NE
perpetuating NE
HIV-1 NE
replication NE
. NE

Increased NE
intracellular Other_B
stores Other_E
of NE
latent Protein_molecule_B
NF-kappa Protein_molecule_M
B Protein_molecule_E
may NE
also NE
result NE
in NE
rapid NE
inducibility NE
of NE
NF-kappa NE
B NE
-dependent NE
cytokine NE
gene NE
expression NE
. NE

In NE
response NE
to NE
secondary NE
pathogenic NE
infections NE
or NE
antigenic NE
challenge NE
, NE
cytokine Other_B
gene Other_M
expression Other_E
is NE
rapidly NE
induced NE
, NE
enhanced NE
, NE
and NE
sustained NE
over NE
prolonged NE
periods NE
in NE
HIV-1 NE
-infected NE
myeloid NE
cells NE
compared NE
with NE
uninfected NE
cells NE
. NE

Elevated NE
levels NE
of NE
several NE
inflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
have NE
been NE
detected NE
in NE
the NE
sera NE
of NE
HIV-1 NE
-infected NE
individuals NE
. NE

Secretion NE
of NE
myeloid Protein_family_or_group_B
cell-derived Protein_family_or_group_M
cytokines Protein_family_or_group_E
may NE
both NE
increase NE
virus NE
production NE
and NE
contribute NE
to NE
AIDS-associated NE
disorders NE
. NE

CD14 NE
-mediated NE
translocation NE
of NE
nuclear NE
factor-kappa NE
B NE
induced NE
by NE
lipopolysaccharide NE
does NE
not NE
require NE
tyrosine NE
kinase NE
activity NE
. NE

During NE
the NE
course NE
of NE
serious Other_B
bacterial Other_M
infections Other_E
, NE
lipopolysaccharide Lipid
( NE
LPS Lipid
) NE
is NE
believed NE
to NE
interact NE
with NE
macrophage Protein_family_or_group_B
receptors Protein_family_or_group_E
, NE
resulting NE
in NE
the NE
generation NE
of NE
inflammatory Protein_family_or_group_B
mediators Protein_family_or_group_E
and NE
systemic NE
symptoms NE
including NE
hemodynamic Other_B
instability Other_E
and NE
shock Other
. NE

CD14 Protein_molecule
, NE
a NE
glycosylphosphatidylinositol-linked Protein_family_or_group_B
antigen Protein_family_or_group_E
, NE
functions NE
as NE
an NE
LPS Protein_family_or_group_B
signaling Protein_family_or_group_M
receptor Protein_family_or_group_E
. NE

A NE
critical NE
issue NE
concerns NE
the NE
mechanism NE
by NE
which NE
CD14 Protein_molecule
, NE
which NE
has NE
no NE
transmembrane Protein_domain_or_region_B
domain Protein_domain_or_region_E
, NE
transduces NE
its NE
signal NE
following NE
LPS Lipid
binding NE
. NE

Recently NE
, NE
investigators NE
have NE
hypothesized NE
that NE
CD14 NE
-mediated NE
signaling NE
is NE
effected NE
through NE
a NE
receptor NE
-associated NE
tyrosine NE
kinase NE
( NE
TK NE
) NE
, NE
suggesting NE
a NE
multicomponent NE
receptor NE
model NE
of NE
LPS NE
signaling NE
. NE

Wild-type NE
Chinese Cell_cultured_B
hamster Cell_cultured_M
ovary Cell_cultured_M
(CHO)-K1 Cell_cultured_M
cells Cell_cultured_E
can NE
be NE
activated NE
by NE
endotoxin NE
to NE
release NE
arachidonate Organic_compound_other
following NE
transfection NE
with NE
human NE
CD14 Protein_molecule
( NE
CHO NE
/ NE
CD14 NE
) NE
. NE

Nuclear NE
translocation NE
of NE
cytosolic NE
NF-kappa NE
B NE
is NE
correlated NE
with NE
a NE
number NE
of NE
LPS NE
-inducible NE
responses NE
. NE

We NE
sought NE
to NE
determine NE
if NE
this NE
pathway NE
were NE
present NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
and NE
to NE
elucidate NE
the NE
relationship NE
of NE
NF-kappa NE
B NE
activation NE
to NE
the NE
CD14 NE
receptor NE
system NE
. NE

LPS NE
-stimulated NE
translocation NE
of NE
NF-kappa NE
B NE
in NE
CHO NE
/ NE
CD14 NE
cells NE
resembled NE
the NE
same NE
response NE
in NE
the NE
murine NE
macrophage-like NE
cell NE
line NE
RAW NE
264.7 NE
. NE

Protein NE
synthesis NE
inhibitors NE
and NE
corticosteroids Lipid
, NE
which NE
suppress NE
arachidonate Organic_compound_other
release NE
and NE
the NE
synthesis NE
of NE
proinflammatory Protein_family_or_group_B
cytokines Protein_family_or_group_E
, NE
had NE
no NE
effect NE
on NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO NE
/ NE
CD14 Protein_molecule
or NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
demonstrating NE
that NE
NF-kappa Other_B
B Other_M
translocation Other_E
is NE
an NE
early NE
event NE
. NE

Although NE
TK Other_B
activity Other_E
was NE
consistently NE
observed NE
by NE
immunoblotting Other_B
extracts Other_E
from NE
activated NE
RAW Cell_cultured_B
264.7 Cell_cultured_M
cells Cell_cultured_E
, NE
LPS NE
-induced NE
phosphotyrosine NE
residues NE
were NE
not NE
observed NE
from NE
similarly NE
treated NE
CHO/CD14 NE
cells NE
. NE

Furthermore NE
, NE
the NE
TK Other_B
inhibitors Other_E
herbimycin Organic_compound_other_B
A Organic_compound_other_E
and NE
genistein Organic_compound_other
failed NE
to NE
inhibit NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
in NE
CHO/CD14 NE
or NE
RAW NE
264.7 NE
cells NE
, NE
although NE
both NE
of NE
these NE
agents NE
inhibited NE
LPS NE
-induced NE
TK NE
activity NE
in NE
RAW NE
264.7 NE
cells NE
. NE

These NE
results NE
imply NE
that NE
TK Other_B
activity Other_E
is NE
not NE
obligatory NE
for NE
CD14 NE
-mediated NE
signal NE
transduction NE
to NE
occur NE
in NE
response NE
to NE
LPS NE
. NE

Induction NE
of NE
a NE
functional NE
vitamin Protein_family_or_group_B
D Protein_family_or_group_M
receptor Protein_family_or_group_E
in NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
-induced NE
monocytic Other_B
differentiation Other_E
of NE
M2-type Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
. NE

Different NE
types NE
of NE
acute Cell_natural_B
myeloid Cell_natural_M
leukemia Cell_natural_M
blast Cell_natural_M
cells Cell_natural_E
were NE
induced NE
to NE
differentiate NE
in NE
vitro NE
with NE
all-trans-retinoic Organic_compound_other_B
acid Organic_compound_other_E
( NE
ATRA Organic_compound_other
) NE
and NE
vitamin Lipid_B
D3 Lipid_E
( NE
VD Lipid
) NE
. NE

M0/M1 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
not NE
sensitive NE
to NE
differentiating Organic_compound_other_B
agents Organic_compound_other_E
, NE
whereas NE
M3 Cell_cultured_B
leukemic Cell_cultured_M
cells Cell_cultured_E
are NE
induced NE
to NE
undergo NE
granulocytic Other_B
differentiation Other_E
after NE
ATRA Organic_compound_other
treatment NE
but NE
are NE
not NE
sensitive NE
to NE
VD Lipid
. NE

M2 Cell_cultured_B
leukemic Cell_cultured_M
blast Cell_cultured_M
cells Cell_cultured_E
behave NE
differently NE
because NE
they NE
undergo NE
monocytic Other_B
differentiation Other_E
with NE
both NE
the NE
differentiation NE
inducers NE
. NE

To NE
gain NE
some NE
insight NE
into NE
the NE
maturation NE
of NE
M2-type Cell_natural_B
leukemic Cell_natural_M
cells Cell_natural_E
, NE
we NE
studied NE
the NE
molecular NE
mechanisms NE
underlying NE
monocytic Other_B
differentiation Other_E
induced NE
by NE
ATRA Organic_compound_other
and NE
VD Lipid
in NE
spontaneous NE
M2 Cell_cultured_B
blast Cell_cultured_M
cells Cell_cultured_E
as NE
well NE
as NE
in NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
(an NE
acute Cell_cultured_B
myeloid Cell_cultured_M
leukemia Cell_cultured_M
M2-type Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
) NE
. NE

Our NE
results NE
indicate NE
that NE
ATRA Organic_compound_other
as NE
well NE
as NE
VD Lipid
efficiently NE
increases NE
the NE
nuclear NE
abundance NE
of NE
VD Protein_family_or_group_B
receptor Protein_family_or_group_E
( NE
VDR NE
) NE
and NE
promotes NE
monocytic NE
differentiation NE
. NE

VDR Protein_family_or_group
is NE
functionally NE
active NE
in NE
ATRA Organic_compound_other
-treated NE
Kasumi-1 Cell_cultured_B
cells Cell_cultured_E
because NE
it NE
efficiently NE
heterodimerizes NE
with NE
retinoid Protein_molecule_B
X Protein_molecule_M
receptor Protein_molecule_E
, NE
binds NE
to NE
a NE
DR3-type DNA_domain_or_region_B
vitamin DNA_domain_or_region_M
D-responsive DNA_domain_or_region_M
element DNA_domain_or_region_E
, NE
and NE
activates NE
the NE
transcription NE
of NE
a NE
vitamin DNA_domain_or_region_B
D-responsive DNA_domain_or_region_M
element-regulated DNA_domain_or_region_M
reporter DNA_domain_or_region_M
gene DNA_domain_or_region_E
. NE

Consistent NE
with NE
these NE
findings NE
, NE
VD NE
-responsive NE
genes NE
are NE
induced NE
by NE
ATRA NE
treatment NE
of NE
Kasumi-1 NE
cells NE
, NE
suggesting NE
that NE
the NE
genetic NE
program NE
underlying NE
monocytic NE
differentiation NE
is NE
activated NE
. NE

The NE
molecular Other_B
mechanism Other_E
by NE
which NE
ATRA Organic_compound_other
increases NE
the NE
nuclear NE
abundance NE
of NE
a NE
functional NE
VDR Protein_family_or_group
is NE
still NE
unknown NE
, NE
but NE
our NE
data NE
clearly NE
indicate NE
that NE
the NE
M2 Cell_cultured_B
leukemic Cell_cultured_M
cell Cell_cultured_E
context NE
is NE
only NE
permissive NE
of NE
monocytic Other_B
differentiation Other_E
. NE

Abnormal NE
regulation NE
of NE
the NE
IL-2 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
in NE
lpr NE
CD4-CD8- NE
T NE
lymphocytes NE
results NE
in NE
constitutive NE
expression NE
of NE
a NE
novel NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
-binding NE
factor NE
. NE

The NE
inert NE
quality NE
of NE
MRL-Ipr/Ipr Cell_cultured_B
(Ipr) Cell_cultured_M
peripheral Cell_cultured_M
CD4-CD8- Cell_cultured_M
(CD4-8-) Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
manifests NE
primarily NE
as NE
an NE
inability NE
to NE
proliferate NE
or NE
produce NE
IL-2 NE
in NE
response NE
to NE
TCR NE
or NE
mitogenic NE
stimulation NE
. NE

Yet NE
these NE
same NE
cells NE
do NE
initiate NE
early NE
TCR NE
-mediated NE
signaling NE
events NE
, NE
such NE
as NE
generation NE
of NE
inositol NE
phosphates NE
and NE
increased NE
intracellular NE
calcium NE
. NE

They NE
also NE
display NE
constitutively NE
high NE
levels NE
of NE
p59fyn Protein_molecule
and NE
CD3 Protein_molecule_B
zeta Protein_molecule_E
tyrosine Other_B
phosphorylation Other_E
. NE

The NE
generation NE
of NE
second Protein_family_or_group_B
messengers Protein_family_or_group_E
in NE
T Cell_natural_B
cells Cell_natural_E
normally NE
leads NE
to NE
downstream Other_B
signaling Other_E
that NE
results NE
in NE
transcriptional Other_B
activation Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

We NE
, NE
therefore NE
, NE
compared NE
the NE
activation NE
state NE
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_M
promoter DNA_domain_or_region_M
region DNA_domain_or_region_E
in NE
freshly NE
isolated NE
and NE
stimulated NE
Ipr NE
CD4-8- NE
T NE
cells NE
with NE
that NE
of NE
normal NE
T NE
lymphocytes NE
. NE

Levels NE
of NE
the NE
octamer Polynucleotide
, NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50-p65 Protein_molecule_B
heterodimer Protein_molecule_E
) NE
, NE
and NE
AP-1 Protein_family_or_group_B
transcriptional Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
constitutively NE
elevated NE
in NE
freshly NE
isolated NE
Ipr NE
CD4-8- NE
T NE
cells NE
, NE
consistent NE
with NE
the NE
activated NE
phenotype NE
of NE
these NE
cells NE
. NE

Upon NE
stimulation NE
with NE
mitogens Organic_compound_other
, NE
formation NE
of NE
the NE
transactivating NE
complex NE
, NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_M
of Protein_family_or_group_M
activated Protein_family_or_group_M
T Protein_family_or_group_M
cells Protein_family_or_group_E
( NE
NF-AT NE
) NE
, NE
occurs NE
with NE
normal NE
kinetics NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Yet NE
, NE
the NE
levels NE
of NE
the NE
activating NE
NF-AT Protein_complex_B
complex Protein_complex_E
never NE
reach NE
those NE
observed NE
in NE
similarly NE
stimulated NE
normal NE
T Cell_natural_B
cells Cell_natural_E
. NE

Furthermore NE
, NE
nuclear Cell_component_B
extracts Cell_component_E
from NE
Ipr Cell_cultured_B
CD4-8- Cell_cultured_M
T Cell_cultured_M
cells Cell_cultured_E
display NE
high NE
levels NE
of NE
a NE
novel NE
specific NE
binding NE
activity NE
at NE
the NE
NF-AT NE
site NE
, NE
which NE
is NE
present NE
at NE
much NE
lower NE
levels NE
in NE
freshly NE
isolated NE
normal NE
T NE
lymphocytes NE
. NE

Upon NE
mitogenic Other_B
stimulation Other_E
, NE
the NE
binding NE
activity NE
of NE
the NE
novel NE
NF-AT NE
-binding NE
factor NE
is NE
rapidly NE
down-regulated NE
in NE
normal NE
T NE
cells NE
, NE
but NE
persists NE
at NE
high NE
levels NE
in NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

These NE
two NE
abnormalities NE
at NE
the NE
NF-AT DNA_domain_or_region_B
site DNA_domain_or_region_E
provide NE
a NE
potential NE
mechanism NE
to NE
account NE
for NE
the NE
defect NE
in NE
IL-2 NE
production NE
from NE
Ipr NE
CD4-8- NE
T NE
cells NE
. NE

Evidence NE
for NE
suppressed NE
activity NE
of NE
the NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
NFAT1 Protein_molecule
at NE
its NE
proximal DNA_domain_or_region_B
binding DNA_domain_or_region_M
element DNA_domain_or_region_E
P0 DNA_domain_or_region
in NE
the NE
IL-4 DNA_domain_or_region_B
promoter DNA_domain_or_region_E
associated NE
with NE
enhanced NE
IL-4 Other_B
gene Other_M
transcription Other_E
in NE
T NE
cells NE
of NE
atopic NE
patients NE
. NE

Allergen-specific NE
T Cell_natural_B
cells Cell_natural_E
in NE
atopic Multicellular_organism_natural_B
patients Multicellular_organism_natural_E
are NE
polarized NE
IL-4 NE
-producing NE
Th2 NE
cells NE
, NE
promoting NE
IgE Other_B
synthesis Other_E
by NE
B NE
cells NE
. NE

The NE
molecular NE
basis NE
for NE
increased NE
IL-4 Other_B
gene Other_M
expression Other_E
in NE
atopy NE
is NE
not NE
fully NE
understood NE
. NE

IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
regulation NE
in NE
general NE
involves NE
the NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
( NE
NFAT NE
) NE
family NE
of NE
transcription NE
factors NE
, NE
of NE
which NE
NFAT1 NE
and NE
NFAT2 NE
are NE
most NE
prominent NE
in NE
peripheral NE
T NE
cells NE
. NE

Recently NE
, NE
a NE
unique NE
inhibitory NE
role NE
of NE
NFAT1 Protein_molecule
in NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
control NE
was NE
shown NE
in NE
the NE
mouse Multicellular_organism_natural
. NE

In NE
a NE
series NE
of NE
electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
with NE
protein Cell_component_B
extracts Cell_component_E
of NE
highly NE
polarized NE
Th2 NE
clones NE
from NE
atopics Multicellular_organism_natural
and NE
Th1 Cell_cultured_B
clones Cell_cultured_E
from NE
controls NE
we NE
compared NE
DNA-binding NE
activities NE
at NE
the NE
two NE
NFAT NE
-binding NE
elements NE
P0 NE
and NE
P1 NE
of NE
the NE
crucial NE
proximal NE
human NE
IL-4 NE
promoter NE
. NE

At NE
the NE
most NE
proximal NE
P0 DNA_domain_or_region
site NE
, NE
NFAT NE
-containing NE
complexes NE
devoid NE
of NE
NFAT2 Protein_molecule
were NE
readily NE
inducible NE
in NE
the NE
Th1 Cell_cultured_B
clones Cell_cultured_E
, NE
but NE
hardly NE
or NE
not NE
in NE
the NE
Th2 Cell_cultured_B
clones Cell_cultured_E
. NE

In NE
contrast NE
, NE
both NE
in NE
Th1 NE
and NE
Th2 NE
clones NE
NFAT NE
-containing NE
complexes NE
were NE
strongly NE
inducible NE
at NE
the NE
P1 NE
site NE
, NE
consisting NE
of NE
NFAT2 NE
and NE
a NE
P0 NE
-compatible NE
NFAT NE
activity NE
, NE
without NE
apparent NE
differences NE
between NE
Th1 NE
and NE
Th2 NE
clones NE
. NE

Like NE
in NE
Th2 Cell_cultured_B
clones Cell_cultured_E
, NE
suppressed NE
NFAT NE
- NE
P0 NE
complex NE
formation NE
was NE
observed NE
also NE
at NE
the NE
polyclonal NE
level NE
in NE
peripheral NE
blood NE
mononuclear NE
cells NE
( NE
PBMC NE
) NE
of NE
three NE
of NE
five NE
severe NE
atopic NE
dermatitis NE
patients NE
with NE
strongly NE
elevated NE
serum NE
IgE NE
levels NE
, NE
but NE
not NE
in NE
control NE
PBMC NE
. NE

These NE
findings NE
suggest NE
that NE
high-level Other_B
IL-4 Other_M
production Other_E
in NE
atopic NE
Th2 NE
cells NE
is NE
associated NE
with NE
selective NE
reduction NE
of NE
suppressive NE
NFAT1 NE
activity NE
at NE
the NE
IL-4 NE
P0 NE
element NE
and NE
that NE
some NE
patients NE
with NE
this NE
multifactorial NE
disease NE
may NE
have NE
a NE
putative NE
systemic NE
disorder NE
at NE
this NE
level NE
. NE

Transcription Protein_family_or_group_B
factors Protein_family_or_group_E
in NE
immune-mediated Other_B
disease Other_E
. NE

A NE
large NE
amount NE
of NE
detailed NE
information NE
about NE
the NE
intracellular Protein_family_or_group_B
proteins Protein_family_or_group_E
regulating NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
and NE
the NE
cellular NE
response NE
to NE
NF-kappa Protein_complex_B
B Protein_complex_E
activation NE
has NE
emerged NE
recently NE
. NE

Several NE
small NE
molecules NE
, NE
an NE
antisense Polynucleotide_B
oligonucleotide Polynucleotide_E
, NE
and NE
gene NE
therapeutic NE
agents NE
that NE
inhibit NE
NF-kappa Other_B
b Other_M
activation Other_E
have NE
been NE
described NE
. NE

Despite NE
this NE
, NE
there NE
are NE
still NE
significant NE
gaps NE
in NE
our NE
understanding NE
of NE
this NE
process NE
and NE
its NE
consequences NE
. NE

In NE
contrast NE
, NE
the NE
characterization NE
of NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
selectively NE
regulating NE
cytokine NE
production NE
by NE
CD4+ Cell_natural_B
T Cell_natural_M
cell Cell_natural_M
subsets Cell_natural_E
is NE
at NE
a NE
very NE
early NE
stage NE
. NE

Three NE
interacting Protein_family_or_group_B
proteins Protein_family_or_group_E
have NE
recently NE
been NE
shown NE
to NE
contribute NE
to NE
subset-restricted NE
expression NE
of NE
the NE
IL-4 DNA_domain_or_region_B
gene DNA_domain_or_region_E
. NE

There NE
are NE
other NE
elements NE
regulating NE
IL-4 Other_B
gene Other_M
expression Other_E
, NE
however NE
, NE
and NE
the NE
relative NE
importance NE
of NE
these NE
recently NE
identified NE
proteins NE
has NE
yet NE
to NE
be NE
determined NE
. NE

Defective Other_B
transcription Other_E
of NE
the NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
is NE
associated NE
with NE
impaired NE
expression NE
of NE
c-Fos Protein_molecule
, NE
FosB Protein_molecule
, NE
and NE
JunB Protein_molecule
in NE
anergic Cell_cultured_B
T Cell_cultured_M
helper Cell_cultured_M
1 Cell_cultured_M
cells Cell_cultured_E
. NE

Anergic Cell_cultured_B
CD4+ Cell_cultured_M
Th Cell_cultured_M
cells Cell_cultured_E
do NE
not NE
produce NE
IL-2 Protein_molecule
when NE
challenged NE
with NE
Ag-pulsed Cell_cultured_B
accessory Cell_cultured_M
cells Cell_cultured_E
because NE
of NE
a NE
transcriptional Other_B
defect Other_E
. NE

In NE
this NE
work NE
, NE
we NE
report NE
that NE
these NE
anergic Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
are NE
defective NE
in NE
their NE
ability NE
to NE
up-regulate NE
protein Other_B
binding Other_E
and NE
transactivation NE
at NE
two NE
critical NE
IL-2 DNA_domain_or_region_B
DNA DNA_domain_or_region_M
enhancer DNA_domain_or_region_M
elements DNA_domain_or_region_E
: NE
NF-AT NE
( NE
nuclear NE
factor NE
of NE
activated NE
T NE
cells NE
; NE
a NE
sequence NE
that NE
binds NE
a NE
heterotrimeric NE
NFATp NE
, NE
Fos NE
, NE
and NE
Jun NE
protein NE
complex NE
) NE
and NE
Activator NE
Protein-1 NE
( NE
AP-1 NE
) NE
(that NE
binds NE
Fos NE
and NE
Jun NE
heterodimers NE
) NE
. NE

Western Other_B
blot Other_M
analysis Other_E
of NE
nuclear Cell_component_B
extracts Cell_component_E
showed NE
that NE
the NE
impaired NE
DNA NE
- NE
protein NE
interactions NE
in NE
anergic NE
T NE
cells NE
were NE
associated NE
with NE
poor NE
expression NE
of NE
the NE
inducible NE
AP-1 NE
family NE
members NE
c-Fos NE
, NE
FosB NE
, NE
and NE
JunB NE
. NE

However NE
, NE
the NE
reduced NE
expression NE
of NE
these NE
proteins NE
was NE
not NE
the NE
result NE
of NE
a NE
global NE
TCR/CD3 NE
-signaling NE
defect NE
because NE
CD3 NE
cross-linking NE
induced NE
an NE
equivalent NE
increase NE
in NE
intracellular-free NE
calcium NE
ions NE
, NE
as NE
well NE
as NE
NFATp NE
dephosphorylation NE
, NE
translocation NE
to NE
the NE
nucleus NE
, NE
and NE
DNA NE
binding NE
in NE
both NE
normal NE
and NE
anergic NE
T NE
cells NE
. NE

Thus NE
, NE
defective NE
IL-2 DNA_domain_or_region_B
gene DNA_domain_or_region_E
transcription NE
appears NE
to NE
be NE
due NE
, NE
at NE
least NE
in NE
part NE
, NE
to NE
a NE
selective NE
block NE
in NE
the NE
expression NE
of NE
the NE
AP-1 NE
Fos NE
and NE
Jun NE
family NE
members NE
in NE
anergic NE
T NE
cells NE
. NE

A NE
novel NE
mitogen NE
-inducible NE
gene NE
product NE
related NE
to NE
p50/p105-NF-kappa NE
B NE
participates NE
in NE
transactivation NE
through NE
a NE
kappa NE
B NE
site NE
. NE

A NE
Rel-related NE
, NE
mitogen NE
-inducible NE
, NE
kappa NE
B NE
-binding NE
protein NE
has NE
been NE
cloned NE
as NE
an NE
immediate-early NE
activation NE
gene NE
of NE
human NE
peripheral NE
blood NE
T NE
cells NE
. NE

The NE
cDNA DNA_family_or_group
has NE
an NE
open DNA_domain_or_region_B
reading DNA_domain_or_region_M
frame DNA_domain_or_region_E
of NE
900 DNA_domain_or_region_B
amino DNA_domain_or_region_M
acids DNA_domain_or_region_E
capable NE
of NE
encoding NE
a NE
97-kDa Protein_molecule_B
protein Protein_molecule_E
. NE

This NE
protein NE
is NE
most NE
similar NE
to NE
the NE
105-kDa Peptide_B
precursor Peptide_M
polypeptide Peptide_E
of NE
p50-NF-kappa Protein_molecule_B
B Protein_molecule_E
. NE

Like NE
the NE
105-kDa NE
precursor NE
, NE
it NE
contains NE
an NE
amino-terminal Protein_domain_or_region_B
Rel-related Protein_domain_or_region_M
domain Protein_domain_or_region_E
of NE
about NE
300 NE
amino NE
acids NE
and NE
a NE
carboxy-terminal Protein_domain_or_region_B
domain Protein_domain_or_region_E
containing NE
six NE
full Protein_substructure_B
cell Protein_substructure_M
cycle Protein_substructure_E
or NE
ankyrin Protein_substructure_B
repeats Protein_substructure_E
. NE

In NE
vitro-translated NE
proteins NE
, NE
truncated NE
downstream NE
of NE
the NE
Rel NE
domain NE
and NE
excluding NE
the NE
repeats NE
, NE
bind NE
kappa NE
B NE
sites NE
. NE

We NE
refer NE
to NE
the NE
kappa NE
B NE
-binding NE
, NE
truncated NE
protein NE
as NE
p50B NE
by NE
analogy NE
with NE
p50-NF-kappa NE
B NE
and NE
to NE
the NE
full-length NE
protein NE
as NE
p97 NE
. NE

p50B Protein_molecule
is NE
able NE
to NE
form NE
heteromeric NE
kappa NE
B NE
-binding NE
complexes NE
with NE
RelB NE
, NE
as NE
well NE
as NE
with NE
p65 NE
and NE
p50 NE
, NE
the NE
two NE
subunits NE
of NE
NF-kappa NE
B NE
. NE

Transient-transfection NE
experiments NE
in NE
embryonal Cell_cultured_B
carcinoma Cell_cultured_M
cells Cell_cultured_E
demonstrate NE
a NE
functional NE
cooperation NE
between NE
p50B Protein_molecule
and NE
RelB Protein_molecule
or NE
p65 Protein_molecule
in NE
transactivation NE
of NE
a NE
reporter DNA_molecule_B
plasmid DNA_molecule_E
dependent NE
on NE
a NE
kappa DNA_domain_or_region_B
B DNA_domain_or_region_M
site DNA_domain_or_region_E
. NE

The NE
data NE
imply NE
the NE
existence NE
of NE
a NE
complex NE
family NE
of NE
NF-kappa NE
B NE
-like NE
transcription NE
factors NE
. NE

A NE
novel DNA_domain_or_region_B
SP-1 DNA_domain_or_region_M
site DNA_domain_or_region_E
in NE
the NE
human NE
interleukin-1 NE
beta NE
promoter NE
confers NE
preferential NE
transcriptional NE
activity NE
in NE
keratinocytes NE
. NE

To NE
investigate NE
the NE
mechanisms NE
of NE
transcriptional Other_B
activation Other_E
of NE
interleukin-1beta Protein_molecule
( NE
IL-1beta Protein_molecule
) NE
in NE
non-monocytic NE
cells NE
, NE
we NE
constructed NE
a NE
series NE
of NE
reporter NE
plasmids NE
with NE
the NE
bacterial NE
chloramphenicol NE
acetyltransferase NE
gene NE
linked NE
to NE
various NE
parts NE
of NE
the NE
human DNA_domain_or_region_B
IL-1beta DNA_domain_or_region_M
promoter DNA_domain_or_region_E
and NE
performed NE
transient NE
transfection NE
experiments NE
. NE

We NE
identified NE
a NE
promoter NE
segment NE
that NE
activates NE
transcription NE
most NE
efficiently NE
in NE
keratinocytes Cell_natural
. NE

Electrophoretic Other_B
mobility Other_M
shift Other_M
assays Other_E
( NE
EMSA Other
) NE
with NE
a NE
43-mer DNA_domain_or_region_B
oligonucleotide DNA_domain_or_region_E
derived NE
from NE
the NE
functionally NE
identified NE
cis-acting DNA_domain_or_region_B
element DNA_domain_or_region_E
revealed NE
specific NE
complexes NE
. NE

By NE
competition NE
analysis NE
with NE
transcription DNA_family_or_group_B
factor DNA_family_or_group_M
consensus DNA_family_or_group_M
sequence DNA_family_or_group_M
oligonucleotides DNA_family_or_group_E
and NE
by NE
immunosupershift Other
, NE
transcription Protein_molecule_B
factor Protein_molecule_M
SP-1 Protein_molecule_E
or NE
a NE
closely NE
related NE
protein NE
was NE
shown NE
to NE
bind NE
to NE
this NE
regulatory DNA_domain_or_region_B
element DNA_domain_or_region_E
. NE

The NE
closest NE
match NE
to NE
the NE
known NE
SP-1 DNA_domain_or_region_B
consensus DNA_domain_or_region_M
sequence DNA_domain_or_region_E
within NE
the NE
respective NE
region NE
is NE
a NE
TCCCCTCCCCT NE
motif NE
. NE

Mutation NE
of NE
this NE
motif NE
almost NE
completely NE
, NE
and NE
specifically NE
, NE
abolished NE
the NE
binding NE
of NE
two NE
low-mobility NE
complexes NE
and NE
led NE
to NE
a NE
95% NE
decrease NE
of NE
constitutive NE
transcriptional NE
activation NE
of NE
a NE
reporter NE
construct NE
IL-1beta NE
(-170/+108) NE
. NE

Likewise NE
, NE
activation NE
of NE
this NE
reporter NE
construct NE
by NE
tumor Protein_molecule_B
necrosis Protein_molecule_M
factor-alpha Protein_molecule_E
depended NE
on NE
the NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
. NE

These NE
observations NE
suggest NE
that NE
a NE
so-far-unrecognized NE
SP-1 DNA_domain_or_region_B
site DNA_domain_or_region_E
in NE
the NE
human NE
IL-1beta NE
promoter NE
may NE
participate NE
in NE
the NE
transcriptional NE
regulation NE
of NE
this NE
gene NE
in NE
keratinocytes NE
. NE

Regulation NE
of NE
the NE
beta-globin DNA_domain_or_region_B
locus DNA_domain_or_region_E
. NE

Transcription NE
of NE
the NE
human DNA_domain_or_region_B
beta-globin DNA_domain_or_region_M
gene DNA_domain_or_region_M
cluster DNA_domain_or_region_E
depends NE
upon NE
upstream DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
sequences DNA_domain_or_region_E
, NE
which NE
are NE
collectively NE
termed NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
. NE

Recent NE
studies NE
have NE
provided NE
new NE
insights NE
into NE
how NE
the NE
individual NE
genes NE
of NE
the NE
cluster NE
are NE
regulated NE
through NE
development NE
. NE

The NE
crux NE
of NE
transcriptional Other_B
activation Other_E
is NE
how NE
the NE
locus DNA_domain_or_region_B
control DNA_domain_or_region_M
region DNA_domain_or_region_E
communicates NE
with NE
the NE
gene-proximal DNA_domain_or_region_B
regulatory DNA_domain_or_region_M
elements DNA_domain_or_region_E
. NE

Inhibition NE
of NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
by NE
dehydroepiandrosterone NE
( NE
DHEA NE
) NE
and NE
an NE
analog NE
of NE
DHEA NE
. NE

The NE
initial NE
infection NE
with NE
human Virus_B
immunodeficiency Virus_M
virus Virus_M
type Virus_M
1 Virus_E
( NE
HIV-1 Virus
) NE
in NE
most NE
individuals NE
usually NE
results NE
in NE
the NE
establishment NE
of NE
a NE
latent NE
or NE
chronic Other_B
infection Other_E
before NE
eventual NE
progression NE
toward NE
acquired Other_B
immunodeficiency Other_M
syndrome Other_E
. NE

HIV-1 Virus
can NE
also NE
establish NE
a NE
latent NE
or NE
persistent NE
infection NE
in NE
some NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
that NE
show NE
minimal NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

However NE
, NE
activation NE
of NE
the NE
T Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
leading NE
to NE
enhanced NE
HIV-1 Virus
replication NE
can NE
be NE
induced NE
by NE
antigens Protein_family_or_group
, NE
mitogens Other
, NE
and NE
cytokines Protein_family_or_group
( NE
tumor Protein_family_or_group_B
necrosis Protein_family_or_group_M
factor Protein_family_or_group_M
alpha Protein_family_or_group_E
[ NE
TNF-alpha Protein_molecule
] NE
, NE
interleukin Protein_molecule_B
1 Protein_molecule_E
, NE
and NE
interleukin-2 Protein_molecule
) NE
. NE

Various NE
gene NE
products NE
from NE
other NE
viruses NE
( NE
HTLV-1 Virus
, NE
HSV Virus
, NE
EBV Virus
, NE
CMV Virus
, NE
HBV Virus
, NE
and NE
HHV-6 Virus
) NE
can NE
also NE
enhance NE
HIV-1 NE
long NE
terminal NE
repeat NE
( NE
LTR NE
)-driven NE
reporter NE
gene NE
activity NE
. NE

On NE
the NE
basis NE
of NE
these NE
observations NE
, NE
it NE
has NE
been NE
proposed NE
that NE
reactivation NE
of NE
latent NE
HIV-1 Virus
harbored NE
in NE
chronically Cell_natural_B
infected Cell_natural_M
T Cell_natural_M
lymphocytes Cell_natural_E
, NE
monocytes Cell_natural
, NE
or NE
macrophages Cell_natural
plays NE
an NE
important NE
role NE
in NE
the NE
pathogenesis NE
of NE
AIDS Other
. NE

So NE
far NE
, NE
there NE
are NE
no NE
drugs NE
or NE
therapy NE
available NE
that NE
can NE
provide NE
protection NE
against NE
HIV-1 Other_B
latency Other_M
reactivation Other_E
. NE

ACH-2 Cell_cultured
, NE
derived NE
from NE
a NE
human Cell_cultured_B
T Cell_cultured_M
cell Cell_cultured_M
line Cell_cultured_E
( NE
CEM Cell_cultured
) NE
, NE
is NE
chronically NE
infected NE
with NE
HIV-1 Virus
, NE
with NE
low NE
levels NE
of NE
constitutive Other_B
virus Other_M
expression Other_E
. NE

ACH-2 Cell_cultured
can NE
be NE
converted NE
to NE
productive NE
infection NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
12-O-tetradecanoylphorbol-13-acetate Organic_compound_other
( NE
TPA Organic_compound_other
) NE
, NE
mitogen Organic_compound_other
or NE
cytokines Protein_family_or_group
( NE
TNF-alpha Protein_molecule
) NE
, NE
or NE
infection NE
with NE
HSV Virus
. NE

Therefore NE
the NE
ACH-2 Cell_cultured
cell NE
line NE
is NE
a NE
good NE
candidate NE
for NE
studying NE
the NE
effects NE
of NE
drugs NE
on NE
HIV-1 Virus
activation NE
. NE

Previously NE
, NE
we NE
have NE
reported NE
that NE
DHEA Lipid
and NE
synthetic NE
analogs NE
of NE
DHEA NE
can NE
be NE
modest NE
inhibitors NE
of NE
HIV-1 Other_B
IIIB Other_M
replication Other_E
in NE
phytohemagglutinin NE
-stimulated NE
peripheral NE
blood NE
lymphocyte NE
cultures NE
. NE

(ABSTRACT NE
TRUNCATED NE
AT NE
250 NE
WORDS) NE

C/EBP Protein_family_or_group_B
activators Protein_family_or_group_E
are NE
required NE
for NE
HIV-1 Other_B
replication Other_E
and NE
proviral NE
induction NE
in NE
monocytic NE
cell NE
lines NE
. NE

Previous NE
work NE
has NE
shown NE
that NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
and NE
C/EBP Protein_family_or_group_B
transcriptional Protein_family_or_group_M
activators Protein_family_or_group_E
are NE
necessary NE
for NE
HIV-1 Other_B
LTR Other_M
activity Other_E
in NE
monocytes/macrophages NE
. NE

We NE
have NE
investigated NE
the NE
role NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
play NE
in NE
induction NE
and NE
replication NE
of NE
HIV-1 Virus
. NE

Ectopic NE
expression NE
of NE
the NE
dominant NE
negative NE
C/EBP NE
protein NE
LIP NE
inhibited NE
HIV-1 NE
mRNA NE
and NE
virus NE
production NE
in NE
activated NE
U1 NE
cells NE
, NE
demonstrating NE
that NE
C/EBP NE
proteins NE
are NE
required NE
for NE
provirus NE
induction NE
. NE

U1 Cell_cultured_B
lines Cell_cultured_E
overexpressing NE
C/EBP Protein_family_or_group_B
activator Protein_family_or_group_E
NF-IL-6 Protein_molecule
produced NE
more NE
viral RNA_family_or_group_B
mRNA RNA_family_or_group_E
and NE
virus Virus_B
particles Virus_E
following NE
cellular Other_B
activation Other_E
than NE
control Cell_cultured_B
lines Cell_cultured_E
, NE
demonstrating NE
that NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
are NE
limiting NE
for NE
virus Other_B
transcription Other_E
. NE

HIV-1 Virus
harboring NE
mutations NE
within NE
two NE
C/EBP DNA_domain_or_region_B
sites DNA_domain_or_region_E
were NE
crippled NE
in NE
their NE
ability NE
to NE
replicate NE
in NE
U937 Cell_cultured_B
promonocytic Cell_cultured_M
cells Cell_cultured_E
, NE
indicating NE
that NE
these NE
sites NE
are NE
required NE
for NE
replication NE
. NE

These NE
data NE
identify NE
C/EBP Protein_family_or_group_B
proteins Protein_family_or_group_E
as NE
regulators NE
of NE
HIV-1 Other_B
expression Other_E
in NE
monocytes/macrophages NE
. NE

IL-10 Protein_molecule
inhibits NE
nuclear Other_B
factor-kappa Other_M
B/Rel Other_M
nuclear Other_M
activity Other_E
in NE
CD3 NE
-stimulated NE
human NE
peripheral NE
T NE
lymphocytes NE
. NE

IL-10 Protein_molecule
markedly NE
reduces NE
nuclear NE
factor NE
(NF)-kappa Other_B
B/Rel Other_M
nuclear Other_M
activity Other_E
induced NE
in NE
PBMC NE
by NE
stimulation NE
with NE
the NE
anti-CD3 NE
mAb NE
OKT3 NE
. NE

The NE
inhibition NE
is NE
exerted NE
specifically NE
on NE
the NE
NF-kappa Other_B
B/Rel Other_M
activation Other_E
induced NE
by NE
mAb NE
OKT3 NE
, NE
and NE
not NE
that NE
produced NE
by NE
PMA NE
. NE

As NE
judged NE
by NE
supershifting NE
the NE
DNA-protein NE
complexes NE
with NE
Abs NE
recognizing NE
specific NE
components NE
of NE
the NE
NF-kappa NE
B/Rel NE
protein NE
family NE
, NE
the NE
p50/p65 NE
( NE
Rel NE
A NE
) NE
heterodimeric NE
form NE
of NE
NF-kappa NE
B NE
is NE
primarily NE
affected NE
. NE

The NE
maximal NE
effect NE
is NE
observed NE
at NE
the NE
IL-10 Other_B
concentration Other_E
of NE
20 NE
U/ml NE
. NE

IL-10 Protein_molecule
inhibitory NE
activity NE
is NE
exerted NE
on NE
T Cell_natural_B
lymphocytes Cell_natural_E
and NE
is NE
mediated NE
by NE
monocytes Cell_natural
. NE

Indeed NE
, NE
monocytes Cell_natural
pretreated NE
with NE
IL-10 Protein_molecule
are NE
able NE
so NE
inhibit NE
NF-kappa Protein_complex_B
B Protein_complex_E
nuclear NE
activity NE
in NE
purified NE
T Cell_natural_B
lymphocytes Cell_natural_E
stimulated NE
with NE
OKT3 Protein_molecule
. NE

Soluble NE
factors NE
do NE
not NE
appear NE
to NE
be NE
involved NE
in NE
the NE
mechanism NE
of NE
inhibition NE
. NE

On NE
the NE
other NE
hand NE
, NE
the NE
up-regulation NE
of NE
CD80 Protein_molecule_B
Ag Protein_molecule_E
, NE
found NE
on NE
monocytes Cell_natural
obtained NE
from NE
PBMC Cell_natural
incubated NE
with NE
OKT3 Protein_molecule
, NE
is NE
not NE
detected NE
after NE
addition NE
of NE
IL-10 Protein_molecule
, NE
and NE
the NE
anti-CD28 Protein_family_or_group_B
mAb Protein_family_or_group_E
CLB-CD28/1 Protein_molecule
restores NE
the NE
NF-kappa Element_B
B/Rel Element_M
nuclear Element_M
activity Element_E
in NE
IL-10 NE
-inhibited NE
lymphocytes NE
. NE

Therefore NE
, NE
the NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
inhibition NE
might NE
be NE
ascribed NE
to NE
a NE
lack NE
of NE
cooperation NE
between NE
accessory NE
cells NE
and NE
T Cell_natural_B
lymphocytes Cell_natural_E
, NE
resulting NE
from NE
down-regulation NE
of NE
a NE
costimulatory NE
molecule NE
, NE
such NE
as NE
CD80 Protein_molecule
, NE
produced NE
by NE
IL-10 Protein_molecule
on NE
activated NE
monocytes Cell_natural
. NE

Our NE
results NE
demonstrate NE
that NE
IL-10 Protein_molecule
can NE
inhibit NE
the NE
induction NE
of NE
NF-kappa Protein_complex_B
B/Rel Protein_complex_E
nuclear NE
activity NE
in NE
CD3 NE
-stimulated NE
T NE
lymphocytes NE
. NE

Since NE
inappropriate NE
activation NE
of NE
kappa DNA_family_or_group_B
B-driven DNA_family_or_group_M
genes DNA_family_or_group_E
has NE
a NE
physiopathologic NE
role NE
in NE
a NE
number NE
of NE
diseases NE
, NE
such NE
as NE
HIV Other_B
infection Other_E
, NE
our NE
findings NE
support NE
the NE
possibility NE
of NE
using NE
this NE
cytokine NE
to NE
suppress NE
an NE
undesirable NE
activation NE
of NE
these NE
transcription Protein_family_or_group_B
factors Protein_family_or_group_E
. NE

Multiple NE
prolactin NE
-responsive NE
elements NE
mediate NE
G1 NE
and NE
S NE
phase NE
expression NE
of NE
the NE
interferon NE
regulatory NE
factor-1 NE
gene NE
. NE

The NE
interferon NE
regulatory NE
factor-1 NE
( NE
IRF-1 NE
) NE
gene NE
is NE
both NE
an NE
immediate-early NE
G1 NE
phase NE
gene NE
and NE
an NE
S NE
phase NE
gene NE
inducible NE
by NE
PRL NE
in NE
rat NE
Nb2 NE
T NE
lymphocytes NE
. NE

To NE
understand NE
the NE
mechanism NE
by NE
which NE
PRL Protein_molecule
regulates NE
the NE
biphasic NE
expression NE
of NE
IRF-1 Protein_molecule
, NE
we NE
cloned NE
the NE
rat DNA_domain_or_region_B
IRF-1 DNA_domain_or_region_M
gene DNA_domain_or_region_E
and NE
functionally NE
characterized NE
the NE
IRF-1 NE
promoter NE
. NE

Upon NE
transfection NE
into NE
Nb2 Cell_cultured_B
T Cell_cultured_M
cells Cell_cultured_E
, NE
1.7 NE
kilobases NE
(kb) NE
of NE
IRF-1 NE
5'-flanking NE
DNA NE
linked NE
to NE
a NE
chloramphenicol NE
acetyl NE
transferase NE
( NE
CAT NE
) NE
reporter NE
gene NE
mediated NE
a NE
30-fold NE
induction NE
of NE
CAT Other_B
enzyme Other_M
activity Other_E
in NE
response NE
to NE
24 NE
h NE
of NE
PRL NE
stimulation NE
. NE

Deletion NE
mutants NE
containing NE
1.3 NE
, NE
0.6 NE
, NE
and NE
0.2 NE
kb NE
5'-flanking NE
DNA NE
were NE
incrementally NE
less NE
transcriptionally NE
active NE
, NE
although NE
0.2 NE
kb NE
still NE
mediated NE
a NE
12-fold NE
induction NE
by NE
PRL NE
. NE

The NE
sequence NE
between NE
-1.7 NE
and NE
-0.2 NE
kb NE
linked NE
to NE
a NE
heterologous NE
thymidine NE
kinase NE
promoter NE
failed NE
to NE
respond NE
to NE
PRL Protein_molecule
stimulation NE
, NE
suggesting NE
that NE
the NE
activity NE
of NE
upstream DNA_family_or_group_B
PRL DNA_family_or_group_M
response DNA_family_or_group_M
elements DNA_family_or_group_E
may NE
require NE
an NE
interaction NE
with NE
promoter-proximal NE
elements NE
. NE

By NE
assaying NE
CAT Other_B
enzyme Other_M
activity Other_E
across NE
a NE
24-h NE
PRL NE
induction NE
time NE
course NE
, NE
we NE
were NE
able NE
to NE
assign NE
G1 NE
vs NE
. NE
S NE
phase NE
PRL NE
responses NE
of NE
the NE
IRF-1 NE
gene NE
to NE
different NE
regions NE
of NE
the NE
IRF-1 NE
5'-flanking NE
and NE
promoter NE
DNA NE
. NE

The NE
0.2-kb NE
IRF- NE
CAT NE
construct NE
was NE
induced NE
by NE
PRL NE
stimulation NE
during NE
the NE
G1 NE
phase NE
of NE
the NE
cell NE
cycle NE
. NE

In NE
contrast NE
, NE
the NE
1.7-kb NE
IRF- NE
CAT NE
construct NE
was NE
inducible NE
by NE
PRL Protein_molecule
during NE
both NE
G1 NE
and NE
S NE
phase NE
of NE
the NE
cell NE
cycle NE
. NE

Hence NE
, NE
the NE
PRL Protein_molecule
-induced NE
biphasic NE
expression NE
of NE
the NE
IRF-1 DNA_domain_or_region_B
gene DNA_domain_or_region_E
appears NE
to NE
be NE
controlled NE
by NE
separate NE
PRL NE
-responsive NE
elements NE
: NE
elements NE
in NE
the NE
first NE
0.2 NE
kb NE
of NE
the NE
IRF-1 NE
promoter NE
region NE
act NE
during NE
early NE
activation NE
, NE
and NE
elements NE
between NE
0.2 NE
and NE
1.7 NE
kb NE
act NE
in NE
concert NE
with NE
the NE
proximal NE
0.2-kb NE
region NE
during NE
S NE
phase NE
progression NE
. NE

Triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
CR1 Protein_molecule
( NE
CD35 Protein_molecule
) NE
and NE
CR3 Protein_molecule
( NE
CD11b/CD18 Protein_molecule
) NE
induces NE
nuclear Other_B
translocation Other_E
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50/p65 Protein_molecule
) NE
in NE
human Cell_natural_B
monocytes Cell_natural_E
and NE
enhances NE
viral Other_B
replication Other_E
in NE
HIV NE
-infected NE
monocytic NE
cells NE
. NE

Monocyte NE
/ NE
macrophages NE
may NE
harbor NE
HIV NE
in NE
a NE
nonproductive NE
fashion NE
for NE
prolonged NE
periods NE
of NE
time NE
. NE

Viral Other_B
gene Other_M
expression Other_E
may NE
be NE
reactivated NE
by NE
stimulation NE
of NE
the NE
cells NE
with NE
LPS Lipid
or NE
cytokines Protein_family_or_group
such NE
as NE
TNF-alpha Protein_molecule
in NE
vitro NE
. NE

The NE
effect NE
of NE
LPS Lipid
and NE
TNF-alpha Protein_molecule
is NE
mediated NE
by NE
their NE
ability NE
to NE
induce NE
nuclear Other_B
translocation Other_E
of NE
the NE
DNA-binding Protein_family_or_group_B
heterodimer Protein_family_or_group_E
NF-kappa Protein_molecule_B
B Protein_molecule_E
( NE
p50/p65 Protein_molecule
) NE
, NE
which NE
binds NE
to NE
a NE
specific NE
sequence NE
in NE
the NE
HIV-long DNA_domain_or_region_B
terminal DNA_domain_or_region_M
repeat DNA_domain_or_region_E
. NE

The NE
present NE
study NE
demonstrates NE
that NE
triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
CR1 Protein_molecule
( NE
CD35 Protein_molecule
) NE
and NE
CR3 Protein_molecule
( NE
CD11b/CD18 Protein_molecule
) NE
enhances NE
viral Other_B
replication Other_E
in NE
HIV NE
-infected NE
human NE
monocytic NE
cells NE
. NE

Monocytic Cell_cultured_B
cell Cell_cultured_M
lines Cell_cultured_E
and NE
normal NE
peripheral NE
blood NE
monocytes NE
were NE
infected NE
with NE
HIV-1 Virus
in NE
vitro NE
and NE
cultured NE
in NE
the NE
presence NE
or NE
absence NE
of NE
F(ab')2 Protein_molecule_B
fragments Protein_molecule_E
of NE
monoclonal NE
anti- NE
CR1 NE
or NE
anti- NE
CR3 NE
Abs NE
or NE
with NE
C3 NE
fragments NE
. NE

Stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
induces NE
a NE
two- NE
to NE
fourfold NE
increase NE
in NE
the NE
amount NE
of NE
cell-associated NE
and NE
released NE
p24 Protein_molecule_B
Ag Protein_molecule_E
in NE
cell Cell_cultured_B
cultures Cell_cultured_E
that NE
was NE
equivalent NE
to NE
that NE
observed NE
in NE
control Cell_cultured_B
cultures Cell_cultured_E
triggered NE
with NE
LPS Lipid
. NE

We NE
further NE
observed NE
that NE
stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
induces NE
the NE
nuclear Other_B
translocation Other_E
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
in NE
infected Cell_natural_B
cells Cell_natural_E
. NE

Translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
was NE
also NE
observed NE
following NE
stimulation NE
of NE
CR1 Protein_molecule
or NE
CR3 Protein_molecule
of NE
uninfected NE
peripheral NE
blood NE
monocytes NE
from NE
HIV-seronegative NE
donors NE
. NE

The NE
amount NE
of NE
protein NE
translocated NE
was NE
similar NE
to NE
that NE
observed NE
when NE
cells NE
were NE
stimulated NE
with NE
rhTNF-alpha Protein_molecule
. NE

TNF-alpha Protein_molecule
did NE
not NE
mediate NE
the NE
translocation NE
of NE
NF-kappa Protein_molecule_B
B Protein_molecule_E
p50/p65 Protein_molecule
induced NE
by NE
triggering NE
of NE
complement Protein_family_or_group_B
receptors Protein_family_or_group_E
. NE

Taken NE
together NE
, NE
these NE
observations NE
suggest NE
that NE
HIV Other_B
gene Other_M
expression Other_E
may NE
be NE
activated NE
in NE
infected Cell_natural_B
monocytes Cell_natural_E
through NE
interaction NE
of NE
the NE
cells NE
with NE
complement-opsonized Protein_family_or_group_B
particles Protein_family_or_group_E
and NE
that NE
enhanced NE
viral Other_B
replication Other_E
is NE
associated NE
with NE
C3 Protein_family_or_group_B
receptor Protein_family_or_group_E
-mediated NE
nuclear Other_B
translocation Other_E
of NE
the NE
NF-kappa Protein_complex_B
B Protein_complex_M
complex Protein_complex_E
. NE

Genes NE
encoding NE
general Protein_family_or_group_B
initiation Protein_family_or_group_M
factors Protein_family_or_group_E
for NE
RNA Protein_molecule_B
polymerase Protein_molecule_M
II Protein_molecule_E
transcription NE
are NE
dispersed NE
in NE
the NE
human DNA_family_or_group_B
genome DNA_family_or_group_E
. NE

General Protein_family_or_group_B
transcription Protein_family_or_group_M
factors Protein_family_or_group_E
are NE
required NE
for NE
accurate NE
initiation NE
of NE
transcription NE
by NE
RNA NE
polymerase NE
II NE
. NE

Human DNA_family_or_group_B
cDNAs DNA_family_or_group_E
encoding NE
subunits NE
of NE
these NE
factors NE
have NE
been NE
cloned NE
and NE
sequenced NE
. NE

Using NE
fluorescence Other_B
in Other_M
situ Other_M
hybridization Other_E
( NE
FISH Other
) NE
, NE
we NE
show NE
here NE
that NE
the NE
genes DNA_family_or_group
encoding NE
the NE
TATA-box Protein_family_or_group_B
binding Protein_family_or_group_M
protein Protein_family_or_group_E
( NE
TBP Protein_family_or_group
) NE
, NE
TFIIB Protein_molecule
, NE
TFIIE Protein_molecule_B
alpha Protein_molecule_E
, NE
TFIIE Protein_molecule_B
beta Protein_molecule_E
, NE
RAP30 Protein_molecule
, NE
RAP74 Protein_molecule
and NE
the NE
62 Protein_molecule_B
kDa Protein_molecule_M
subunit Protein_molecule_E
, NE
of NE
TFIIH Protein_molecule
are NE
located NE
at NE
the NE
human NE
chromosomal NE
bands NE
6q26-27 NE
, NE
1p21-22 NE
, NE
3q21-24 NE
, NE
8p12 NE
, NE
13q14 NE
, NE
19p13.3 NE
and NE
11p14-15.1 NE
, NE
respectively NE
. NE

This NE
dispersed NE
localization NE
of NE
a NE
group NE
of NE
functionally NE
related NE
gene NE
provides NE
insights NE
into NE
the NE
molecular Other_B
mechanism Other_E
of NE
human Other_B
genome Other_M
evolution Other_E
and NE
their NE
possible NE
involvement NE
in NE
human NE
diseases NE
. NE

Cell Cell_natural_B
type Cell_natural_M
specificity Cell_natural_E
and NE
activation NE
requirements NE
for NE
NFAT-1 Protein_molecule
( NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_E
of NE
activated Cell_natural_B
T-cells Cell_natural_E
) NE
transcriptional NE
activity NE
determined NE
by NE
a NE
new NE
method NE
using NE
transgenic Multicellular_organism_genetically_modified_B
mice Multicellular_organism_genetically_modified_E
to NE
assay NE
transcriptional Other_B
activity Other_E
of NE
an NE
individual NE
nuclear Protein_family_or_group_B
factor Protein_family_or_group_E
. NE

Nuclear Protein_family_or_group_B
factor Protein_family_or_group_E
of NE
activated Cell_natural_B
T-cells Cell_natural_E
( NE
NFAT-1 Protein_molecule
) NE
is NE
a NE
transcription Protein_family_or_group_B
factor Protein_family_or_group_E
which NE
is NE
considered NE
to NE
be NE
an NE
important NE
regulator NE
in NE
early NE
T-cell Other_B
activation Other_E
. NE

We NE
have NE
developed NE
a NE
system NE
to NE
monitor NE
the NE
transcriptional Other_B
activity Other_E
of NE
NFAT-1 Protein_molecule
at NE
the NE
single Cell_natural_B
cell Cell_natural_M
level Cell_natural_E
in NE
whole Multicellular_organism_natural_B
animals Multicellular_organism_natural_E
. NE

The NE
system NE
is NE
based NE
on NE
the NE
use NE
of NE
an NE
oligomerized Polynucleotide_B
NFAT-1 Polynucleotide_M
binding Polynucleotide_M
motif Polynucleotide_E
that NE
directs NE
transcription NE
of NE
SV40 NE
T-antigen NE
in NE
transgenic NE
mice NE
. NE

This NE
report NE
represents NE
the NE
first NE
demonstration NE
that NE
a NE
multimerized Polynucleotide_B
short Polynucleotide_M
binding Polynucleotide_M
motif Polynucleotide_E
can NE
function NE
appropriately NE
in NE
transgenic Multicellular_organism_genetically_modified_B
mice Multicellular_organism_genetically_modified_E
. NE

NFAT-1 Protein_molecule
activity NE
had NE
previously NE
been NE
thought NE
to NE
be NE
confined NE
to NE
activated Cell_natural_B
T-lymphocytes Cell_natural_E
upon NE
release NE
of NE
intracellular NE
calcium NE
. NE

By NE
targeting NE
NFAT-1 Protein_molecule
-dependent NE
gene NE
expression NE
in NE
transgenic Multicellular_organism_genetically_modified_B
mice Multicellular_organism_genetically_modified_E
we NE
discovered NE
new NE
sites NE
of NE
NFAT-1 Other_B
activity Other_E
. NE

Besides NE
in NE
T-lymphocytes Cell_natural
NFAT-1 Other_B
activity Other_E
could NE
also NE
be NE
induced NE
in NE
T-lymphocyte NE
-depleted NE
spleen NE
cells NE
and NE
purified NE
B-lymphocytes NE
and NE
requires NE
agents NE
that NE
both NE
release NE
intracellular NE
calcium NE
and NE
activate NE
protein NE
kinase NE
C NE
. NE

A NE
difference NE
in NE
the NE
time NE
course NE
of NE
appearance NE
of NE
NFAT-1 Other_B
activity Other_E
between NE
T-lymphocytes NE
and NE
non-T-lymphocytes NE
was NE
revealed NE
. NE

Constitutive Other_B
expression Other_E
was NE
observed NE
in NE
a NE
small NE
population NE
of NE
cells NE
in NE
the NE
dermis Tissue_natural
and NE
some NE
mice NE
have NE
developed NE
skin Tissue_natural_B
lesions Tissue_natural_E
. NE

Interestingly NE
, NE
the NE
tissue NE
pattern NE
of NE
expression NE
of NE
the NE
NFAT-1 Protein_molecule
activity NE
resembles NE
the NE
expression NE
pattern NE
described NE
for NE
HIV-LTR/tat Multicellular_organism_natural_B
transgenic Multicellular_organism_natural_M
mice Multicellular_organism_natural_E
(Vogel NE
, NE
J. NE
, NE
Hinrichs NE
, NE
S NE
. NE
H. NE
, NE
Reynolds NE
, NE
R NE
. NE
K. NE
, NE
Luciw NE
, NE
P NE
. NE
A. NE
, NE
and NE
Jay NE
, NE
G NE
. NE
(1988) NE
Nature NE
335 NE
, NE
606-611) NE
. NE

This NE
similarity NE
in NE
expression NE
and NE
the NE
fact NE
that NE
NFAT-1 Protein_molecule
has NE
been NE
shown NE
to NE
bind NE
functional NE
sequences NE
in NE
HIV-LTR NE
suggest NE
a NE
role NE
for NE
NFAT-1 Protein_molecule
in NE
dermal Other_B
activation Other_E
of NE
the NE
HIV-LTR DNA_domain_or_region
. NE

Human Other_B
MHC Other_M
class Other_M
II Other_M
gene Other_M
transcription Other_E
directed NE
by NE
the NE
carboxyl NE
terminus NE
of NE
CIITA NE
, NE
one NE
of NE
the NE
defective NE
genes NE
in NE
type NE
II NE
MHC NE
combined NE
immune NE
deficiency NE
. NE

Type Other_B
II Other_M
major Other_M
histocompatibility Other_M
complex Other_M
combined Other_M
immune Other_M
deficiency Other_E
( NE
type NE
II NE
MHC NE
CID NE
or NE
bare NE
lymphocyte NE
syndrome NE
) NE
is NE
a NE
congenital NE
immunodeficiency NE
disease NE
characterized NE
by NE
absent NE
MHC NE
class NE
II NE
expression NE
. NE

Four NE
distinct NE
complementation NE
groups NE
have NE
been NE
identified NE
. NE

Recently NE
, NE
the NE
defective DNA_family_or_group_B
gene DNA_family_or_group_E
in NE
group Other_B
II Other_M
type Other_M
II Other_M
MHC Other_M
CID Other_E
has NE
been NE
isolated NE
and NE
termed NE
CIITA NE
. NE

Here NE
, NE
we NE
demonstrate NE
that NE
CIITA DNA_domain_or_region
is NE
an NE
MHC DNA_family_or_group_B
class DNA_family_or_group_M
II DNA_family_or_group_M
gene-specific DNA_family_or_group_M
transcription DNA_family_or_group_M
activator DNA_family_or_group_E
. NE

The NE
transcription Other_B
activation Other_M
function Other_E
is NE
provided NE
by NE
the NE
N-terminal Protein_domain_or_region_B
acidic Protein_domain_or_region_M
domain Protein_domain_or_region_E
( NE
amino Protein_domain_or_region_B
acids Protein_domain_or_region_M
26-137 Protein_domain_or_region_E
) NE
, NE
which NE
is NE
experimentally NE
exchangeable NE
with NE
a NE
heterologous Protein_domain_or_region_B
viral Protein_domain_or_region_M
transcription-activating Protein_domain_or_region_M
domain Protein_domain_or_region_E
. NE

The NE
specificity NE
of NE
CIITA Protein_molecule
for NE
three NE
major NE
MHC DNA_domain_or_region_B
class DNA_domain_or_region_M
II DNA_domain_or_region_M
genes DNA_domain_or_region_E
, NE
DR NE
, NE
DQ NE
and NE
DP NE
, NE
is NE
mediated NE
by NE
its NE
remaining NE
C-terminal NE
residues NE
( NE
amino NE
acids NE
317-1130 NE
) NE
. NE

The NE
transactivation NE
of NE
multiple DNA_domain_or_region_B
cis DNA_domain_or_region_M
elements DNA_domain_or_region_E
, NE
especially NE
S DNA_domain_or_region
and NE
X2 DNA_domain_or_region
, NE
of NE
the NE
DR DNA_domain_or_region_B
alpha DNA_domain_or_region_M
proximal DNA_domain_or_region_M
promoter DNA_domain_or_region_E
in NE
group NE
II NE
CID NE
cells NE
is NE
CIITA NE
dependent NE
. NE

Since NE
CIITA Other_B
overexpression Other_E
in NE
normal NE
cells NE
did NE
not NE
increase NE
class NE
II NE
expression NE
, NE
we NE
propose NE
that NE
initiation NE
of NE
CIITA NE
expression NE
serves NE
as NE
the NE
on-off NE
switch NE
, NE
while NE
availability NE
of NE
downstream NE
interactor NE
(s) NE
limits NE
transcription NE
. NE

